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Summary
Bread wheat (Triticum aestivum) is an allohexaploid plant, with a genome size 
ve times bigger than the human genome. It is worldwide the third staple crop, 
aer maize and rice, grown in many parts of the world. Wheat grains contain 
gluten, a polymer of glutenin and gliadin proteins, which build a network that 
gives wheat dough its unique properties and quality. ey are encoded by a total 
of ve large gene families. Gluten proteins harbour immunogenic epitopes which 
can trigger Coeliac Disease (CD), an auto-immune reaction, to which 1-2% of the 
world population are sensitive, as described in the General Introduction. A gluten-
free diet, excluding wheat, barley and rye, is the only remedy. is diet is dicult 
to adhere to, partly because wheat gluten is added to many processed products for 
their viscoelastic properties. In addition, gluten-free products typically require the 
inclusion of numerous additives, resulting in products that are oen less healthy 
than gluten-based equivalents, and more expensive. ere is therefore a need to 
develop alternative methods in order to provide Coeliac patients with healthier 
food products, yet safe for them to consume. 
Various strategies can be deployed towards the development of food products 
containing gluten that would be hypoimmunogenic for Coeliac patients. Chapter 
1 gives an overview of the food processing and plant breeding strategies to create 
coeliac-safe and healthy wheat products. We found that several candidate food 
processing techniques exist that aim to remove or modify gliadins or all gluten, 
to produce low-gluten food products from wheat. In parallel, wheat breeding 
strategies are starting to be developed, to remove immunogenic epitopes from 
the gluten proteins in new varieties, or to remove complete gluten gene families 
altogether, whilst maintaining the food-processing properties. is chapter 
highlights the fact that all the existing solutions have limitations. Hence, solutions 
decreasing gluten immunogenicity from food processing and plant breeding 
should be combined in order to have the safest wheat product possible for CD 
patients. 
Among the existing plant breeding strategies to reduce wheat gluten 
immunogenicity, gene editing, a targeted mutagenesis approach, is a very 
encouraging new approach. It makes it possible to precisely remove gliadin 
genes or modifying the CD epitopes. It constitutes the core of the present PhD 
18060-Aurelie_Jouanin_PM.indd   8 02-01-19   12:18
SSummary
9
thesis. In Chapter 2, I describe the generation of lines of hexaploid bread wheat 
cultivar Fielder stably transformed with CRISPR/Cas9 constructs containing 
up to six multiplex sgRNA targeting α-gliadin genes, γ-gliadin genes or both 
simultaneously. ese sgRNAs guide the Cas9 protein to several positions within 
these genes to induce double-strand breaks in the DNA. Plants regenerated may 
have mutations at these positions due to incorrect repair, which may knockout 
gene expression. Indeed, the resulting grains displayed altered gliadin protein 
proles on Acid-PAGE, including absence of certain gliadin proteins, and in some 
of these lines the changes were similar to what was observed in Paragon mutant 
lines – obtained using γ-irradiation, which is a random mutagenesis approach.
e gliadin protein mutations observed in the wheat grains of γ-irradiated and 
gene-edited mutant wheat lines were then quantitatively studied at the genomics 
level. Chapter 3 describes the development of a duplex droplet digital PCR 
(ddPCR) assay to simultaneously assess the copy number of a reference gene 
and that of the α-gliadin genes. e results enable calculating the copy number 
of the gliadins, and quantication of gene editing-induced deletions of α-gliadin 
genes. e duplex ddPCR was validated using Paragon γ-irradiated lines which 
showed a reduction of over 1/3 of the α-gliadin gene copies. e comparison of 
two dierent duplex ddPCR assays made it feasible to distinguish small indels 
from larger deletions with a single Fielder-CRISPR line containing small indels 
(1-50bp) in up to 10 α-gliadin genes and large deletions (>300bp) in 20 α-gliadin 
genes out of the 87 α-gliadin genes present in Fielder.
e gliadin gene mutations induced by γ-irradiation and gene editing were 
also studied qualitatively. Chapter 4 presents GlutEnSeq as a qualitative method 
to reduce the complexity of the wheat genome and enables analysing genomic 
variation of gluten genes in hexaploid wheat by sequencing. is chapter describes 
the development of an in-solution gluten gene exome capture for enrichment and 
sequencing, and the analysis of the resulting sequencing data, against the bread 
wheat reference genome. Mutations and deletions of complete genes are visible as 
dierences in the gluten coverage proles between mutant plants and the original 
cultivar. Paragon γ-irradiated mutant lines were homozygous for deletions of 
complete gluten-containing loci on chromosome 1 or 6. Fielder-CRISPR mutant 
lines also showed loss, either in homozygous or heterozygous form, of all α-gliadin 
genes at locus Gli-2 on chromosome 6A or γ-gliadin genes at the Gli-1 locus on 
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1B. GlutEnSeq thus enables zooming in on where deletions have taken place. 
For characterizing the mutations in the DNA within gliadin genes, further data 
analysis will be necessary.
Aside from being a cutting-edge technology, the regulation of gene editing as 
GM (Genetic Modication) in Europe is currently a hot topic. Chapter 5 shows 
the inconsistency of the European regulation, by displaying the similarities 
of mutations in gliadin genes that are obtained using random γ-irradiation 
mutagenesis and those obtained by targeted mutagenesis using gene editing, the 
former being exempted from GM regulation while the latter being subjected 
to GM regulation. is chapter covers the topics of risks and safety, public 
acceptance, distinguishability and labelling, and potential politico-economic 
issues, related to the regulation of gene-edited plants as GM product in Europe, in 
contrast to other countries, following the ruling of the European Court of Justice 
in July 2018. It also advises the European Commission to review its position on 
the matter and to regulate gene editing based on scientic evidence regarding the 
generated products, and on the innovation principle as part of responsible research 
innovation initiatives. 
Finally, a General Discussion elaborates on the necessity of developing 
hypoimmunogenic wheat using plant breeding. e relative level of success that 
is obtained with CRISPR/Cas9 gene editing for developing wheat lines with lower 
gliadin immunogenic epitopes is discussed. Some recently developed CRISPR 
approaches are presented that may result in faster development of wheat with 
hypoimmunogenic gluten, or simplify screening during the process. e relevance 
of high-throughput screening methods and their adaptation is discussed. e 
benets and potential risks related to gene-edited wheat with hypoimmunogenic 
gluten are described. e requirement for producing and processing these varieties 
are touched upon.  Lastly, the development of methods to test for “safe-gluten” food 
products made of hypoimmunogenic gluten is addressed, since current “gluten-
free” tests will not be relevant in this case. To conclude, we indicate that although 
the rst step towards the development of wheat varieties with hypoimmunogenic 
gluten was promising, few more years will be necessary before commercially 
releasing wheat varieties with gluten safe for all CD patients.
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Wheat and gluten
From diploid grass to polyploid commercial wheat
Triticum aestivum, commonly known as bread wheat, is an allohexaploid 
autogamous monocot plant domesticated more than 10,000 years ago in the Fertile 
Crescent (Eckardt, 2010). Initially, Triticum derived from a diploid grass ancestor 
(2n=14) of which the genome evolved separately into various diploid genomes 
(A, S/B and D genome Gramineae). Around 0.5 million years ago (Huang et al., 
2002), a natural allopolyploidisation occurred between Triticum urartu (AA) and 
Aegilops speltoides (BB or SS), resulting in tetraploid emmer wheat, T. turgidum 
spp. dicoccoides (AABB, 4n=28). During cultivation of emmer, T. turgidum 
(AABB) underwent a spontaneous allopolyploidisation with Aegilops tauschii 
(DD) resulting in the hexaploid wheat species, Triticum aestivum (AABBDD, 6n 
=42), 10,000 years ago (Gupta et al., 2008) (Fig. 1). Due to their polyploidy, T. 
turgidum and T. aestivum are more vigorous and provide bigger grains. Since its 
domestication, lots of selection has been done on wheat. e focus has been on 
improving wheat grain yield and on quality for food products. 
Wheat gluten specicity
Cereal kernels and derived ours or extracts form the basis of a large range of 
staple foods (bread, pasta, semolina, etc.) and other products (alcoholic beverages, 
food additives) worldwide, using the protein and/or starch from the grains. Wheat 
endosperm contains water-soluble proteins (globulins) and water-insoluble 
proteins (prolamins or glutelins). Gluten is a polymer of two major protein groups, 
the glutelins and the prolamins that are grain storage proteins. 
For food processing, polymeric wheat glutelins, composed of High and Low 
Molecular Weight Glutenin Subunits (HMW-GS and LMH-GS), form a strong 
Glutenin Macro Polymer (GMP) network that provides elastic properties, 
which determine dough quality. ese glutenins are combined with monomeric 
wheat prolamins called α-, γ- and ω-gliadins that bring viscosity, which has a 
lesser impact on dough quality. e type of HMW-GS glutenins and the ratio of 
glutenins to gliadins determines dough viscoelastic superiority required for bread 
making or other products (Weegels et al., 1996). 
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Figure 1. e origins of hexaploid bread wheat.
Bread wheat is allohexaploid and originates from two events of natural hybridisations. e rst natural 
hybridisation occurred between two wild diploid Gramineae species, Triticum urartu (AA) and Aegilops 
speltoides (BB), up to 0.5 million years ago. e resulting tetraploid Triticum turgidum (AABB) was 
cultivated by farmers when a second natural hybridisation occurred with the wild diploid species Aegilops 
tauschii (DD) about 8-10,000 years ago, resulting in the hexaploid Triticum aestivum (AABBDD), cultivated 
as bread wheat. is Figure has been adapted from http://www.cerealsdb.uk.net/cerealgenomics/WheatBP/
Documents/DOC_Evolution.php.
Hexaploid T. aestivum (bread wheat) generates better bread dough quality than 
tetraploid T. Turgidum spp. durum (durum or pasta wheat), due to specic types of 
HMW-GS glutenins that improve bread baking properties and which are located 
on the D genome in T. aestivum (Payne et al., 1984). However, this D genome also 
codes for gliadin proteins with peptides (epitopes) that are highly immunogenic 
(van Herpen et al., 2006; Salentijn et al., 2012) for some human individuals.
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Gluten from other cereals
Barley (Hordeum vulgare), rye (Secale cereale) and oat (Avena sativa) grains 
contain gluten as well. However, their gluten do not contain polymeric glutelins 
and therefore lack the strong GMP network essential for high dough quality. 
is factor strongly limits their bread-baking potential. Gluten of these cereals 
mainly consists of monomeric prolamins called hordeins, secalins and avenins, 
respectively. Hordeins and secalins also contain immunogenic epitopes while 
avenins have been shown to contain non-immunogenic epitopes, making them 
safer for consumption (Londono et al., 2013; Smulders et al., 2018), consistent 
with the results on long-term cohort studies of CD patients regularly eating oats, 
amongst others in Nordic countries (Aaltonen et al., 2017).
Gliadin immunogenicity and Coeliac Disease
Despite its prevalence in most diets, the ingestion of wheat gluten turns out 
to be unsafe for one to two percent of the world population (Mäki et al., 2003; 
Rewers, 2005; Catassi et al., 2014; Vriezinga et al., 2015), due to the presence 
of immunogenic gluten epitopes that can trigger an enterogastric autoimmune 
reaction called Coeliac disease (CD) (Fig. 2). e autoimmune response and 
associated CD symptoms occur only in the presence of four elements: 
1- Ingestion of gluten containing certain immunogenic epitopes 
(determined by wheat plant genetics)
2- Migration of large gluten fragments in the lamina propria 
(determined by human intestine condition)
3- Presence of specic HLA-DQ receptors (DQ2, DQ8) subunits on 
antigen-presenting cells (APC) (determined by human genetics) 
4- Presence of specic T-cells receptors subunits (determined by 
human immune history or sensitisation)
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Gluten ingestion and immunogenic epitopes
CD is triggered by the ingestion of gluten from wheat, barley or rye. Gluten 
proteins, especially gliadins, are glutamine- (Q) and proline- (P) rich, which make 
them recalcitrant to hydrolysis by gastro-intestinal luminal and brush-border 
proteases and peptidases (Qiao et al., 2009). is impedes their complete digestion 
into small three amino-acids peptides (Hausch et al., 2002), necessary for active 
transport into the bloodstream as nutrients. e 9-mer to 33-mer gliadin epitopes 
are too large and should be directed to the rectum for excretions. 
Gliadin epitopes migration into lamina propria and innate immune 
response
In instances of lower permeability of the small intestine (e.g. due to infections 
or due to the presence of zonulin potentially stimulated by gluten itself), large 
peptides may pass the epithelium, enter the intestinal lamina propria (the sub-
epithelial area containing blood vessels) and trigger an innate immune response 
(Fig. 2). e enterocytes release interleukins IL-15 which stimulate intra-epithelial 
lymphocytes to migrate in-between enterocytes. is triggers the release of tissue 
TransGlutaminase (tTG), an enzyme synthesised by the damaged enterocytes. ese 
tTGs will alter the gluten peptides by deaminating glutamines (Q) into negatively 
charged glutamic acid (E), thus creating more eciently binding epitopes. 
Genetic predisposition 
Humans have, in their immune system, Antigen Presenting Cells (APC). ese 
cells harbour on their surface receptors called Human Leucocyte Antigen (HLA), 
whose role is to bind antigens and present them to T cells. ey bind 9-amino 
acid peptides. HLA-DQ proteins are a combination of various β- and α- subunits 
forming dimers, creating receptors. e nature of the β (2 or 8) and α (2 or 5) 
subunits are human-allele dependent. Humans carrying the gene combination 
DQ 2.5 (β chain gene allele 2, α chain gene allele 5), will have APC receptors 
HLA-DQ2.5, which can bind gliadin epitopes and present them as antigens to 
the T cells. A person being heterozygous for both β (2 or 8) and α (2 or 5) allele 
can develop APC with HLA-DQ2.5, HLA-DQ2.2, HLA-DQ8.5 and HLA-DQ8.2, 
recognising most epitopes. ese persons are genetically predisposed to CD, 
but do not systematically develop it. In fact, only around 5% of all HLA-DQ2.5 
homozygote people develop CD, while heterozygote people have an even lower 
chance (Koning, personal communication).
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HLA-DQ binding gliadin epitopes
Depending on their sequences, the 9-mer gliadin epitopes may interact with the 
groove of these HLA receptors. Negative charges are necessary, which are not 
common in gliadin proteins. However, tTG deamination of glutamines (Q) into 
negatively charged glutamic acid (E) at positions P4 and P6 of specic 9-mer 
gliadin epitope motifs ensures strong binding to the groove of the HLA-DQ2.5 
receptor subunits (Molberg et al., 1998; van de Wal et al., 1998). In addition, the 
identity of the amino acids at P1, P7 and P9 inuences the binding potential of 
the epitope (Vartdal et al., 1996). A strong gliadin epitope-HLA-DQ complex 
increases the chance of the APC to successfully present the gliadin epitope as an 
antigen to the T Cell (Fig. 2). Consequently, a single amino acid change can make 
the dierence between strong binding and no binding (Koning, 2005).
Specic T cell synthesis against gliadin epitopes: sensitisation
Helper T cells harbour antigen receptors on their surface. If these receptors bind 
the peptide being presented to them as antigens by the HLA receptor on the APC 
it is a conrmation for the immune system that the peptide held is an antigen. 
ese Helper T cells will then trigger an immune response to get rid of these 
antigens (Fig. 2). is binding event depends on the combination of the subunits 
constituting the Helper T cell receptor and their anity with the gliadin epitope 
(Petersen et al., 2014). 
Adaptive and autoimmune response mechanisms
For individuals carrying Helper T cells with receptors that bind the gliadin epitope 
presented as an antigen by the APC’s HLA-DQ receptors, a chain of adaptive 
immune responses starts in the small intestine (Petersen et al., 2014; Fasano, 2009), 
initiating CD. Helper T cells will secrete cytokines that activate B cells. B cells 
will produce specic antibodies against gliadin epitopes but also, following “the 
guilty by association” rule, against tTG deaminating gliadin epitopes. In addition, 
Helper T cells will stimulate the development of Killer T cells directed against 
enterocytes - which are synthesising the tTG- and will release pro-inammatory 
cytokines and chemokines causing atrophy of microvilli (reviewed in Fasano, 
2009) (Fig. 2). e targeting of the individual’s tTG, enterocytes and microvilli by 
its own immune system constitutes the starting point of the autoimmune reaction. 
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Figure 2. Coeliac Disease mechanism: from gluten protein ingestion to autoimmune reaction. 
1) Individual with a leaky gut, where epithelial cells’ tight junctions are disrupted. 2) Undigested gluten 
peptides enter the lamina propria and trigger a rst immune response. 3) e enterocytes release IL-15 that 
stimulates intra-epithelial cells to localise in-between enterocytes, damaging them. 4) Damaged enterocytes 
release tissue transglutaminase (tTG) that deaminates the gluten peptides. ese deaminated gluten peptides 
may bind to specic HLA-DQ2 or -DQ8 receptors potentially present on the surface of antigen presenting 
cells (APC). 5) If it is the case, APC display the gluten peptide recognised as an antigen to the Helper T 
cells. 6) If the Helper T cells carry receptors that also bind the gluten epitope, they secrete pro-inammatory 
cytokines. 7) e cytokines also trigger the dierentiation of B cells releasing antibodies against the gluten 
peptides but also against the tTG that deaminated the gluten peptides. 8) In addition, following the “guilty 
by association principle”, these cytokines trigger the dierentiation of Killer T cells, which directly attack the 
enterocytes that generated the tTG. is constitutes the starting point of the CD autoimmune reaction. is 
Figure has been adapted from Fasano et al. (2009).
Coeliac Disease symptoms
e rst symptoms of CD are abdominal pain related to the inammation caused 
by autoimmune reaction, the enterocyte degradations and the microvilli atrophy. 
is is gradually degrading the epithelium, causing a loss of its “protective barrier” 
function. e atrophy of microvilli brush (a border membrane of epithelial cells) 
decreases the nutrients absorption surface between the small intestine and the 
blood stream, leading to malnutrition and all sorts of indirectly related symptoms 
such as fatigue, diarrhoea, weight loss. 
e anti-tTG antibodies will travel in the body via the bloodstream and degrade 
tTG everywhere they are present. is is going do have a general negative impact 
on the body functioning since tTG enzymes are involved in many processes such 
as wound healing and more (Upchurch et al., 1991). Other major CD symptoms 
are headache, dermatitis herpetiformis and eventually death in extreme cases 
(Zipser et al., 2003; Reunala, 1998). 
18060-Aurelie_Jouanin_PM.indd   21 02-01-19   12:18
General Introduction
22
Gluten-free diet to prevent Coeliac Disease
Up until now, no medical treatment is known. e only remedy for CD is a 
free-gluten (GF) diet, which allows the small intestine to recover, abolishing 
the symptoms. However, in daily life, a gluten-free diet is dicult to follow 
considering the presence of wheat, barley or rye derivatives in a large range of 
processed food products, oen as a “hidden ingredient”, not labelled. In addition, 
the use of ours from other crops as substitute in GF products means that they 
lack the nutritional value of wheat and the viscoelastic properties of wheat gluten, 
which is necessary for good bread dough quality. To compensate for the lack of 
nutrients and baking quality and to improve taste and texture of these gluten-free 
products, many additives are used (Caponio et al., 2008; Capriles and Arêas, 2014; 
Belz, 2016; Horstmann et al., 2016). GF product are therefore less healthy when 
consumed on a regular basis. Alternative durable solutions are therefore needed 
to prevent CD.
erefore, breeding for wheat varieties that are free of immunogenic epitopes or 
contain a reduced amount of them, is a potential solution for healthier products 
safe to consume by CD patients (Jouanin et al., 2018; Ribeiro et al., 2018).
Complex gliadin gene families and epitope diversity 
Gliadin proteins consist of three large gene families: α/β-, γ-, and ω-gliadins (Shewry 
et al., 2003). Gliadin genes do not contain introns but do include high numbers of 
pseudogenes (90% in case of α-gliadins (van Herpen et al., 2006)). e number of 
gluten genes present in each family is variable between dierent wheat varieties. 
For each gliadin family, genes are clustered together as repetitive sequences in 
characterised loci. In hexaploid wheat, a total of 60-150 α-gliadin gene copies is 
estimated (Anderson et al., 1997; Ozuna et al., 2015), divided over the six Gli-2 
loci, each being located on the short arm of one of the six chromosomes 6 (pair of 
chromosome 6AS, 6BS and 6DS) (Fig. 3). Similarly, the short arm of chromosomes 
1 (1AS, 1BS and 1DS) contains the Gli-1 loci with around 39 γ-gliadins (Sabelli 
and Shewry, 1991; Salentijn et al., 2012) and the Gli-3 locus, with approximately 16 
ω-gliadins copies (Sabelli and Shewry, 1991), in the hexaploid genome. e Gli-1 
and Gli-3 loci are close to each other and overlap. ey also overlap with Glu-3 loci 
that contain 35 copies of LMW-glutenins, which carry few immunogenic epitopes 
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(Sabelli and Shewry, 1991). e 20 HMW-glutenin genes, however, are present at 
Glu-1 loci on the long arm of chromosome 1 (AL, 1BL and 1DL) and do not carry 
known immunologic epitopes (Forde, 1985).
Figure 3. e complex genetics of bread wheat represented by the situation of α-gliadins at the Gli-2 loci on 
the homoeologous chromosomes 6.
Bread wheat (2n=6x=42) is hexaploid containing three genomes A, B and D, each carrying seven 
chromosome pairs. On the short arms of the chromosomes 6 are located the Gli-2 loci, where α-gliadin 
genes are clustered. e α-gliadin genes present in one Gli-2 locus dier in length and sequences. e Gli-
2 loci from genome A, B and D contain dierent numbers of α-gliadin genes and some α-gliadin gene 
sequences are genome-specic. Similar situations occur for the four other gluten gene families. 
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Each gene of a gene family is composed of relatively conserved motifs, repeat 
motifs, and variable motifs. e epitopes reside in the repetitive regions. Not 
all gene copies from a gene family are similar: Some carry specic variations, 
deletions or repetition of some motifs within the epitope sequences. erefore, 
in one gliadin gene family of one common wheat plant, gene copies encode for 
gliadin proteins carrying dierent numbers of epitopes, with some being more 
immunogenic than others. Not all genes are expressed. e large gene families 
also contain pseudogenes, estimated up to 90% for α–gliadins (van Herpen et al., 
2006), which have early stop codons. A feature of gliadin genes is the absence 
of introns, enabling protein epitope prediction directly from genomic DNA 
sequences rather than from messenger RNA. Interestingly, it has been shown that 
reduction or increase of expression in one family usually leads to compensation 
by other families (Galili et al., 1986; Pistόn et al., 2011). α-gliadins are the most 
immunogenic types of gliadin, followed by γ-gliadins and ω-gliadins. In this 
thesis, I focussed on reducing α-gliadins and γ-gliadins as proof of concept.
Gliadin epitopes, immunogenicity and homoeologous genomes
α-gliadins
α-gliadin proteins are up to 320 amino acids long. One can distinguish six domains: 
signal peptide, repetitive domain, polyQ repeat domain 1, unique domain 1, polyQ 
repeat domain 2 and unique domain 2 (Fig. 4). e innate epitope and four other 
overlapping DQ2.5 CD epitopes can be present in the repetitive region while the 
DQ8.x epitope can be found in the unique domain 2. Several transcriptomics, 
proteomics and immunology studies revealed dierences in gliadins encoded on 
short arm of dierent homoeologous chromosomes 6. 
e rst one to be encountered in the protein, p31-49 innate epitope 
(PGQQQPFPPQQPYPQPQPF), located at the beginning of the repetitive 
domain, triggers mainly an innate immune response. It is present in genes from 
chromosome 6DS, although variants are found in 6AS and 6BS. 
Downstream, also within the repetitive domain, another epitope domain is located 
where one to six overlapping epitopes can be identied. e common α-gliadin 
epitopes recognised by HLA-DQ2.5 (Sollid et al., 2012) (Fig. 4) are as following: 
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· DQ2.5-glia-α1a: PFPQPQLPY, on chromosome 6DS (variants on 
6AS)
· DQ2.5-glia-α1b: PYPQPQLPY, on chromosome 6DS
· DQ2.5-glia-α2: PQPQLPYPQ, on chromosome 6DS (variants on 
6AS), is the most common immunogenic α-gliadin epitope
· DQ2.5-glia-α3: FRPQQPYPQ, on chromosome 6AS and 6DS. 
(Bold and underlined glutamine (Q) can be deaminated into a glutamic acid 
(E) by tTG):
Some epitopes can be found as overlapping combinations (Fig.4), in proteolysis-
resistant peptides, increasing their immunogenicity: 
· DQ2.5-glia-α19mer: LQLQPFPQPQLPYPQPQPF,  
2 overlapping epitopes, on chromosome 6DS (or variants on 6AS 
and 6BS),
·  DQ2.5-glia-α26mer: LQLQPFPQPQLPYPQPQLPYPQPQPF,  
4 overlapping epitopes, on chromosome 6DS,
· DQ2.5-glia-α33mer: LQLQPFPQPQLPYPQPQLPYPQPQLPYPQPQPF, 
6 overlapping epitopes, on chromosome 6DS (Molberg et al., 2004).
Within the unique domain 2, another immunogenic epitope is found that is 
recognised by HLA-DQ8.x: DQ8-glia-α1: QGSFQPSQQ (Sollid et al., 2012), 
present in genome D.
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Typically, the expression level and immunogenicity rate of α-gliadins can be 
ordered as D > A > B (van Herpen et al., 2006). e dierences in immunogenicity 
are explained by the sequence variation of genes coming from dierent 
homoeologous chromosomes, coding for dierent amino acids at positions P1, 
P7 and P9 and by dierent possibilities of Q deamination at P4 and P6, inuenced 
by the anking amino acids within the epitope (Brusco et al., 1999; Vartdal et al., 
1996). ese parameters inuence the binding anity of the epitopes to HLA-DQ 
and the T cells.
· e α-gliadin genes from genome D usually code for the highest 
number, most complex combinations and the most immunogenic 
epitopes, with Q’s at positions P4 and P6 that can easily be 
deaminated by tTG (Salentijn et al., 2013).
· e α-gliadin genes from the B genomes code for a variant of the 
26-mer DQ2.5-glia that carry deletions of Lysine (L) at P11 and 
Glutamine (Q) at P15, that aect the four overlapping DQ2.5-
glia-α1a, DQ2.5-glia-α2, DQ2.5-glia-α1b, and 2nd DQ2.5-glia-α2 
epitopes at P7, P5, P9, P4 and P2 respectively. is renders those 
epitopes much less or non-immunogenic (Mitae et al., 2010), both 
individually and combined. 
· e α-gliadin genes from genome A usually code for a variant of the 
19-mer DQ2.5-glia that carry substitution of Proline (P) by Serine 
(S) at P12 that aect the two overlapping DQ2.5-glia-α1a, DQ2.5-
glia-α2 at P8 and P6 respectively, rendering them less immunogenic 
(Mitae et al., 2010) both individually and combined. 
γ-gliadins
γ-gliadin proteins are up to 370 amino acids long. One can distinguish ve 
domains: signal peptide, repetitive domain, unique domain 1, Q repeat domain 
and unique domain 2. e DQ2.5-glia-γ4d and six other overlapping DQ2.5 
epitopes are present in the repetitive region while the DQ2.5-glia-γ2 epitope can 
be found in the unique domain 2. Several studies showed dierences in gliadins 
related to homoeologous genomes. 
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e rst one, DQ2.5-glia-γ4d (PQPQQPFCQ), located at the beginning of the 
repetitive domain is absent from chromosome 1AS. 
Downstream, also within the repetitive domain, another epitope domain is located 
where one to six overlapping epitopes can be identied. e common γ-gliadin 
epitopes recognised by HLA-DQ2.5 are (Sollid et al., 2012):
· DQ2.5-glia-γ1: PQQSFPQQQ, found on 1AS, 1BS and 1DS, is the 
most immunogenic γ-gliadin epitope 
· DQ2.5-glia-γ3: QQPQQPYPQ, probably present only on 
chromosome 1BS
· DQ2.5-glia-γ4a: SQPQQQFPQ, only present in a few pseudogenes 
from chromosome 1DS
· DQ2.5-glia-γ4b: PQPQQQFPQ, probably present only on 
chromosome 1BS
· DQ2.5-glia-γ4c: QQPQQPFPQ, found on 1AS, 1BS and 1DS, most 
common epitope
· DQ2.5-glia-γ5: QQPFPQQPQ, on chromosome 1BS and 1DS, one 
of the most common epitopes, rarely found on chromosome 1AS
Some epitopes can be found as overlapping combinations, proteolysis-resistant, 
increasing their immunogenicity: 
· DQ2.5-glia-γ17mer:  QQPQQPFPQQPQQPFPQ, 
3 overlapping epitopes, on chromosome 1DS
· DQ2.5-glia-γ26mer: FLQPQQPFPQQPQQPYPQQPQQPFPQ,  
3 overlapping epitopes, on chromosome 1DS
Within the unique domain 2, another immunogenic epitope, DQ2.5-glia-γ2: 
IQPQQPAQL, is found except in γ-gliadins on chromosome 6AS. 
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Typically, the expression level and immunogenicity rate of γ-gliadins can be 
ordered as D > A > B (Salentijn et al., 2012), as for α-gliadins (van Herpen et al., 
2006). Salentijn et al. (2012) showed that specic DQ2.5-glia-γ1 epitope variants 
in which Q2 and Q9 are deamidated stimulate the T cell clone while variants in 
which Q8 instead of Q9 is deamidated or the F5 is replaced by S5 do not display 
such activity. us, natural variants of the DQ2-γ-I epitope exist that inuence the 
T-cell stimulatory capacity. ey also showed the eect of anking amino acids on 
glutamine deamination.
Breeding for hypoimmunogenic gluten in wheat
A challenge too complex for conventional breeding
An alternative to gluten-free food for CD patients is to breed for wheat varieties 
that are free of immunogenic epitopes or contain a reduced amount of them, is an 
attractive solution for healthier products safe to consume by CD patients (Jouanin 
et al., 2018; Ribeiro et al., 2018). Breeding wheat without immunogenic epitopes 
(Gilissen et al., 2014) would be a denitive solution for CD patients (Shewry 
and Tatham, 2016). As a rst step, developing “hypoimmunogenic gluten” wheat 
varieties that retain baking quality is already very challenging. Firstly, gluten 
proteins are encoded by ve gene families containing many immunogenic 
epitopes. Within these families, α-gliadins on chromosomes 6 trigger CD 
strongly, followed by γ-gliadins, ω-gliadins and, to a lesser extent, LMW glutenins 
on chromosomes 1. Secondly, bread wheat is allohexaploid, with three sets of 
chromosomes referred to as genome A, B and D. Each of these genomes contains 
all gluten gene families. As a result, a single bread wheat variety has a combination 
of gliadins and glutenins, some without any CD epitopes, others with one or more 
immunogenic epitopes (van Herpen et al., 2006; Tye-Din et al., 2010; Salentijn et 
al., 2013). No cultivated wheat or wild relative has been identied that contains 
only CD safe gluten epitopes (van den Broeck et al., 2010a; 2010b). Consequently, 
gluten hypoimmunogenic wheat cannot be produced by conventional breeding 
that aim at identifying and introgressing naturally occurring CD-safe gliadin gene 
variants into a variety.
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Hurdles faced by Genetically Modied plants and mutation breeding
RNAi targeting all three gliadin families successfully decreased 97% of gliadin 
expression in bread wheat grain and its gluten extract did not stimulate CD patient 
T cells while dough quality was barely aected (Gil-Humanes et al., 2010; 2014). 
Similarly, Becker et al. (2012) decreased the expression of 20 α-gliadins although 
increasing expression of other storage proteins. Wen et al. (2012) reduced the 
expression of DEMETER, preventing DNA-methylation changes and thus 
repressing glutenin and gliadin gene expression in the endosperm. However, RNAi 
construct has to remain in the wheat genome to silence the gliadin genes. RNAi 
wheat lines are therefore hold back by GM regulation, despite the considerable 
improvement they represent for CD patients. 
Another approach towards wheat with hypoimmunogenic gluten is mutation 
breeding based on random mutagenesis. is method which is exempted from 
GM regulation, has recently been applied to develop “ultra-low gluten” barley 
(Tanner et al., 2016), and is being used to produce gluten-free beer in Germany. 
Developing wheat with hypoimmunogenic gluten using a similar approach is 
theoretically possible although it constitutes a greater challenge (Ribeiro et al., 
2018). Wheat γ-irradiated lines have to be identied that miss large region on 
short arm of chromosomes 1 or 6, having lost gliadin or LMW-glutenin genes 
in one of the three homoeologous genome. Plants with these 12 dierent events 
have to be self to become homozygous for the deletion and then inter-crossed to 
obtain hypoimmunogenic gluten while maintaining bread wheat unique baking 
quality conferred by HMW-glutenin loci. However, a potential consequence of 
supressing all gliadin loci is an eect on bread dough viscosity. Moreover, this 
process is highly time consuming and lots of plants need to be screened since 
the mutations are random. In addition to the deletion of gliadin loci, many other 
mutations occur, which can have an eect on the plant. 
Project aim: use of gene editing to decrease α- and γ-gliadin 
immunogenicity in bread wheat
An alternative approach to generate wheat varieties with non-immunogenic 
gluten is the precise editing of gluten genes, which can be achieved with a targeted 
mutagenesis approach, such as using the CRISPR/Cas9 system. 
18060-Aurelie_Jouanin_PM.indd   30 02-01-19   12:18
General Introduction
31
I
e CRISPR/Cas9 system
e CRISPR/Cas9 system was originally described as a bacterial defence 
mechanism against viral infections (Barrangou et al., 2007) and has since been 
customised to induce mutations and deletions at specic locations within a target 
gene in animals and plants (Doudna and Charpentier, 2014). CRISPR/Cas9 is 
relatively fast and easy to customise to target dierent genes of interest and mutate 
them at specic sites. It is composed of a single guide RNA (sgRNA) that contains 
a sub-sequence of 20-mer which may be customised to be complementary to the 
genome site to target and mutate. e sgRNA guides a Cas9 endonuclease to the 
target region within the genome and binds to it. en, the Cas9 generates a double-
strand break in the DNA, three bases upstream of a specic protospacer adjacent 
motif (PAM) (Fig. 5). is triggers the cell’s DNA repair mechanism, which in 
case of a double-stranded break in plants is mostly done by non-homologous end 
joining (NHEJ). is can result in nucleotide insertion/deletions (indels) or other 
mutations (Belhaj et al., 2013), and ospring in which such mistakes have been 
made can be selected.
CRISPR/Cas9 constructs can be integrated in plant genomes to generate the 
desired double-strand breaks, and the construct can be out-crossed in subsequent 
generations while the mutations of interests are retained. is is a considerable 
advantage compared to GM techniques such as RNAi, in which the transgene 
must remain present for the desired eect. e CRISPR/Cas9 complex can even, 
in certain cases, be delivered into plant protoplast cells as riboprotein complex 
(Woo et al., 2015), which generates the targeted double-strand break and is 
subsequently naturally degraded. e mutations that are generated would remain 
in the regenerated plant and its progenies. In addition, CRISPR/Cas9, being a 
targeted mutagenesis method, generates less o-target mutations compared to 
random mutagenesis, or even no o-type mutations at all (Feng et al., 2014). 
e targeted approach also decreases the minimal number of mutant plants to 
generate and screen before identifying a desired mutation, which is time and cost 
ecient. Furthermore, when dealing with multiple genes, CRISPR/Cas9 enables 
simultaneous mutations either by multiplexing sgRNA with dierent targets or by 
targeting conserved regions (Xing et al., 2014). e mutations that are generated 
may be homozygous for all copies within a unique generation. 
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is PhD project
e concept of the project is to use CRISPR/Cas9 to generate mutations within 
α- and γ-gliadins in order to modify or remove the immunogenic epitopes, to 
completely remove the genes, or to prevent their expression (Fig. 5). is approach 
would enable obtaining wheat plants producing grains containing fewer or no 
immunogenic gliadin epitopes yet retaining nutritious values and acceptable 
bread dough quality provided by the untargeted glutenins and newly generated 
CD-safe gliadins. Although “safe-gluten” wheat is the ultimate goal, we use the 
term “hypoimmunogenic” gluten and wheat. 
Figure 5. Representation of a CRISPR/Cas9 complex targeting a Gli-2 locus containing α-gliadin genes.
CRISPR/Cas9 consists of a sgRNA (in purple) that contain a protospacer sequence designed to be 
complementary to the DNA sequence of the genes to target - which are here α-gliadins or γ-gliadins – (in 
green). e sgRNA nds the gliadin sequence targeted within the wheat genome (represented as the orange 
strand) and bind to it, bringing alongside a nuclease enzyme called Cas9 (in blue). e Ca9 envelops the 
double-stranded DNA, recognises the protospacer adjacent motive PAM (in red) and generates a DNA 
double strand break three base pairs upstream of the PAM. e DNA repair mechanism of the plant cell 
may produce a mistake during the damage repair, generating mutations such as insertion or deletion of few 
nucleotides. In addition, as α-gliadin genes occur in tandem repeats, simultaneous double-strand breaks in 
two non-consecutive copies could generate the deletion of a large DNA fragment carrying several α-gliadins 
gene copies. is gure has been adapted from GenScript, Nanjing, China. 
When the project started, CRISPR/Cas9 had successfully been used in polyploid 
wheat protoplasts to induce mutations in one genes in the homoeologous genomes 
(Shan et al., 2013) or in diploid mice embryogenic stem cells to target a small 
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gene family containing 5 genes (Wang et al., 2013a). However, no one had ever 
reported the use of CRISPR/Cas9 to target large gene families with clustered genes 
in polyploid crops. At that time, the way of regulating gene-edited plants was not 
decided in Europe nor elsewhere. erefore, the three main questions driving the 
research were:
· Can CRISPR/Cas9 successfully mutate a sucient number of gliadin 
gene copies to modify gliadin proteins expressed in hexaploid wheat 
grain?   
· What screening method can be used rst to identify the mutants 
and then to characterise the mutations generated?
· How much can gene-edited regulatory decisions impact research, 
development and commercialisation of gene-edited wheat with 
hypoimmunogenic gluten?
is project should therefore be seen as a pilot research project regarding the 
development of a methodology and the applicability of CRISPR/Cas9 gene 
editing approaches to create bread wheat containing hypoimmunogenic gluten 
for CD patients. is proof of concept will not immediately remove all epitopes 
in the targeted gene families, let alone those in ω-gliadins and LMW-glutenins. 
Furthermore, once all known epitopes would be removed, the Cas9 construct 
should be outcrossed, lines should be made homozygous and gluten should be 
tested for immunogenicity and dough rheology. 
e structure of the thesis
In this PhD thesis, Chapter 1 gives an overview of the food processing and plant 
breeding strategies to create coeliac-safe and healthy wheat products. is chapter 
highlight the fact that solutions decreasing gliadin immunogenicity exists in food 
processing but should be combined with plant breeding strategies in order to have 
the safest wheat product possible for CD patients. 
Among the plant breeding strategies described to reduce gliadin immunogenicity 
in wheat, the use of CRISPR/Cas9 targeted mutagenesis editing α- and γ- gliadin 
genes constitutes the theme of Chapter 2. is chapter describes the generation 
18060-Aurelie_Jouanin_PM.indd   33 02-01-19   12:18
General Introduction
34
of hexaploid Fielder wheat plants containing CRISPR/Cas9 constructs with 
gRNA editing α- and γ- gliadin genes. It presents the Acid-PAGE screening 
results identifying α- and γ- gliadin Fielder-CRISPR mutant plants. ese basic 
proteomics results were compared to the ones obtained for the mutants of 
bread wheat cultivar Paragon that were generated using γ-irradiation, a random 
mutagenesis approach. 
ese basic proteomics evidences of wheat gliadin mutations needed to be 
further studied using genomic analysis. Consequently, Chapter 3 describes the 
development of a droplet digital PCR assay as a quantitative method to determine 
gene copy number variation and gene-editing detection of α-gliadin gene family, 
in hexaploid wheat. In this chapter, the methodology for setting up a ddPCR 
assay that can estimate gene copy number variations in large gene families, in 
polyploids, is described. Aer optimisation, ddPCR was implemented on wild 
type and γ-irradiated Paragon lines previously revealing gliadins mutations in 
order to test the possibility of quantifying deleted gene copies. e ddPCR assay 
was then applied to the Fielder-CRISPR gliadin mutant plants to quantify and 
distinguish between Cas9 induced small indels and large DNA fragments deletion. 
Quantitative data regarding gliadin genomic mutations are not sucient and 
mutations generated must be qualitatively characterised. us, Chapter 4 presents 
GlutEnSeq, gluten gene enrichment and sequencing, as a qualitative method 
to analyse genomic variation of gluten genes in hexaploid wheat. is chapter 
describes the design and development of a solution-based gluten exome capture 
baits assays used to perform gluten gene enrichment followed by next generation 
sequencing, based on REnSeq. e method was rst tested on reference cultivar 
Chinese Spring, before it was implemented on Paragon and Fielder cultivars and 
associated gliadin mutant lines in order to get qualitative information on the type 
of genetic mutations generated. 
Gene editing being the core of the project and its new regulation as GM in 
Europe is currently a hot topic. Chapter 5, entitled “Development of wheat with 
hypoimmunogenic gluten obstructed by the gene editing policy in Europe” 
covers the topics of safety, public acceptance, distinguishability and labelling, 
and potential politico-economic issues, related to the regulation of gene-edited as 
GM product in Europe in contrast to other countries, following the ruling of the 
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European Court of Justice in July 2018. It also advises the European Commission 
to review its position on the matter and to regulate gene editing based on the 
generated products and the innovation principle. 
Finally, a General Discussion elaborates on the necessity of developing gluten-
safer products using plant breeding. e level of success of CRISPR/Cas9 gene 
editing for developing wheat lines with lower gliadin immunogenic epitopes is 
discussed. Alternative solutions are presented for faster development of wheat 
with hypoimmunogenic gluten. e relevance of fast mutant screening methods 
and their adaptation is discussed. e necessity of developing methods to test 
food for “safe-gluten” rather than “gluten-free” is also suggested. 
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Abstract
A strict gluten-free diet is currently the only treatment for the 1-2% of the world 
population who suer from coeliac disease (CD). However, due to the presence of 
wheat and wheat derivatives in many food products, avoiding gluten consumption 
is dicult. Gluten-free products, made without wheat, barley or rye, typically 
require the inclusion of numerous additives, resulting in products that are oen 
less healthy than gluten-based equivalents. Here, we summarise and contrast two 
broad approaches to decrease wheat gluten immunogenicity for CD patients. e 
rst is based on food processing strategies, which aim to remove gliadins or all 
gluten from edible products. We nd that several of the candidate food processing 
techniques to produce low gluten-immunogenic products from wheat already 
exist. e second approach focuses on wheat breeding strategies to remove 
immunogenic epitopes from the gluten proteins, whilst maintaining their food-
processing properties. A combination of breeding strategies, including mutation 
breeding and possibly genome editing, will be necessary to produce coeliac-safe 
wheat. Individuals suering from CD and people genetically susceptible who may 
develop CD aer prolonged gluten consumption would benet from reduced 
CD-immunogenic wheat. Although the production of healthy and less CD-toxic 
wheat varieties and food products will be challenging, increasing global demand 
may require these issues to be addressed in the near future by food processing and 
cereal breeding companies.
Key words: Gluten, Gliadin, T cell Epitope, Coeliac Disease, Plant breeding, Food 
processing, Mutation breeding, Genome editing.
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Introduction
Wheat forms the basis of a diverse range of staple foods globally, which includes 
bread and bakery items in addition to other products such as alcoholic beverages 
and food additives. Two major storage protein families are present in wheat grains: 
glutenins and gliadins (belonging to glutelins and prolamins, respectively), which 
are collectively known as gluten. e qualitative and quantitative properties of 
wheat gluten are important factors for baking quality. Despite its predominance in 
the human diet, wheat can cause allergies and/or intolerances aer consumption 
in susceptible individuals (Fasano, 2006). Wheat contains immunogenic proteins, 
but the prevalence of wheat allergy, which is mediated by IgE antibodies, is low 
(Zuidmeer et al., 2008; Gilissen et al., 2014). However, gluten can also trigger 
intolerance reactions in 1-2% of the human population, the most common of 
which is coeliac disease (CD) (Mäki et al., 2003; Rewers 2005; Catassi et al., 2014; 
Vriezinga et al., 2015).
CD is a chronic inammation of the small intestine, which leads to a variety of 
symptoms that can include malnutrition, bowel disorders, skin, bone, nerve, and 
muscle problems. It is induced by epitopes (peptide sequences of nine amino 
acids) present in gluten proteins from wheat, barley and rye. ese epitopes are 
bound by human leucocyte antigen sub-units (HLA-DQ2 or HLA-DQ8) located 
on antigen presenting cells in humans, which are subsequently recognised by T 
cells, triggering an immune reaction (for reviews see Fasano 2009; Koning 2012). 
CD develops in genetically predisposed individuals, and is induced by gluten 
ingestion. A strict gluten-free diet is currently the only treatment to stop the 
immune reaction and inammation, allowing the intestine to recover, aer which 
the symptoms gradually disappear.
Avoiding consumption of gluten is dicult to do in practice, due to the presence 
of wheat derivatives in many supermarket products (Atchison et al., 2010). 
erefore there is a need for new strategies to create food products with low 
gluten immunogenicity. Here, we summarise several strategies to decrease wheat 
gluten toxicity for CD patients, based on food processing and on wheat breeding 
(Fig. 1). e food processing strategies aim at removing gliadins or whole gluten 
from edible products (Gilissen et al., 2016b) whereas the wheat breeding strategies 
focus on the removal of immunogenic epitopes from the gluten proteins, whilst 
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potentially maintaining their food-technological properties (Smulders et al., 
2015; Shewry and Tatham 2016). If successful, the latter strategy may result in 
food products considered coeliac-safe, despite containing large amounts of 
gluten, which would require alternative labelling from the term ‘gluten-free’. A 
comparison of the applicability of these approaches, in terms of technical and 
economic aspects, is presented. Two groups of people may benet especially 
from food products derived from such reduced CD-immunogenic wheat: (1) 
individuals suering from CD, whether they are already or not yet diagnosed as 
CD patient, and (2) genetically predisposed individuals who may develop CD 
aer prolonged wheat or gluten consumption.
Food processing-related strategies to manufacture gluten-
free products or to lower the content of CD epitopes
Wheat gluten is a polymer composed of two types of proteins: glutenins and 
gliadins. e type of HMW subunits and the ratio of glutenins and gliadins 
determine the viscoelasticity properties required for bread, cakes or other baking 
products (Weegels et al., 1996; Shewry et al., 2009). e high and low molecular 
weight glutenin subunits (HMW-glutenins and LMW-glutenins) form a strong 
glutenin macro polymer (GMP) network, formed by inter-chain disulphide 
bonds, which determines dough elasticity. e monomeric gliadin proteins (α/β-
gliadins, γ-gliadins and ω-gliadins) are linked to the GMP and can be envisaged 
to ‘dilute’ the strength of the GMP, thus inuencing dough viscosity (Shewry 
2009). e glutenins are the less immunogenic gluten proteins for CD. e 
monomeric gliadin proteins (α/β-gliadins, γ-gliadins and ω-gliadins) are the most 
immunogenic. 
Two types of products can be generated during food production: gluten-free 
products made without ingredients from wheat, barley or rye (Fig. 1a), or products 
with low gluten immunogenicity based on the processing of these cereal grains to 
remove the immunogenic gluten fraction (Fig, 1b) (as reviewed by Kucek et al., 
2015). Food products can be labelled as ‘gluten-free’ as long as they contain less 
than 20 ppm of gluten (Saturni et al., 2010).
18060-Aurelie_Jouanin_PM.indd   40 02-01-19   12:18
Food and breeding strategies towards hypoimmunogenic gluten
41
1
Figure 1. Food supply chains producing gluten-free or coeliac-safe(r) products.
Depicted are simplied food supply chains comprising of two steps, plant breeding and food processing, 
leading to the nal food product. ree variants, a), b) and c), of this food supply chain can be envisaged, 
depending on the step at which eorts are made to generate gluten-free or coeliac-safe(r) products and 
whether the process includes wheat ingredients or not. ese three variants are presented here in the same 
order as described in the paper. a) Gluten-free products are generated using substitutions for wheat to avoid 
the presence of its immunogenic gluten fraction. b) Coeliac-safer of celiac-safe products could be made at 
the food-processing step by processing wheat grains to decrease their immunogenic gluten fraction before 
proceeding to processing of the nal product. c) Coeliac-safer or coeliac-safe products could be made based 
on plant breeding of wheat varieties with reduced immunogenic gluten fraction, used in a standard grain 
processing and nal food product processing. Note that b) and c) can complement each other to achieve a 
further reduction of gluten immunogenicity.
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Gluten-free products made without ingredients from wheat, barley and 
rye 
With increasing numbers of patients with CD being diagnosed, the gluten-free 
market is becoming more important, and gluten-free products are increasingly found 
on grocery shop shelves. Such products generally do not contain any wheat, barley 
or rye, but include several additives (Fig. 1a) to recreate the viscoelastic properties of 
gluten present in these cereal grains (as summarised by Gustafson 2016).
Current composition of gluten-free products
Currently commercial gluten-free bread is usually made from a mixture of ours, 
including maize, rice, sorghum and oat. Oat can be consumed safely by CD 
patients without a daily limit (Kaukinen et al., 2013; Hardy et al., 2015; Gilissen et 
al., 2016a and references therein). Alternatively, our from pseudo-cereals (such 
as amaranth, buckwheat and quinoa), legumes and nuts have been proposed as 
new candidates for gluten-free products. 
Issues encountered with these gluten-free ours are their lack of viscoelasticity 
and their low ability to retain water and CO2, the properties responsible for 
dough rising conferred by the gluten network. Starch may be added to increase 
viscosity and provide some binding abilities to the dough. Starches from potato, 
corn, rice and cassava (tapioca) are mostly used. Hydrocolloids, also known as 
gums, are also important additives in gluten-free baking products. ey are used 
as substitute for glutenins to confer elasticity to the dough, as well as gas and 
moisture retention for higher loaf volumes and longer shelf life. Inulin, xanthan, 
guar gum, and hydroxypropyl methylcellulose (HPMC) are the most commonly 
used hydrocolloids in gluten-free bread. Protein concentrates such as soybean, 
egg and whey proteins are also used for their gelling properties, contributing 
to dough quality improvement. e addition of lipids, such as sunower and 
saower oil, retards the staling process, due to the gas-retaining properties of 
polar lipids (Horstmann et al., 2016). Additionally, emulsiers such as glycerol 
monostearate and lecithin are commonly used to reduce staling and to increase 
shelf-life. Sodium stearoyl-2-lactylate is also an emulsier but acts by stretching 
the gluten network. High salt content is oen used to improve taste, texture and 
bread stability (Belz, 2016). e addition of dietary bre through incorporation of 
oat or rice bran could become a solution to compensate for the low bre content 
of gluten-free bread (Gilissen et al., 2016b). Rice bran also appears to improve 
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rheology and sensory aspects of gluten-free bread, whereas dough acidication 
with acetic, citric, or lactic acid, or monosodium phosphate can also help improve 
bread volume. 
Health issues associated with current gluten-free products
Gluten-free bread thus contains far more additives than standard wheat bread. As 
a result, regular consumption of gluten-free bread may in itself cause health issues, 
e.g. the mineral content can be very low, leading to iron and calcium deciency, and 
despite the inclusion of protein additives for dough improvement, it is a relatively 
poor source of protein. Gluten-free bread is usually low in bre, which decreases 
the sensation of satiety; in contrast, it is rich in starch, thereby enhancing the 
risk of hyperglycaemia and diabetes. Gluten-free bread also contains high levels 
of salt, which is a risk for cardiovascular and renal disease. In addition to being 
high in lipids, gluten-free products contain trans fatty acids, which may provoke 
metabolic imbalance (Caponio et al., 2008). Several countries try to reduce or 
eliminate them from food products. Fructan-type inulin is used in gluten-free 
bread as a hydrocolloid but is known to be a possible cause of irritable bowel 
syndrome (IBS) (Capriles and Arêas, 2014). IBS is mainly caused by fermentable 
oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) such 
as fructan, a fructose polymer. Since fructans are present in the wheat grain, IBS is 
oen associated with wheat as non-coeliac gluten sensitivity or non-coeliac wheat 
sensitivity (NCGS), and is sometimes wrongly auto-diagnosed as CD. While a 
low FODMAPs diet will usually decrease IBS symptoms, some gluten-free bread 
products containing inulin may not be suitable for these patients. In such cases, 
it is important to be diagnosed with the correct disorder. Nonetheless, based on 
the frequency of people with clinical bowel complaints that appear to improve 
under a gluten-free diet, the prevalence of NCGS might be as high as 6% of the 
population (Gilissen et al., 2014), but more recent evidence suggests that ‘true’ 
NCGS is only slightly more than 1% of the population (Catassi, 2015). Although 
no biomarkers have been identied yet, a state of systemic immune activation 
in conjunction with a suggested compromised intestinal epithelium could be 
observed in a subset of individuals with NCGS (Uhde et al., 2016). In addition to 
individuals diagnosed with CD or IBS, other consumers have actively decided to 
avoid wheat and gluten based on personal choice. However, such choices are oen 
made following self-diagnosis based on personal health-related preference, rather 
than for clear medical reasons, despite the dietary concerns described above. 
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Gluten contamination elimination diet (GCED)
Some coeliac patients have persistent symptoms and villous atrophy despite strict 
adherence to a gluten-free diet. ey are referred to as having ‘non-responsive 
CD’. Some non-responding CD patients may react to minute amounts of gluten, 
likely present as contaminants in processed gluten-free foods. For example, 
industrial conversion of wheat starch into other food-grade carbohydrates may 
not eliminate all gluten (Scherf et al., 2016). erefore, foods containing these 
modied carbohydrates may still contain very low levels of stable, and potentially 
immunogenic, gluten. Furthermore, when chemically deamidated gluten protein, 
which is even more immunogenic than natural gluten proteins, is used for 
increased emulsifying applications (Wu et al., 1976) it may be undetectable in the 
R5 monoclonal antibody assay used for routine gluten screening by commercial 
companies (Kanerva, 2011). ese undetected deamidated gluten fractions can 
also contribute to contamination of food labelled as ‘gluten-free’. 
Over 80% of the non-responsive patients showed health improvement under a 
‘gluten contamination elimination diet’ (GCED), that includes only fresh and 
unprocessed foods. ese patients were able to return to a traditional gluten-free 
diet without return of symptoms (Hollon et al., 2015). A subset of ‘non-responsive 
CD’ patients do not show any decrease in symptoms under GCED, and therefore 
suer from true ‘refractory CD’ (RCD). 
Development of wheat-based products with low gluten immunogenicity
Due to the low dietary value and health risks associated with non-wheat based 
gluten-free products, alternative food processing methods for wheat are being 
investigated (Fig. 1b). e main aim is to use wheat (conserving the rheological 
properties conferred by the glutenins), whilst removing the most immunogenic 
gluten fraction (the gliadins). is approach would decrease the need for additives 
to reach adequate dough quality and dietary values, thus improving the healthiness 
of gluten-free or ‘gluten-safe’ products. 
Malting
e malting process is not only relevant for brewing beer, but also for the baking 
sector. Malting represents the rst step in seed germination, during which amylase 
enzymes become active, degrading starch into maltose to provide the source of 
energy for the embryo to germinate. Malting produces higher amounts of maltose, 
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which enhances further fermentation. In addition, endogenous proteolytic 
enzymes in the grain degrade storage proteins (i.e. gluten), releasing amino acids 
that are used by the growing seedling. Gliadins become degraded through the 
activity of proteases (Bigiarini et al., 1995). Because of this degradation process, 
in practice many brands of beer are technically gluten-free or contain only small 
amounts of gluten.
Malting has been used for many years to add avour and crust colour to bread, 
and can even enhance sourdough fermentation when the malting process is not 
fully stopped. It has been shown that malted and fermented wheat sourdough 
eectively degrade 95% of the gliadins (Loponen et al., 2007), leading to bread 
that is low in gliadins. An alternative approach is the use of enzyme extracts from a 
small stock of germinated seeds (particularly barley seeds). is has recently been 
suggested to be applicable to the large-scale production of our with a reduced 
gliadin content (Stenman et al., 2010; Schwalb et al., 2012). 
Sourdough fermentation and dough acidication
Sourdough is the result of the activity of micro-organisms (Lactobacilli and yeast) 
naturally present in our, becoming active when water is added. Lactobacillus 
ferments the our/water mixture creating lactic acid, acidifying the mixture. 
is enhances the activity of propyl endopeptidase (PEP) enzymes produced by 
other micro-organisms to degrade gluten proteins (Hartmann et al., 2006; Gänzle 
et al., 2008; Loponen et al., 2009). Sourdough fermentation has been suggested 
as a way of enabling the manufacture of ‘gluten-free’ or ‘low-in-gluten’ (< 100 
ppm) wheat-based products through proteolytic gluten degradation (Loponen, 
2006). Similarly, chemical acidication of conventional dough has been shown 
to activate PEP activity, resulting in increased prolamin degradation (Kanerva, 
2011), although not as much as in traditional sourdough. However, articially 
acidied dough may trigger more intestinal permeability (Di Cagno et al., 2004) 
and enhance non-enzymatic deamination of gluten peptides, which may render 
them more immunogenic (Arentz-Hansen et al., 2000). 
Sourdough fermentation is a traditional baking process with a long history, 
particularly in Germany. e prevalence of CD in Germany (measured using a 
single antibody test) has been found to be remarkably low, 0.4% and 0.2% in women 
and men, respectively (Kratzer et al., 2013), conrming earlier data showing a 0.1-
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0.4% prevalence on the basis of anti-tTG and anti-endomysial antibody (EMA-
IgA) tests (Mustalahti et al., 2010). Recent estimations of the celiac prevalence in 
Germany have increased to 0.8%, especially in children and young adults up to 17 
years old (Laass et al., 2015). is may reect under-diagnosis in earlier studies. 
However, if sourdough indeed reduces the exposure to intact gluten epitopes, then 
the recent increase in CD prevalence in young people may reect a change in the 
diet of German children towards white and yeast-based bread.
Recently, Greco et al. (2011) described a two-step hydrolysis including fungal 
proteases and Lactobacillus endo-peptidase activity, which resulted in a wheat 
our-derived product with less than 10 ppm gluten. is product was found not to 
be harmful to CD patients (Greco et al., 2011). ese observations are promising, 
but further research on the potential of sourdough products in a safe ‘gluten-free’ 
diet is needed, examining individual cases. Firstly, a strict denition on the type of 
sourdough is required, and the process of gluten degradation needs to be analysed 
in detail. Secondly, it needs to be determined whether large-scale consumption by 
the general population of well-dened sourdough products can indeed contribute 
to the reduction of the incidence and symptom severity of CD and NCWS. is 
will require large-scale epidemiological studies.
Degradation of gluten using a peptidase
Walter et al. (2014) showed that AN-PEP, an Aspergillus niger prolyl endopeptidase, 
can be used to degrade gluten in wheat bran to below 20 ppm. Such treated wheat 
bran could have a use in increasing the nutritional value of the gluten-free diet, 
e.g. by increasing soluble bre content. 
Separation of gliadins from total gluten 
Extraction of HMW-glutenins from total gluten and substitution of the highly 
immunogenic wheat gliadins with, for instance, coeliac-safe oat avenins in order 
to maintain good baking quality (van den Broeck et al., 2011), is a realistic option 
in foods aiming at a strongly reduced immunogenic gluten load. Nearly complete 
separation can be achieved at the lab scale (Bassi et al., 1997; Gilissen et al., 2012; 
Lagrain et al., 2013). Industrial scale-up to economically and technologically 
viable levels appears to be more problematic, and would need further research. 
Alternatively, α-gliadins, the most immunogenic gluten proteins, can be partially 
removed mechanically using roller-milling to remove the seed sub-aleurone layer, 
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in which a large fraction of the α-gliadins are deposited (van Herpen et al., 2008; 
Sutton et al., 2015).
Reduction of the use of vital gluten
Vital (or puried) wheat gluten is a major side-product of wheat starch production. 
Starch is used to make native and modied starch, glucose syrup, maltodextrins, 
and liquid and crystalline polyols, with wide applications in the food industry. 
Wheat starch is also used for the production of alcohol, including bioethanol. 
Since wheat starch is economically more important than our for bakery purposes, 
vital gluten production (as side-product of starch isolation) is large, and its cost 
relatively low.
Vital gluten is increasingly applied as a protein additive in food products to 
improve technological characteristics. In bread and bakery products vital gluten is 
added to maintain high loaf volumes, but most of its use is in the form of a ‘hidden’ 
ingredient, oen not labelled, in a large number of processed food products. 
is may have contributed to the increase in total gluten consumption: between 
1977 and 2007, gluten intake in the western world has tripled (Kasarda, 2013). 
Currently, a ‘back to basics’ philosophy in modern bakeries in e Netherlands 
has led to ‘clean label’ strategies, and avoidance (or strong reduction) of bread 
quality-improving ingredients such as enzymes and vital gluten in artisanal and 
industrial whole grain breads. ere is, however, no indication of a reduction in 
the use of vital gluten in other food production sectors. 
Wheat breeding strategies for products with low gluten 
immunogenicity 
An alternative strategy for the production of gluten-free wheat-based food is to 
develop wheat varieties with fewer or no immunogenic CD epitopes (Fig. 1c) 
(Gilissen et al., 2008; Shewry and Tatham 2016). To be able to generate such 
varieties, one must be aware of the complexity of wheat genome and the structure 
of gene families coding for gliadin immunogenic CD epitopes.
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Wheat breeding background: genomics, gluten gene families and gliadin 
protein epitopes
e ancestor of all wild and cultivated wheat species was a diploid grass (2n=14), 
which evolved into several diploid species (e.g. Goncharov, 2011; Goryunova et 
al., 2012). Natural allopolyploidisation occurred through hybridisation between 
the diploid species Triticum urartu (AA genome) and Aegilops speltoides (BB or 
SS) followed by chromosome doubling, resulting in tetraploid emmer wheat, T. 
turgidum spp. dicoccoides (AABB). Much later, tetraploid emmer hybridized with 
goat grass, Aegilops tauschii (DD), followed by chromosome doubling, resulting 
in hexaploid bread wheat, Triticum aestivum (AABBDD) (Gupta et al., 2008). e 
latter allopolyploidisation took place in agricultural elds early aer the start of 
cultivation of emmer wheat; bread wheat does not exist in nature.
e α-gliadins are encoded by a large gene family around 100 genes, located 
on the short arms of the group 6 chromosomes (6AS, 6BS and 6DS) (Ozuna et 
al., 2015). e γ-gliadins, ω-gliadins and LMW-glutenins are encoded by gene 
families located on the short arms of the group 1 chromosomes (1AS, 1BS and 
1DS), while the HMW-glutenins are encoded by gene families located on 1AL, 
1BL and 1DL.
e presence of the D genome in hexaploid T. aestivum provides additional gluten 
proteins, which considerably improve its bread baking properties compared 
to tetraploid wheat, particularly HMW-glutenin subunits (Payne et al., 1984). 
However, the D genome also encodes for gliadins that have been reported as 
highly immunogenic. 
CD epitopes are 9 amino acids in length, and form the peptide fragment that ts 
into the T cell HLA-DQ2 and HLA-DQ8 epitope-presenting receptor grooves. 
e list of well-dened CD epitopes (Sollid et al., 2012) comprises: twenty-
four DQ2 epitopes and seven DQ8 epitopes, including six epitopes present in 
α-gliadins and eleven in γ-gliadins, complemented by two ω-gliadin epitopes, 
three LMW-glutenin, and two HMW-glutenin epitopes. e HLA-DQ8 epitopes 
play a minor role in the development of CD, since over 90% of CD patients are 
HLA-DQ2 positive and react to α-gliadins (Koning, 2012; 2015). e HLA-DQ / 
gliadin peptide / T cell interactions have been characterised extremely well. e 
positions that are crucial for immune reactivity of α-gliadins, identied by T cell 
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tests (e.g., Mitea et al., 2010), correspond exactly with the amino acid residues 
that form the crucial hydrogen bridges that connect HLA-DQ2 (Petersen et al., 
2014) to the T cell receptor, a connection which, if suciently stable, triggers the 
immune reaction in humans. e structure of the HLA-DQ8 / gliadin peptide / T 
cell interaction has also been characterised in detail (Petersen et al., 2016).
At the genomic level, the occurrence of CD epitopes varies between gliadin genes 
(each locus comprising multiple gene copies), between homoeologous wheat 
chromosomes (A, B, D), and among wheat varieties and species (Spaenij-Dekking 
et al., 2005; Molberg et al., 2005; van Herpen et al., 2006; Salentijn et al., 2009; 
2012; van den Broeck et al., 2010a; 2010b). e α-gliadins from the D genome 
contribute most CD epitopes, while those from the B genome contribute the least 
(van Herpen et al., 2006; Salentijn et al., 2009). For γ-gliadins, the highest number 
of CD epitopes has also been found in genes present on the D genome (Salentijn et 
al., 2009; 2013). While less sequence information is available for ω-gliadins, their 
involvement in CD immunogenicity has been recently recognized from cross-
reactivity of T cells with rye and barley epitopes (Tye-Din et al., 2010). 
We will rst discuss research approaches aimed at identifying naturally occurring 
variation within gliadin gene sequences and loci. is genetic variation can be 
used in conventional breeding and forward genetics approaches, by introgression 
into new wheat varieties. However, there is limited prospect for success, as 
multiple gliadin loci occur in the polyploid wheat genome, and glutenins and 
gliadins are encoded by large gene families, so multiple genes need to be screened. 
Many of the genes are closely linked in the genome, which limits the frequency 
of recombination, making selection of appropriate variation through a breeding 
approach dicult. erefore, the use of reverse genetics approaches, such as 
random or directed mutagenesis and transgenic methods (such as gene silencing) 
or gene editing are considered attractive options to create wheat varieties with 
reduced gluten immunogenicity. We will discuss such approaches later in this 
review.
When these approaches lead to wheat varieties with fewer gliadin proteins, this 
may aect baking quality. e eect should be compensated for, and one approach 
is the addition of celiac-safe proteins that perform the same function in the GMP 
(Gilissen et al., 2012, Smulders et al., 2015), as was demonstrated for oat avenins 
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added to our of wheat deletion lines lacking certain groups of gliadins (van den 
Broeck et al., 2009).
Selection of low CD-toxic wheat accessions and varieties
Genebanks around the world contain modern and old varieties of hexaploid and 
tetraploid wheat varieties, as well as landraces (locally adapted wheat accessions), 
wild emmer (Triticum dicoccoides) and wild diploid species that are related to the 
ancestors of cultivated wheat (crop wild relatives). ese collections are a useful 
source of wheat germplasm for analysing the relationships between individual 
gluten genes or proteins, the occurrence of epitope variants, and the resulting CD 
immunogenicity.
Whilst there may be large variation in the presence of intact CD epitopes 
amongst individual α -gliadin genes, all wheat varieties or accessions express 
multiple gliadins (Salentijn et al., 2013), which reduces the variation detected 
between varieties by immunogenic screening approaches. Indeed, screening with 
monoclonal antibodies (mAbs) for two CD epitopes revealed limited genetic 
variation in gliadins immunogenicity among modern wheat varieties (van den 
Broeck et al., 2010a). Some older hexaploid wheat varieties were identied with 
somewhat lower mAb response, as well as two lines derived from a heterogeneous 
tetraploid durum wheat landrace (van den Broeck et al., 2010b). In addition, 
analysis of nine landraces of farro wheat (T. turgidum ssp. dicoccum) revealed three 
landraces that caused negligible proliferation of T-cell lines from CD patients, 
whereas the other landraces studied showed intermediate to very high responses 
(Vincentini et al., 2009).
Diploid einkorn wheat (T. monococcum, A genome) has good nutritional 
characteristics and bread making quality. Food products made from the variety 
‘Monlis’ have been shown to be tolerated by CD patients, revealing similar absence 
of CD toxicity-related symptoms as found for rice (Zanini et al., 2013). New 
combinations of gluten genes can be made by crossing and selection at the diploid 
level. Although this is a time-consuming procedure, the increasing incidence of 
CD in recent decades would justify selection for reduced CD epitopes levels as a 
novel quality trait for wheat breeding (van den Broeck et al., 2011).
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e utility of screening wheat germplasm using epitope-specic mAbs is, 
however, limited. e specicity of mAbs is not exactly the same as that of the 
T cell epitopes, as mAbs only recognise peptide sequences of 4-6 amino acids in 
length, which is substantially shorter than the 9 amino acid T cell epitopes that 
cause CD (Londono et al., 2013). erefore, the identication of wheat genotypes 
with reduced CD toxicity using mAbs should be regarded as a preliminary screen, 
to be followed by screening of selected lines with more accurate methods. 
Salentijn et al. (2013) have examined the CD immunogenic potential of tetraploid 
durum wheat by deep sequencing of α-gliadin transcripts, including the sequences 
coding for both the N-terminal domain and the repetitive domain, where the CD 
epitopes occur, from developing grains. ey found dierences among varieties, 
but no variety was identied as safe for CD patients. Dubois et al. (2016) screened 
spelt lines by sequencing α-gliadin genes expressed in the developing grains. ey 
saw no clear separation in the occurrence of epitopes between spelt and bread 
wheat accessions, although some spelt lines expressed more B-genome α-gliadins, 
which contain fewer epitopes.
A direct approach would be to use quantitative proteomics to identify the gliadins 
in mature grains, as this would determine the exact amino acid sequence and 
the quantity of the proteins produced during grain development. However, this 
is complicated by the diversity of gluten genes in any single wheat variety, and 
the relative insensitivity of these proteins to the proteolysis step necessary for 
analysis. A method has recently been developed that enables identication and 
quantication of specic CD-epitopes in chymotryptic gluten digests (van den 
Broeck et al., 2015).
Reconstituting hexaploid bread wheat: synthetic hexaploids
Overall, the genetic variation of the D genome in hexaploid bread wheat is 
much lower than the genetic variation present in the A and B genomes. is is 
consistent with the theory that the hybridisation that led to hexaploid bread wheat 
resulted in a strong genetic bottleneck (Reif et al., 2005; Jones et al., 2013). Indeed, 
several studies have found high levels of genetic diversity among wild Ae. tauschii 
accessions (Wang et al., 2013b; Jones et al., 2013). In order to introduce additional 
genetic diversity into bread wheat, programmes that recreate the hybridisation 
process to generate ‘synthetic hexaploid wheat’ (SHW) have been undertaken at 
18060-Aurelie_Jouanin_PM.indd   51 02-01-19   12:18
Chapter 1
52
various institutes around the world, including the International Maize and Wheat 
Improvement Centre (CIMMYT, Mexico), NIAB (UK), and the Commonwealth 
Scientic and Industrial Research Organisation (CSIRO, Australia). e process 
involves hybridising T. turgidum spp. durum with Ae. tauschii, followed by rescue 
of the triploid embryo, and subsequent chromosome doubling using colchicine 
to generate hexaploid individuals. Careful selection of diverse Ae. tauschii donors 
can result in SHW accessions that maximise the D genome variation captured, 
and so increase the potential benet of SHW in wheat breeding programmes. 
Ae. tauschii accessions which are low in CD-toxic gliadins could for instance be 
hybridised with two tetraploid durum wheat landraces that have been shown to 
possess a relatively low mAb response (van den Broeck et al., 2010b), to generate 
a low gluten immunogenic SHW wheat. ese SHWs could then be used in 
pre-breeding programmes for crossing with commercial varieties, combining 
screening for low gluten immunogenic progeny with the presence of competitive 
agronomic characters.
Mutation breeding 
Mutation breeding is based on the random induction of genome-wide 
mutations, followed by selection of plants carrying mutations in the gene(s) of 
interest; products of mutation breeding can be released on the market without 
regulation. e type and frequency of mutations obtained in classical mutagenesis 
programmes depends on the method used (chemical or ionizing radiation), the 
type and concentration of mutagen, and the duration of the treatment, which 
are adjusted on a case by case basis. Polyploid crops in general tolerate higher 
mutation loads than diploid crops (Shu et al., 2011; Oladosu et al., 2016). is 
is certainly necessary for gliadin mutagenesis in wheat: stacking mutations in 
multiple gliadin genes into a single plant through crossing is very challenging, due 
to the number of gliadin genes and their close physical linkage, so this strategy can 
only be eective if each of the starting lines already contain many mutated gliadin 
genes.
EMS
Ethyl methane sulfonate (EMS) is a chemical mutation approach that primarily 
results in transitions of G/C to A/T nucleotides in the DNA. In the context of 
α-gliadin and γ-gliadin genes, EMS treatment may result in mis-sense mutations 
within epitopes, which could disrupt binding to the Antigen Presenting Cells, 
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or non-sense mutations upstream of the epitopes which truncate the protein or 
prevent its translation. EMS mutations are detected using an approach termed 
Targeting Local Lesions IN Genomes (TILLING). Detection of induced mutations 
originally relied on enzyme-mediated cleavage of mismatched nucleotides 
(McCallum et al., 2000), but is now commonly done by DNA sequencing of either 
the complete genome or a subset of the genome, either produced with restriction 
enzymes or using approaches such as exome capture. Acevedo-Garcia et al., 
(2017) used TILLING to identify missense mutations in each of the three wheat 
Mildew Locus O (TaMLO) homoeologues, which were subsequently stacked 
to produce plants with enhanced, yet incomplete, resistance towards powdery 
mildew (Blumeria graminis f. sp. tritici (Bgt)).
A simple screening system for EMS TILLING populations has been constructed in 
tetraploid (T. turgidum cv. Kronos) and hexaploid (T. aestivum cv. Cadenza) wheat. 
Both TILLING populations have recently been sequenced using exome capture 
(Krasileva et al., 2017), allowing identication of TILLING mutants in target 
genes via DNA sequence searches of online databases (www.wheat-tilling.com/). 
Gluten gene mutants can be identied bioinformatically in these populations, but 
in practice few mutated gliadin genes have been found. e high copy number 
and sequence similarity make it dicult to correctly assemble gliadin sequences. 
As a consequence, assembly of sequence reads from a mutated population runs 
the risk of combining reads with point mutations from multiple genes into single 
sequence assemblies. If ltered out, this could lead to an articially low mutation 
frequency, but if not ltered, it could result in an over-estimation of the average 
number of mutations per gene. e use of Pacic Bioscience Circular Consensus 
Sequencing (PacBio CCS), which produces longer sequence reads, may solve some 
assembly issues. However, the resulting sequence data would likely still need to be 
combined with more accurate short read sequencing approaches (e.g. Illumina) to 
compensate for the relatively high PacBio sequencing error rate. 
γ-irradiation
γ-irradiation produces reactive oxygen species (ROS) that cause DNA oxidative 
damage or DNA single/double strand breaks. Double strand breaks are repaired 
by the cell’s non-homologous end joining (NHEJ) mechanism, which is a 
relatively error-prone process. Most errors lead to small deletions, although base-
pair substitutions, inversions, and small insertions also may be found (Cockram 
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et al., 2007; Morita et al., 2009). γ-irradiation therefore has the potential to mutate 
epitopes, remove whole gliadin genes, or even delete multiple gliadin genes. 
In barley, γ -irradiated accession Risø 56 (lacking B-hordeins), Risø 1508 (lacking 
C-hordeins) and R118 (an Ethiopian derived line which lacks D-hordeins) 
have been intercrossed to produce an Ultra Low Gluten variety (ULG 2.0) with 
a reduction of hordein (gluten) content below 5 ppm, thus allowing it to be 
classied as ‘gluten-free’ (Tanner et al., 2016). Subsequent crossing and selection 
with commercial varieties resulted in a variety with good malting and brewing 
characteristics (now marketed as ‘Kebari’). Interestingly, in several countries the 
products made with this variety cannot legally be marketed as gluten-free, solely 
because it contains barley. 
In wheat a strategy to introduce similar resources into commercial breeding 
programs could be based on screening γ-irradiated hexaploid wheat populations, 
such as that created in the UK from the commercial cultivar Paragon. We are 
currently screening these lines for changes in their gluten pattern on acid PAGE 
protein gels (Cooke 1995), prior to further characterisation of a subset of lines 
using approaches such as RNA-seq, qPCR, and/or proteomics. 
Deletion lines
Wheat deletion lines are available in which whole chromosomes, or parts of 
chromosomes, have been deleted by crossing monosomic with tetrasomic lines, or 
by introgression of alien addition or translocation lines into cv. ‘Chinese Spring’ to 
induce deletions (Endo and Gill, 1996). A set of these hexaploid wheat cv. ‘Chinese 
Spring’ deletion lines has been used to test the eects of individual deletions on the 
reduction of CD epitopes and on technological properties. A deletion line missing 
the short arm of chromosome 6D (6DS) in which the 6D α-gliadin locus had been 
deleted, was found to have strongly decreased mAb responses against Glia-α1 
and Glia-α3 epitopes (van den Broeck et al., 2009). e absence of these α-gliadin 
proteins also led to a signicant change in dough mixing properties and dough 
rheology, as the dough became stier and less elastic. In contrast, the deletion 
of the ω-gliadins, γ-gliadins and LMW-glutenin subunits on chromosome 1DS 
removed some epitopes, but the technological properties were retained (van den 
Broeck et al., 2009). 
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Transgenic approaches to reduce CD toxicity
Until recently, wheat was considered a challenging crop for genetic transformation; 
particle bombardment was routinely used for delivery of gene constructs, despite 
its many drawbacks in the quality of plants generated, which included multiple 
insertions with complex rearrangements. Furthermore, only a limited range of 
germplasm could be utilised. e development of supervirulent Agrobacterium 
tumefaciens strains (Wu et al., 2008), plus changes to media components and the 
introduction of new techniques (Wu et al., 2003; Risacher et al., 2009) improved 
eciency. However, the major breakthrough was made by Ishida et al. (2015), 
using the US so white wheat, Fielder. is new technology is implemented 
at NIAB and has been used to both extend the range of UK spring and winter 
germplasm which can be transformed, and to support a high throughput wheat 
transformation platform.
Gene silencing using RNA interference
RNA interference (RNAi) is a conserved biological process initially identied as 
a plant defence mechanism, in which a viral double-stranded RNA (dsRNA) is 
cleaved, silencing viral gene expression and inhibiting further replication (Ratcli 
et al., 1997). It has since been demonstrated that genetic transformation of plants 
with a construct encoding a dsRNA molecule similar to an endogenous plant 
single-stranded mRNA, triggers silencing of that specic plant gene (Waterhouse 
and Helliwell, 2003).
Two research groups have successfully silenced gliadin expression using RNAi. 
Becker et al. (2012) silenced α-gliadins, eliminating 20 dierent storage proteins 
from the grain, whereas Gil-Humanes et al. (2010) down-regulated gliadins from 
all groups in bread wheat, with an average reduction of 92.2% in the R5 mAb 
assay. T cell tests demonstrated a 10-100-fold reduction in DQ2 and DQ8 epitopes 
from α-gliadins, γ-gliadins and ω-gliadins. Indeed, total gluten extracts of three 
transgenic wheat lines did not to stimulate T cell clones. Down-regulation of 
γ-gliadins resulted in an increase of other gluten proteins in the grains (Pistόn et 
al., 2011), but little or no eect was found on dough strength or gluten and starch 
properties (Pistόn et al., 2011; Gil-Humanes et al., 2012; 2014).  
RNAi has also been used to suppress the DEMETER (DME) homoeologues 
in wheat (Wen et al., 2012). e DME gene encodes a 5-methylcytosine DNA 
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glycosidase that demethylates the promotor regions of gliadins and LMW-
glutenins in the wheat endosperm. is demethylation is essential for activation of 
the genes during endosperm development. DME RNAi transgenic plants showed 
a high degree of DME transcript suppression, resulting in >75% reduction in the 
amount of immunogenic prolamins. 
Providing their agronomic properties and yields are acceptable, such RNAi 
wheat lines may become candidates for the production of wheat-based products 
for ‘gluten-free’ or ‘low-in-gluten’ diets. However, it should be noted that these 
strategies require a stable integration of the RNAi cassette into the genome, 
thus resulting in a genetically modied (GM) plant. It is therefore subject to 
relevant national and international GM regulations, with the accompanying long, 
expensive, and uncertain procedure for market approval. 
Targeted mutagenesis to generate small indels and to delete genes
In contrast to mutation breeding, genome (gene) editing approaches aim to induce 
mutations only within specic targets. ese methods include Meganucleases, 
Zincnger nucleases, TALENs and CRISPR-Cas9. e regulatory status of plants 
and plant products derived from gene editing is currently unclear in the European 
Union (Sprink et al., 2016b). e current method of choice is CRISPR-Cas9 
due to its ease of use (e.g., Schaart et al., 2016). e CRISPR-Cas9 system was 
originally described as a bacterial defence mechanism against viral infections 
(Barrangou et al., 2007) and has since been customised to induce mutations and 
deletions at specic locations within a target gene in animals and plants (Zhou et 
al., 2014; Schaart et al., 2016). Mutations can be induced by introducing genomic 
RNA (gRNA) complementary to the gene of interest, plus an expression cassette 
to express the Cas9 endonuclease protein. e 20-mer gRNA directs the Cas9 
nuclease to the target site within the gene of interest, where the nuclease generates 
a double strand DNA break, three bases upstream of a specic protospacer 
adjacent motif (PAM). In plants, repair by NHEJ can result in insertion/deletions 
(indels) and other mutations that can result in benecial phenotypes (Belhaj et al., 
2013; van de Wiel et al., 2017). 
CRISPR-Cas9 and other site-directed nucleases have been successfully used to 
target homeologous genes in diploid and polyploid crops (Brooks et al., 2014; 
Lawrenson et al., 2015). In potato, the four copies of Granule-bound starch 
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synthase (GBSS) have been simultaneously modied to alter starch composition 
in tetraploid potato (Andersson et al., 2017). In bread wheat, the TALEN system 
was used to simultaneously mutate the three homoeologs of a TaMLO gene (Wang 
et al., 2014). Using a Cas9/guide ribonucleoprotein complex in plant callus, 
protoplasts and immature embryos, homoeologous genes were successfully edited 
in hexaploid and durum wheat (Zhang et al., 2016; Liang et al., 2017). In this 
system no foreign DNA is added to the plant cell, so plants developed in this 
manner might not be regulated as GM, as was recently propositioned by the U.S. 
Department of Agriculture’s (USDA) Animal and Plant Health Inspection Service 
(APHIS) in its proposed revision of regulations (USDA, 2017).
With these examples, it should also be feasible to modify and/or delete gliadin 
genes from hexaploid wheat. Such experiments are ongoing at NIAB and 
elsewhere.  In theory, several types of mutations could be generated in the gliadin 
genes. Small indels, within or upstream of the epitope region, can generate 
premature stop codons resulting in truncated proteins that lack CD epitopes or 
within modied epitopes which are no longer immunogenic. Moreover, genes of 
the α-, γ- and ω- gliadin families are each grouped at single loci on the short arms 
of the group 6 and 1 chromosomes, respectively. e α-gliadin Gli-2 loci contains 
α-gliadin interspersed with retrotransposons (Gu et al., 2004). e γ-gliadin locus 
also includes other prolamin and non-prolamin genes (Gao et al., 2007). Cas9-
mediated double strand breaks generated simultaneously in at least two gliadin 
genes on the same chromosome may result in a deletion of the intervening genes. 
Similarly, multiplexing gRNAs to target dierent sites within one gliadin gene 
could, together with a high mutation rate, delete only the immunogenic epitopes 
from the gliadin protein. 
Following wheat transformation with the gliadin gene editing construct, T1 seed 
could be analysed by Acid-PAGE separation of storage proteins, allowing rapid 
identication of plants with modied gliadin proles. Lines of interest could then 
be further analysed using methods such as deep sequencing of the genome, digital 
drop real-time PCR to determine gliadin copy number, and RNA-seq of developing 
grains to determine gene expression proles. In Chapter 4, we developed a process 
termed ‘Gluten genes Enrichment and Sequencing’ (GlutEnSeq), a protocol 
based on REnSeq methods (Jupe et al., 2013). is approach uses exome capture 
to enrich for gluten gene DNA from lines of interest for targeted re-sequencing, 
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preferably using a long read technology such as PacBio. Proteomics methods such 
as LC-QTOF-MSMS could be used to generate information on the composition of 
the gliadins produced in mutant lines, to quantify epitope levels, and to determine 
the occurrence of amino acid changes in epitope-harbouring peptide fragments. 
Prospects for the low gluten immunogenicity strategies
e food processing and wheat breeding strategies described represent two major 
routes for the development of cereal products with low gluten immunogenicity. 
Gluten-free products, made without wheat, barley or rye, are now increasingly found 
on grocery store shelves. However, these products typically require the inclusion of 
numerous additives, resulting in products that are oen less healthy than gluten-
based equivalents. To overcome this issue, other strategies have to be deployed.
Malting may be one of the most applicable methods for large-scale preparation of 
products with low gluten immunogenicity in the food processing industry, and it 
can even enhance sourdough fermentation when the malting process is not fully 
stopped. Similarly, sourdough is a traditional method used to increase loaf volume 
for bread baking which is possible to implement at industrial scale. Sourdough can 
also be combined with malting for further reduction of gluten immunogenicity. 
However, in addition to being more time consuming, sourdough has a taste that 
may not be widely accepted by consumers. 
While the separation of gliadins from glutenins, followed by substitution of 
gliadins for non-immunogenic oat avenins, is possible at a laboratory scale, 
large-scale implementation could be challenging and would require considerable 
infrastructure. From another perspective, the labelling and reduction in the use of 
vital gluten as an additive, used as source of protein to improve food structure, is 
a simple approach that would improve the healthiness of gluten-sensitive patients. 
Unlike GM breeding techniques, most of the candidate food processing techniques 
for making low gluten-immunogenic products are already implemented, and do 
not arouse ethical and political issues.
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From a wheat breeding perspective, very few polyploid wheat accessions show 
low gliadin immunogenicity, and those that do lack the agronomic characteristics 
required for commercial varieties. Introgression of the multiple low immunogenic 
gliadin loci involved into commercial varieties would be a complex undertaking. 
Since the expected result would only be a low-immunogenic line, not a CD-safe 
wheat, it is not anticipated to be a likely near-term target in wheat breeding.
Mutation breeding represents an attractive option to create wheat with low gluten 
immunogenicity. EMS TILLING on members of large gene families is challenging. 
Again multiple mutations are necessary, but if these occur in multiple plants then 
a programme of backcrossing followed by recurrent self-pollination would be 
required to remove background mutations, while retaining as many homozygous 
gliadin mutations as possible. However, as the gliadins are closely linked on 
chromosome 1 and 6, the recombination events required to combine all mutations 
in a single genetic background might be very rare. Induced mutations using 
γ-irradiation would be a more tractable approach, since multiple gliadin genes 
may be removed in single deletion events. is approach has been successfully 
undertaken in the diploid crop barley, where inter-crossing γ-irradiated lines, 
each missing a dierent prolamin gene family, generated an Ultra Low Gluten 
line that was successfully crossed with commercial varieties (Tanner et al., 2016), 
leading to a commercial variety with less than 20 ppm gluten. In theory, this line 
could be used for breeding more low-gluten barley varieties, although it would 
represent a major bottleneck for genetic diversity around these deletions. e 
variety also comes with a yield penalty. It is not expected that this line will be 
used by other breeders to generate low-gluten barley in the short term (Tanner, 
personal communication). However, the case for wheat may be stronger, as CD 
patients encounter wheat gluten in many food products, but can easily avoid 
barley by drinking only gluten-free beer.
e use of RNAi in wheat has been shown to be very ecient in decreasing 
the amount of gliadins expressed in the grain, without greatly altering dough 
properties. Nonetheless, the RNAi construct must be retained in the plant genome, 
resulting in a GM plant. Multiple factors restrict the commercial feasibility of using 
GM crops, including the costs of the regulatory process in those countries that 
allow GM crops (Laursen, 2016). However, this may not be the case with CRISPR-
Cas9 technology, as aer having generated inheritable mutations in target genes, 
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the T-DNA can be crossed out. Whether the resulting products, which do not 
contain foreign DNA, will be regulated as GM plants, is under debate (Sprink et 
al., 2016b). In some countries, process-based regulation may dene them as GM, 
whereas other countries with a more product-based approach may consider them to 
be identical to plants produced by conventional or mutation breeding. e European 
Food Safety Authority (EFSA) GMO panel (2015) considered the use of site-directed 
nucleases for inducing small deletions or insertions at a precisely dened location 
in the genome (SDN-1) as a form of mutagenesis. Acceptance by consumers may 
also be an issue (Ishii and Araki, 2016) but acceptance of products that are tailored 
to the needs of specic groups of consumers (e.g., hypoallergenic fruits, nuts etc.) is 
probably much higher than that of products tailored to the needs of producers or 
the general public (Schenk et al., 2008; 2011; Kronberger et al., 2014).
In the future, low gluten immunogenicity may become one of many traits included 
in commercial breeding programs. Achieving low gluten-immunogenic wheat, 
and ultimately food products, will require a great deal of eort and is likely to 
require changes in industrial grain and food processing processes. Despite these 
challenges, the importance of wheat (and other gluten-containing immunogenic 
grains) in the human diet, along with the increasing worldwide incidence of 
immunogenic diseases such as CD, means that it is imperative that these challenges 
are now addressed. 
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Abstract
Wheat grains contain gluten proteins, which harbour immunogenic epitopes 
that trigger Coeliac disease in 1-2% of the human population. Wheat varieties or 
accessions containing only safe gluten have not been identied and conventional 
breeding alone struggles to achieve such a goal, as the epitopes occur in gluten 
proteins encoded by ve multigene families, these genes are partly located in 
tandem arrays, and bread wheat is allohexaploid. Gluten immunogenicity can be 
reduced by modication or deletion of epitopes. Mutagenesis technologies provide 
a route to obtain bread wheat containing gluten proteins with fewer immunogenic 
epitopes. However, CRISPR/Cas9 has never been used to edit multigene families 
in a polyploid crop. In this study, we analysed the genetic diversity of over 600 
α- and γ-gliadin gene sequences to design six sgRNA sequences on relatively 
conserved domains that we identied near coeliac disease epitopes. ey were 
combined in four CRISPR/Cas9 constructs to target the α- or γ-gliadins, or both 
simultaneously, in the hexaploid bread wheat cultivar Fielder. We compared the 
results with those obtained with random mutagenesis in cultivar Paragon by 
γ-irradiation. For this, Acid-PAGE was used to identify T1 grains with altered 
gliadin protein proles compared to the wild-type endosperm. We rst optimised 
the interpretation of Acid-PAGE gels using Chinese Spring deletion lines. We 
then analysed the changes generated in 360 Paragon γ-irradiated lines and in 
117 Fielder CRISPR/Cas9 lines. Similar gliadin prole alterations, with missing 
protein bands, could be observed in grains produced by both methods. e results 
demonstrate the feasibility and ecacy of using CRISPR/Cas9 to simultaneously 
edit multiple genes in the large α- and γ-gliadin gene families in polyploid bread 
wheat. Additional methods, generating genomics and proteomics data, will be 
used to determine the exact nature of the mutations generated with both methods. 
Key words: Gene editing, CRISPR/Cas9, Mutation breeding, γ-irradiation, Wheat, 
Polyploid, Gene family, Gluten, α-gliadin, γ-gliadin, Epitope, Coeliac disease. 
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Introduction
Bread wheat (Triticum aestivum) is a staple crop worldwide and an important 
source of energy, bre and protein. e largest protein fraction in wheat grains is 
gluten, a polymer of glutenins and gliadins. Glutenins provide elastic properties, 
which are essential for bread dough quality, while gliadins provide viscosity with 
less impact on dough quality (Shewry et al., 2009). 
Wheat can cause allergies and/or intolerances aer consumption in susceptible 
individuals (Fasano, 2006; Gilissen et al., 2014). e most common disorder is 
an autoimmune reaction triggered by gluten immunogenic epitopes, known as 
coeliac disease (CD), which occurs in 1-2% of the human population (Dicke et 
al., 1953; Mäki et al., 2003; Rewers, 2005; Catassi and Fasano, 2014; Vriezinga et 
al., 2015). Currently, the only treatment is a gluten-free (GF) diet, excluding all 
wheat, barley and rye. On a daily basis, the GF diet is dicult to follow as wheat 
gluten is added to a large range of food products. In addition GF products are 
less healthy, with low levels of proteins and nutrients plus high levels of salt and, 
many additives are needed to simulate the unique rheological properties of wheat 
gluten (Caponio et al., 2008; Capriles and Arêas, 2014; Belz, 2016; Horstmann 
et al., 2016). Breeding for wheat varieties that are free of, or have reduced levels 
of immunogenic epitopes, is therefore a potential solution for healthier products 
which are safe to consume by CD patients (Jouanin et al., 2018; Ribeiro et al., 
2018).
Bread wheat is hexaploid, so each locus is present on the homoeologous 
chromosome pairs of the three dierent sub-genomes, A, B and D. Immunogenic 
epitopes occur in α-, γ- and ω- gliadins and to a lesser extent in low molecular 
weight (LMW) glutenins while high molecular weight (HMW) glutenins are 
mostly safe for CD patients and constitute the main gluten family responsible for 
bread dough quality (Payne et al., 1984; Shewry et al., 2009). Gliadin proteins are 
encoded by large gene families. ey are clustered together as repetitive sequences 
in characterised loci, do not contain introns but do include high numbers of 
pseudogenes (90% in case of α-gliadins (Van Herpen et al., 2006)). In hexaploid 
wheat, the α-gliadin genes are grouped in the Gli-2 locus on the short arm of each 
of the six chromosome 6 and number between 60 and 150 copies (Anderson et al., 
1997; Ozuna et al., 2015). e short arm of each of the six chromosomes 1 contains 
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the Gli-1 locus with around 40 γ-gliadins and the Gli-3 locus, with approximately 
16 ω-gliadins copies (Sabelli and Shewry, 1991), in hexaploid genome. Variants of 
the immunogenic epitopes that are not recognised by T cell receptors, also exist in 
hexaploid bread wheat (Mitea et al., 2010), but in all genotypes they are found in 
combination with other, highly immunogenic epitope variants (Van Herpen et al., 
2006; van den Broeck et al., 2010a; 2010b; Salentijn et al., 2013). ere is a trend 
between the level of immunogenicity of gliadin epitopes and the sub-genome by 
which they are coded (Salentijn et al., 2012); gliadins from genome B tend to be 
less immunogenic while gliadins from genome D trigger the most CD. Given this 
level of complexity, it is not surprising that conventional breeding alone has not 
yet succeeded in generating “gluten-safe” wheat, containing only gliadins with 
non-immunogenic epitopes or even with no gliadin at all (Smulders et al., 2015; 
Sánchez‐León et al., 2018; Jouanin et al., 2018). 
Alternatively, RNAi targeting all three gliadin families has successfully decreased 
97% of gliadin expression in bread wheat grain and the gluten extract did not 
stimulate CD patient T cells while dough quality was barely aected (Gil-Humanes 
et al., 2010; 2014). Similarly, Becker et al. (2012) decreased the expression of 20 
α-gliadins yet increased expression of other storage proteins. Wen et al. (2012) 
reduced the expression of DEMETER, preventing DNA-methylation changes and 
thus repressing glutenin and gliadin gene expression in the endosperm. As the 
transgenic RNAi construct remains in the wheat genome to silence the genes, these 
plants are subject to the hurdles of GM regulation. Another approach towards 
wheat with hypoimmunogenic gluten is mutation breeding. is method which 
is exempted from GM regulation, has recently been applied to develop “ultra-low 
gluten” barley (Tanner et al., 2016), and is being used to produce gluten-free beer 
in Germany. Developing wheat with hypoimmunogenic gluten using a similar 
approach is theoretically possible although it constitutes a greater challenge (Ribeiro 
et al., 2018). Wheat γ-irradiated lines have to be identied that miss large regions on 
the short arm of chromosomes 1 or 6, yet have lost gliadin or LMW-glutenin genes 
in one of the three homoeologous genomes. Plants with these 12 dierent events 
have to be self-fertilised to become homozygous for the deletion and then inter-
crossed to obtain hypoimmunogenic gluten while maintaining bread wheat unique 
baking quality conferred by HMW-glutenin loci. Gene editing using CRISPR/Cas9 
represents an alternative approach that enables modication or deletion of the 
immunogenic gliadin genes in order to generate non-immunogenic gluten while 
18060-Aurelie_Jouanin_PM.indd   66 02-01-19   12:18
Gene editing of α- and γ- gliadin families in bread wheat
67
2
retaining the viscosity provided by gliadins required for good bread dough quality. 
CRISPR/Cas9 has successfully been used in polyploid wheat to induce mutations 
in all six alleles of single copy genes. Zhang et al. (2016) targeted up to four genes 
in bread wheat, using various gene editing approaches. Gil-Humanes et al. (2017) 
targeted two single-copy genes simultaneously for gene targeting (i.e. with a DNA 
repair template) without integrating a Cas9 construct in the genome. CRISPR/
Cas9 has been used once before to modify gluten, when Sánchez‐León et al. (2018) 
targeted multiple α-gliadin genes.
In this study, we have transformed hexaploid bread wheat cultivar Fielder with 
constructs containing Cas9 and combinations of single guide RNAs (sgRNA) 
targeting specic sites upstream of, or within, the CD epitopes in the α-gliadin 
as well as the γ-gliadin gene family. ese constructs would potentially create 
nucleotide changes and small indels in the epitope regions, or deletion of the 
epitope regions, either in, or out of frame. In the ideal scenario, small in-frame 
mutations would be generated, producing non-immunogenic gliadins which 
retained the desired rheological properties. Small out of frame mutations upstream 
the epitope region, would generate a knock out of the gliadin that should prevent 
the immunogenicity but may slightly decrease bread dough quality. However, 
the transcription of the truncated protein could prevent the oen reported 
compensation by other gliadin genes (Pistόn et al., 2011; Galili et al., 1986). Since 
gliadin genes are clustered as repeat sequences, simultaneously targeting non-
consecutive genes could generate the deletion of intervening gliadin gene copies. 
is possibility, similar to but more precise than γ-irradiation events, presents 
the advantage of fully supressing the epitopes, but oen triggers compensation of 
expression by the remaining gliadin genes. is attempt to use CRISPR/Cas9 to 
mutate gliadin families in polyploid wheat was a pilot experiment. e aim was to 
mutate as many gliadin genes as possible, in any manner, to test whether CRISPR/
Cas9 could be an appropriate method to simultaneously modify sucient gene 
copies in order to change qualitatively and/or quantitatively the gliadin content 
in wheat grains. An additional aim was to study the frequency of the dierent 
mutation types and to identify the most relevant methods to use in order to screen 
for wheat grain with mutated gliadins. 
Due to the high sequence complexity, variability and number of targeted gliadin 
genes, a simple PCR on wild type plants would already give several bands. A 
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CAPS assay to reveal mutations by identifying restriction site loss, would not be 
possible since not all sequences would carry the site. In addition, regular gene 
cloning and sequencing would not be an ecient pre-screening method, given 
the uncertainly that any editing occurred in targeted gliadin genes. Indeed, the 
cloning of the 50 to 100 single dierent gene copies present in a plant cannot be 
guaranteed and would require deep sequencing for every single Fielder-CRISPR 
plant tested. In addition, as many gliadin genes are pseudogenes (van Herpen et 
al., 2006), the actual inuence of potential mutations on the phenotype could 
not quickly be assessed. Moreover, using this approach on cDNA would have 
been inappropriate at this stage since mRNA extraction would have to be done 
on endosperm from immature grain, without damaging the embryo required to 
grow the potential mutant progeny. Advanced proteomics techniques for gliadin 
identication are currently under development at WUR. However, being both 
time consuming and expensive, they would be more appropriately used as a nal 
epitope characterisation method, rather than pre-screening one. Consequently, 
Acid-PAGE was employed as a rst screening method to identify gliadin protein 
prole changes simultaneously in targeted and untargeted gliadin gene families. 
is method has the advantage of being cheap and revealing mutations in 
expressed genes with an impact on the proteome, necessary to develop wheat lines 
with hypoimmunogenic gluten. However, this method reveals mainly full gene 
copy deletions, non-sense or o-frame mutations implying absence or truncation 
of gene translation but not mis-sense or small in frame mutations. 
We compared the changes that occurred in our Fielder-CRISPR gene-edited lines 
with those we found in selected lines from a γ-irradiated mutant collection in 
variety Paragon (Shaw et al., 2013), and in selected chromosome arm deletion 
lines in the reference wheat cultivar Chinse Spring (Sears, 1966; Endo, 1988).
Materials and methods
Gliadin sequence alignment 
Over 438 α-gliadin gene sequences from 30 wheat accessions and 187 γ-gliadin 
gene sequences from hexaploid wheat were downloaded from NCBI database in 
September 2014 and July 2015 respectively, translated into amino acid sequences, 
manually aligned using Mega_6 and clustered based on their combination of 
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known CD epitopes (Sollid et al., 2012). To deduce the sub-genome of origin of 
dierent epitopes, which is linked with the level of immunogenicity, sequences 
from diploid bread wheat ancestors Triticum monococcum and Triticum 
urartu (A genome), Aegilops speltoides (for the B genome), Aegilops tauschii (D 
genome) and tetraploid durum wheat Triticum turgidum (genome AB) were 
added that were present in NCBI or generated at WUR-PBR (Schaart, personal 
communication). To complete the alignments and facilitate sgRNA design, 
primers F: 5’-ATGAARACMTTTCYCATC-3’ (Salentijn et al., 2013) and R: 
5’-YAGTTRGTACCRAAGATGM-3’ were used to clone and sequence seven 
intact α–gliadin genes from Fielder, the spring  bread wheat variety used for 
transformation. ese α-gliadin gene sequences were similar to the one already 
present in the databases. is incorporation increased the total number of 
sequences used to 1273 α-gliadins and 442 γ-gliadins.
sgRNA protospacer design
Six sgRNA protospacers were designed on conserved regions that were identied 
based on the sequence alignments and were present in the sequences of the 
hexaploid wheat cultivar Fielder. Of these six sgRNAs, three targeted α-gliadins 
and the other three targeted γ-gliadins (Fig. 2). In each case, one targeted 
downstream of the signal peptide, the other two targeted in or near epitopes. 
ese sgRNA target the complementary DNA strand and should therefore be 
reverse-complemented to be found in the Genbank sequences.
sgRNA_α87: 5’-GATTTTGTGGCTGCAATTG-3’ targets α-gliadins downstream 
the signal peptide, P87
sgRNA_α213: 5’-ATGGTTGTTGTGATGGAAA-3’ targets α-gliadins upstream the 
epitope region, P213
sgRNA_α324: 5’-GTTGTGGTCGAAATGGTTG-3’ targets α-gliadins downstream 
the epitope region, P324
sgRNA_γ86: 5’-TTGTTGTGGCCATTGTACT-3’ targets γ-gliadins downstream 
the signal peptide, P86
sgRNA_γ272: 5’-AATGGTTGTTGTGGTTGCTG-3’ targets γ-gliadins within the 
epitope region, P272
sgRNA_γ603: 5’-TGCTGGGGGAATGATTGTTG-3’ targets γ-gliadins downstream 
the epitope region, P603
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ese sgRNA protospacers where tested in silico for the absence of o-targets 
using BLAST in the Ensembl! plant wheat database, for absence of secondary 
structures using RNAfold web server and for absence of cross-dimers between 
multiplexed sgRNAs using ermoFisher Scientic Primer Analyzer. 
Each sgRNA, including a wheat-optimised U6 promoter, gliadin-specic 
protospacer and sgRNA scaold sequence (Shan et al., 2013), anked by multiple 
unique restriction sites, was individually synthesised by GenScript.
 
CRISPR/Cas9-sgRNA constructs
Type II-A Streptococcus pyogenes 2NLS-Cas9 gene, codon-optimized for rice and 
wheat expression, was cloned from the pJIT163-2NLS-Cas9 plasmid (Shan et 
al., 2013). Its ribosome binding site (RBS) “CACC” was mutated into “CCACC”, 
using site directed mutation PCR approach, for better expression in wheat. e 
optimised 2NLS-Cas9 gene plus CaMV terminator sequence was transferred into 
binary vector pSC4Act-R1R2-SCV (Perochon et al. 2015), containing a rice actin 
promoter to drive the expression of the Cas9 gene. Each sgRNA, was combined 
using multiple unique restriction sites and then integrated into the nal binary 
plasmids (Fig. 1) (named pAJ2_ followed by sgRNA names).
Figure 1. CRISPR/Cas9 T-DNA construct 2α _sgRNA.
Construct 2α_sgRNA that contain sgRNA_ α213 and sgRNA_ α324. e four T-DNA constructs generated 
are similar, only the number and nature of sgRNA integrated are dierent.
Four T-DNA constructs were produced by combining dierent sgRNAs, using 
multiple unique restriction sites:
Construct 1α_sgRNA = sgRNA_α87
Construct 2α_sgRNA = sgRNA_α213 + sgRNA_α324 
Construct 3γ_sgRNA = sgRNA_γ86 + sgRNA_γ272 + sgRNA_γ603
Construct 2α3γ_sgRNA =  sgRNA_α213 + sgRNA_α324 + sgRNA_γ86 + 
sgRNA_γ272 + sgRNA_γ603 (i.e., it combines 
Construct 2α_sgRNA and Construct 3γ_sgRNA). 
18060-Aurelie_Jouanin_PM.indd   70 02-01-19   12:18
Gene editing of α- and γ- gliadin families in bread wheat
71
2
Stable transformation and generation of Fielder-CRISPR plants and 
derived grains 
e CRISPR/Cas9-sgRNA binary vectors were transferred to A. tumefaciens and 
used to transform immature embryos of Fielder, (Segovia et al., 2014). Selection 
of transformed tissues was based on the presence of the nptII gene conferring 
resistance to the G418 antibiotic. Regenerated T0 plantlets were transferred to 
soil and tested for T-DNA copy number using an nptII-based qPCR assay (Milner 
et al. 2018), for presence of Cas9 gene and all sgRNA using PCR, and whether 
Cas9 was expressed using RT-PCR. Plantlets positive in all these tests were grown 
in climate controlled growth chambers, bagged during anthesis, and T1 grains 
harvested. 
e individual T1 grains were rst cut transversally, alongside the embryo, so that 
this could be germinated later. e resulting endosperm section was then cut in 
half longitudinally. One half was used for Acid-PAGE. Selected T1 embryos were 
germinated in Petri dishes containing lter paper soaked with water. Seedlings 
were potted in compost aer sucient root development and transferred to growth 
chambers until grain set. Ears containing T2 grains were harvested individually. 
Other plant materials
Chinese Spring (CS) wild type (WT) and selected CS Kansas deletion lines (Endo, 
1988; Endo and Gill, 1996) that lacked parts of chromosome 1 or 6, were obtained 
from Kansas State University (Table 1). In addition, CS nullisomic-tetrasomic 
lines (Sears, 1966) were obtained from the Germplasm Resources Unit (GRU JIC, 
Norwich, UK) (Table 1). e CS lines were used to set up and optimise the Acid-
PAGE separation. 
e Paragon γ-irradiated population (Shaw et al., 2013), obtained from JIC 
(Norwich, UK) based on hexaploid spring wheat cultivar Paragon, was also 
screened. Mature grains from a subset of 360 lines self-pollinated for 4 generations 
(M4) were analysed on Acid-PAGE. e lines screened were numbered from P3-
47 to P6-79 and from P10-19 to P10-96 (Table 1). 
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Table 1. List of Triticum aestivum lines used to set up the screening method and subsequent comparison.
Triticum aestivum Lines Description
Cultivar 
'Chinese Spring'
(CS)
WT Control
1AS-1
1AS-3
1BS-9
1BS-10
1DS-1
1DS-5
Kansas Deletion lines 
missing part of Chr 1 short arm
that contain  Gli-1 and/or Gli-3 loci 
where  γ- and/or ω-gliadin genes are located
6AS-1
6BS-4/5BS-2
6DS-4
6DS-4/1BS-19
Kansas Deletion lines 
missing part of Chr 6 short arm
that contain  Gli-2 loci 
where α-gliadin genes are located
N1AT1D =  1DDB
N1AT1B = 1BBD
N1DT1A = 1AAB
N1DT1B = 1BBA
N1BT1D = 1DDA
N1BT1A = 1AAD
Nullisomic-tetrasomic lines  
with one homoeologous pair of Chr 1
that contain  Gli-1 and/or Gli-3 loci 
where  γ- and/or ω-gliadin genes are located 
substituted by another homoeologous pair of 
Chr 1
N6AT6D =  6DDB
N6AT6B = 6BBD
N6DT6A = 6AAB
N6DT6B = 6BBA
N6BT6D = 6DDA
Nullisomic-tetrasomic lines  
with one homoeologous pair of Chr 6
that contain  Gli-2 loci 
where  α-gliadin genes are located 
substituted by another homoeologous pair of 
Chr 6
Cultivar 
'Paragon'
WT Control
Line P3-47 to P6-79 and
Line P10-19 to P10-96
360 γ-irradiated lines 
M4 generation
Acid-Polyacrylamide Gel Electrophoresis (Acid-PAGE)
For each Fielder-CRISPR plant, a minimum of 8 T1 grains were screened 
individually, alongside Fielder. e grain samples were loaded in duplicate. As 
Fielder exhibit some heterogeneity in its storage protein prole on Acid-PAGE, 
grains from multiple Fielder plants were loaded alongside on the gel. For T2, 
four grain samples from four dierent ears were loaded in duplicates. A similar 
procedure was applied for screening of CS and Paragon, with the exception that 
only 2 grains were tested as they are homogeneous for the mutations due to several 
generations of self-pollination.
Each half endosperm sample was crushed into ne powder, and the gliadin fraction 
extracted overnight at 4°C, in 150 µl of 25% dichloroethanol solution containing 
0.05% Pyronin Y. Duplicate 30µl samples were loaded in wide slots on 13% 
polyacrylamide gels (acrylamide-bis 19:1) and run at 180V, for 4 hours at room 
temperature (adapted from Cooke, 1987). Gels were stained overnight in 10:1 
solution of 15% trichloroacetic acid (TCA): industrial methylated spirits (IMS) 
containing 10g/L Coomassie Brilliant Blue G250, then destained overnight in water.
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Results
Sequence alignment and sgRNA design 
Genomic sequences of 1273 α-gliadin and 442 γ-gliadin genes from several species 
and varieties were translated into protein sequences and manually aligned to 
infer position of epitope and most conserved regions, and to superimpose this 
information on the DNA sequence. e alignment was optimised by hand, especially 
around the repetitive parts of α- and γ-gliadin as presented in Supplementary 
Figure 1 and 2, respectively. ese Supplementary Figures are useful to quickly 
visualise the species and homoeologous genome to which they are associated and 
the sub-grouping based on the α- and γ-gliadin sequence pattern and the position 
or absence of the dierent overlapping CD canonical epitopes. 
In α-gliadins, ve protein subgroups exist based on sequence patterns, two 
associated to genome A, two to genome B, and one that presents a unique amino-
acid variant specic for genome A or D. Some CD epitopes were present or absent 
in specic protein subgroups. As a consequence, some CD epitopes are specic 
for one homoeologous genome (Suppl. Fig.1 and 2). Pseudogenes were identied 
having similar sequences to intact genes but harbouring early stop codons at 
various places (Anderson, 1991). 
In γ-gliadins, six protein subgroups exist based on sequence patterns, two 
associated to genome A, one to genome B and the three others are at least not 
associated to genome A (Suppl. Fig. 1 and 2). Some CD epitopes were only 
present in some specic protein subgroups. However, this does not lead to a 
good correlation between epitopes and a homoeologous genome, most epitopes 
occur in γ-gliadins from all three genomes. (Suppl. Fig.1 and 2). Six groups of 
pseudogenes were observed that did not simply contain an early stop codon but 
also had divergent sequences compared to the 6 groups of full length γ-gliadins. 
is is consistent with the hypothesis of Goryunova et al. (2012) that the various 
γ-gliadin groups largely predate the evolution of the genomes within the genus 
Triticum/Aegilops. Consequently, sgRNA were designed focusing on full length 
genes while considering pseudogenes as much as possible.
Six sgRNAs were designed, three of which target α-gliadins (Fig. 2a) and the other 
three targeting γ-gliadins (Fig. 2b). In each gene family one target site was placed 
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upstream in the gene, soon aer the signal peptide, with the aim of disrupting 
the open reading frame and the two others were near or in the innate or DQ2.5 
coeliac disease epitope regions in order to modify or remove the epitope region. 
Figure 2. Alignment of α- and γ-gliadin protein sequences with sgRNA position and potential sites of gene 
editing.
A representation of the protein sequence alignments of α-gliadins (a) and γ-gliadins (b) based on a total 
of 438 and 187 DNA sequences, respectively. e variation in the sequences form patterns which are 
grouped here and associated to the genome in which they are mostly found (A, B, D on the le side of 
each group), based on comparison of hexaploid wheat sequences with sequences from diploid relatives. 
e dierent gliadin protein domains are indicated and the position of the CD immunogenic epitopes are 
boxed. e DQ2.5 epitopes box includes the DQ2.5-α1, - α2 and - α3 epitopes (Supplementary Fig.1 and 
2). e sgRNAs targeted motifs are highlighted in yellow and the potential gene editing sites are marked 
with scissors. SgRNA_γ272 may cut multiple times, depending on the number of repetitions of the most 
abundant γ-gliadin CD epitope, DQ2.5-glia-γ4c, which it targets. Details on the alignment, sequence 
patterns and CD epitopes can be found in Supplementary Fig. 1 and 2. 
Our alignment shows that as a result of the existing sequence dierences, 
largely within the DQ2.5 epitope region (Suppl. Fig.1 and 2), one sgRNA cannot 
theoretically target all the intended sites present in the hexaploid bread wheat 
genome. For instance, sgRNA_α324 may not target the two groups of genes 
associated with genome B while sgRNA_α87 may only target some genes related 
to one of the two α-gliadin groups of the B genome. sgRNA_α213, however, should 
recognise its target motif in all 5 dierent α-gliadins DQ2.5 groups, regardless of 
the genome they are associated to (Fig 2a). For the γ-gliadins, sgRNA_γ86 may 
not target one of the DQ2.5 groups typical for hexaploid wheat (possibly genome 
D) and sgRNA_γ603 may not target a group of genes associated to genome A. 
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sgRNA_γ272 should target most of the γ-gliadin DQ2.5 sequences and enable 
cutting them between 1 and 6 times depending on the number of repetitions of 
the targeted motif, corresponding to the most abundant γ-gliadin CD epitope 
DQ2.5-glia-γ4c, throughout the epitope region (Fig 2b; Suppl. Fig.2). 
Multiplexing sgRNAs in clustered gene families can generate many dierent types 
of mutation (Fig. 3). Indeed, a simultaneous Cas9 cut within two non-consecutive 
gliadin genes can delete the intervening genes. In addition, a simultaneous Cas9 
cut upstream of and downstream of the epitope region, may enable a minimal 
deletion of only the potentially immunogenic region. Finally, simple single cuts 
may create small indels or base substitutions at that site. 
Figure 3. Representation of one α-gliadin Gli-2 locus and dierent mutation types potentially induced by 
CRISPR/Cas9. 
α-gliadin Gli-2 loci representation with genes clustered and dierent types of mutations that can be induced 
by sgRNA. Simultaneous cuts in non-consecutive genes can delete the intervening genes. Similarly, two 
simultaneous cuts anking the epitope can delete only this region, whilst simple small indels or base 
substitutions can also occur.
Generation of CRISPR/Cas9_sgRNA constructs and transgenic Fielder 
wheat plants 
Four dierent CRISPR/Cas9_sgRNA binary constructs were created containing 
Cas9 plus dierent combinations of the sgRNAs (Table 2), transferred to A. 
tumefaciens and used in stable transformation experiments with immature 
embryos from cultivar Fielder. e number of T0 plants regenerated and 
expressing the Cas9 (as determined by RT-PCR on leaf samples) are presented in 
Table 2, together with the number of plantlets harbouring 1or 2 copies of the nptII 
gene, part of the T-DNA containing the CRISPR/Cas9 construct.
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Table 2. Summary of T0 Fielder-CRISPR regenerated plants expressing Cas9 and their transgene copy 
number
T0 Fielder wheat plants
Regenerated Expressing 
Cas9
1 or 2 transgene 
copies   
Construct α1_sgRNA
sgRNA_α87
40 38 (95%) 21 (55%)
Construct α2_sgRNA
sgRNA_α213 + sgRNA_α324
32 12 (38%) 4 (33%)
Construct γ3_sgRNA
sgRNA_γ86 + sgRNA_γ272 + sgRNA_γ603
36 35 (97%) 26 (74%)
Construct α2γ3_sgRNA 
sgRNA_α213 + sgRNA_α324 + sgRNA_γ86 + 
sgRNA_γ272 + sgRNA_γ603
42 32* (76%) 12 (38%)
TOTAL 150 117 (78%) 63 (54%)
For each construct, between 32 and 42 plants were regenerated. e * indicates that 34 plants 
expressed Cas9 but 2 were discarded since they did not contain all 5 sgRNAs. On average, 78% 
of plants expressed the Cas9, among which 54% had 1 or 2 npTII copies.
A total of 150 T0 Fielder-CRISPR plantlets were regenerated, using the four 
constructs, among which 31 plants did not express the Cas9, had prematurely 
aborting grains or died. Among the plants carrying the T-DNA, only two plants 
transformed with the α2γ3_sgRNA construct did not carry all the sgRNAs. 
Generally, T0 wheat plants generated 4 to 6 ears and 80-250 T1 grains. A subset of 
grains samples was analysed using Acid-PAGE.
Acid-PAGE 
Acid-Polyacrylamide Gel Electrophoresis has been used for decades to 
dierentiate and identify wheat varieties based on their characteristic gliadin 
protein prole (Cooke, 1987). It is a non-denaturing procedure, separating on a 
combination of molecular weight and charge. Here, we used it to identify grains 
with modied gliadin protein proles from Fielder-CRISPR plants compared with 
wild-type Fielder, and to determine the type of changes that had occurred. We rst 
optimised the interpretation of the gels using Chinese Spring deletion lines, and 
also analysed a Paragon γ-irradiated population to be able to compare the type of 
changes induced by irradiation mutagenesis with those induced by gene editing.
Chinese Spring
Chinese Spring (CS), a model variety for hexaploid bread wheat, plus the 
CS nullisomic-tetrasomic and CS Kansas deletion lines, identied as either 
missing and/or having substitutions of gliadin genes on known homoeologous 
chromosomes arms, were used to set up and optimise the gliadin protein prole 
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screening method. We renamed the nulli-tetra lines based on the homoeologous 
genomes they contain, e.g. N1AT1B was renamed 1BBD and lack 1A.
Figure 4. Acid-PAGE of Chinese Spring deletion lines showing altered endosperm gliadin protein proles.
Gliadin extracts from grains of Chinese Spring nulli-tetra lines and deletion lines were run 
on non-denaturing Acid-PAGE alongside a gliadin extract from Chinese Spring. e lanes 
displayed next to each other have been run alongside each other on the same gel but each panel 
represents a dierent gel. Each sample was always run alongside CS as a control. e black and 
grey arrows point at the changes in the protein groups from the deleted chromosome arms and 
in others respectively. CS gliadin prole in absence of a) Chr1-AS, b) Chr1BS, c) Chr1-DS, d) 
part of Chr6-AS, e) Chr6-DS, f) part of Chr1-BS and Chr6-DS.
ese deletion and substitution lines revealed dierences in gliadin protein 
patterns compared with to CS. Various bands were missing or shied on the 
Acid-PAGE, depending on which chromosomes (Chr1 γ- and ω-gliadins or Chr6 
carrying α-gliadins) and which homoeologous genome (A, B or D) were changed 
(Fig. 4). As expected, deletion lines and nullisomic-tetrasomic lines supported 
each other. For instance, in panel e) and f) of Fig. 4, the same two α-gliadin proteins 
are missing at the bottom of the gel. Band shis or changes in band intensity were 
sometimes also seen in a gene family for which the loci had not been changed, 
such as ω-gliadins in case of a deletion in chromosome 6 (Fig. 4d, 4e). Deletion 
or substitution of genome 6B did not show any perceptible change, neither in the 
α-gliadin proteins, nor in the other gliadin families (picture not shown).
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In addition to optimising the method, the use of the CS set of lines gave indications 
on the position of bands from α-, γ- and ω-gliadins which are specically associated 
with gliadin proteins originating from A, B or D homoeologous genomes. is 
will constitute benchmarks to infer, on non-characterised mutant lines, which 
homoeologous chromosome is the most likely to have been impaired. 
Paragon γ-irradiated population 
Wheat grains from various Paragon γ-irradiated lines were screened using Acid-
PAGE. Dierences of gliadin proteins proles were observed between Paragon 
and M4 grains in 14 out of 360 γ-irradiated lines tested (3.88%). 
Figure 5. Acid-PAGE of selected Paragon γ-irradiated mutant lines that showed changes in gliadin protein 
proles.
Gliadin extracts from grains of the M4 generation of Paragon γ-irradiated mutant population were run on 
non-denaturing Acid-PAGE alongside a gliadin extract from Paragon (Paragon). Each panel represent a 
dierent gel. e lanes displayed next to each other have been run alongside each other. e black arrows 
point at the changes observed in the irradiated lines.  a) and b) α-gliadin bands missing, probably correlated to 
changes in Chr6-AS, c) and d) α-gliadin bands changes that are dierent from any change observed in deletion 
lines and nullisomic-tetrasomic lines, e) γ- and ω-gliadin bands missing, probably due to changes in 1BS, f) 
γ-gliadin bands missing and ω-gliadin bands shis and intensity changes, probably due to changes in Chr1-AS.
ree lines showed dierences in only the α-gliadins (Fig. 5a, 5b, 5c), one line 
displayed variations in only the γ-gliadins while four lines presented variations in 
only the ω-gliadins. One line showed dierences in both α- and γ-gliadins (Fig. 
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5d) while two lines presented changes in both γ-and ω-gliadins (Fig. 5e, 5f). No 
line screened showed variations in all three gliadin families (Table 3).
By comparing the Paragon mutant gliadin protein proles with those obtained 
from CS deletion lines and CS nullisomic-tetrasomic lines, it was possible to 
infer the homoeologous chromosome location of the gliadin genes altered by 
γ-irradiation mutagenesis in these lines (Table 3).
Table 3. γ-irradiated Paragon lines and the likely altered chromosome arms underlying the gliadin protein 
prole variations
Altered protein prole Altered protein prole
α γ ω α γ ω
P3-75 6AS   -    -  P6-43 6DS 1AS   -  
P4-34   -  1BS   -  P6-57 6AS   -    -  
P4-84   -  1BS 1BS P6-59 6DS   -    -  
P4-86   -  1BS 1BS P6-60   -    -  1AS
P5-20   -  1AS 1AS P6-65   -    -  1AS
P5-53   -    -  1BS P6-74   -    -  1AS
P6-02   -  1AS 1AS P10-73   -  1AS 1AS
Paragon γ-irradiated lines and the gliadin families in which altered protein proles are seen on Acid-PAGE. 
e chromosome arms inferred to be altered by the γ-irradiation and to cause the protein proling changes 
are indicated in the table. In total, 4 lines showed changes in the α-gliadins, 7 lines had dierences in the 
γ-gliadins and 9 lines displayed variations in the ω-gliadins. P6-57 had large changes in α-gliadins from 
most likely 6AS. 
Fielder CRISPR-Cas9 plants
For all of the 117 T0 plants expressing the Cas9 mRNA and carrying the full 
complement of expected sgRNAs, 8 or more randomly selected T1 grains per 
plants were screened on Acid-PAGE. Dierences in the gliadin protein prole 
were observed between Fielder wild type and T1 grains harvested from some T0 
CRISPR/Cas9 plants (Fig. 6; Table 4.). 
Modied proles were found for each of the 4 CRISPR/Cas9_sgRNA constructs 
used (Fig. 6). When a modied grain was found, most of the other T1 grains of 
that transformed plant showed a wild type prole. When several mutated T1 
grains were found from one T0 plant, in some cases they contained similar prole 
modications (Fig. 6e), in other cases the changes were dierent. Similarly altered 
gliadin protein proles were sometimes seen in grains coming from dierent T0 
individuals carrying the same CRISPR/Cas9_sgRNA constructs or even from 
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dierent constructs (Fig. 6a, 6d, at α-gliadin level). e “clear type of protein 
prole changes” observed were protein bands disappearing or appearing on the 
gel (Fig. 6a, 6b, 6e). Bands could also be present at a dierent intensity (Fig. 6c, 6d) 
or have a shied position (Fig. 6c, 6e) that was not always very clear and therefore 
qualied as “potential changes” type. e term “any changes” refer to both clear 
and potential changes. e changes in protein expression were mostly present in 
the targeted gliadin families. However, dierences in intensity or shis in size were 
sometimes seen in bands associated with non-targeted gliadin families (Fig. 6c, 
6d, 6e). Based on the deletion of 3 α-gliadin bands obtained with construct α1 in 
grain α1-14_G1, 21 more grains from the T0 α1-14 plant were screened. However, 
none of them had an altered gliadin protein prole compared with Fielder. 
Figure 6. Acid-PAGE of  Fielder-CRISPR T1 grains showing altered gliadin protein proles
Gliadin extracts from Fielder-CRISPR T1 grain from each of the 4 constructs were run on non-denaturing 
Acid-PAGE alongside the gliadin extract from Fielder wild type. Each panel represent a dierent gel. e 
lanes displayed next to each other have been run alongside each other. e start of the sample names refers 
to the constructs with the sgRNAs they include (α1, α2, γ3 or α2γ3), followed by the T0 plant line and grain 
number. e black and grey arrows point respectively at the changes intended or unintended by the 
construct present in the plant that set the grains. a) α-gliadin bands missing likely related to mutations on 
Chr6-AS, b) α-gliadin bands missing or lower expressed likely related to mutations on Chr6 in all 3 
homoeologous genomes, c) ω-gliadin bands shied up and γ-gliadin band with lower expression level likely 
related to mutations on Chr1-BS or DS, d) ω- γ- and α-gliadin bands with lower expression likely related to 
mutations on Chr6-AS, e) ω-gliadin bands shied up and γ-gliadin bands missing likely to be related to 
Chr1-AS, similar mutant prole in two dierent T1 grains from the same T0 plant. 
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e constructs diered signicantly in mutation eciency for any changes 
(Chi square, P= 0.015) but not for clear changes (P=0.097) (Table 4). Construct 
α1_sgRNA had the lowest mutation eciency, with very low number of grains 
showing any mutations on Acid-PAGE while having the highest number of T0 
plants expressing Cas9. Construct α2_sgRNA had the lowest number of T0 plants 
expressing Cas9 but the highest percentage of grains showing clear changes. 
Construct γ3_sgRNA generated the highest number of grains with any sort of 
mutations. Construct α2γ3_sgRNA gave only 3 plants with clearly mutated grains 
but these plants gave 3 or 4 mutant grains each, which is the highest ratio of 
mutated grain per plant (Table 4). 
It was observed that construct γ3_sgRNA and construct α2γ3_sgRNA produced 
grains which relatively oen had dierences in ω-gliadin expression although 
these constructs do not target this gliadin family. is phenomenon was rarely 
observed with construct α2_sgRNA and seen only once with construct α1_sgRNA. 
No correlation was found between transgene copy number present in a plant and the 
number of grains presenting an altered gliadin protein prole, nor in the number of 
mutations seen per grain. Since the Cas9 expression was observed by RT-PCR, but 
was not quantied, no correlation can be made between its expression level and the 
number of gliadin protein changes observed on the Acid-PAGE.
Of the T1 grains obtained with α1_sgRNA construct, 3 embryos were grown to 
mature plants and from the obtained T2 grains 8 were tested. ese grains all had 
a similar prole to the wild type. An additional 100 T2 grains were tested from 
the most promising α1-14_G1 T1 plant from which the T1 grain clearly displayed 
abnormal protein prole, but also these had a normal prole. T2 grains from other 
CRISPR/Cas9 constructs remain to be tested.
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Discussion
In this study, CRISPR/Cas9 was deployed in hexaploid bread wheat to target 
gliadin genes. e Cas9-induced mutations were designed to remove gliadin 
gene copies or disrupt immunogenic epitopes in gliadins, preventing them from 
triggering the human immune system and causing coeliac disease upon wheat 
gluten consumption. At the start of this study, CRISPR/Cas9 had not been used 
to target large clusters of repeated gene families, such as the gliadins, in polyploid 
crops such as hexaploid wheat. erefore, the challenge was not only to generate 
such mutant plants but also to develop screening methods to identify them and 
characterise their mutations further. 
Gliadin alignments, sgRNA design and Fielder-CRISPR lines generation
In the absence of α- and γ-gliadin genomic or proteomic sequences from the 
hexaploid wheat cultivar Fielder used for gliadin gene editing experiments, and 
considering the time and resources necessary to fully clone and sequence these 
gene families, an alternative approach has been used mainly based on publically 
available data. Only seven α-gliadins from Fielder were cloned, sequenced 
and merged with all α-gliadin genomic sequences from Genbank. e Fielder 
sequences were dierent to one another but similar to some sequences already 
present in Genbank. Deduced protein sequences were manually aligned to enable 
inferring gliadin epitope positions and conserved regions in gliadin gene sequences 
across cultivars. Using this approach, it is possible to design sgRNA targeting as 
many genes as possible near their epitope region, not only in Fielder but also in 
many other dierent cultivars. It also revealed the presence of groups based on 
sequences patterns, some associated to specic homoeologous genomes, similarly 
to what was observed by Ozuna et al. (2015). e same approach was used for 
γ-gliadins, although no Fielder γ-gliadins were sequenced. e association of CD 
epitopes and genomes of origin was possible for α-gliadins whereas it was not 
straightforward for γ-gliadins. 
e sequences downloaded from Genbank originated from dierent hexaploid 
varieties. When sequences from one cultivar are uploaded into the database, 
there is no guarantee that the set of sequence variants per cultivar is complete. 
Furthermore, gliadin genes are present in each homoeologous genome and 
clustered in specic loci as multiple copy repeats, with identical or variable 
sequences. A gene sequence found multiple times in one cultivar, is uploaded only 
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once as new sequence to avoid redundancy. However, if an identical sequence was 
found in dierent cultivars or in the same cultivar dierent studies by dierent 
groups, it will be present several times in the database. erefore, the frequency 
with which a sequence is present in the alignments generated for this study does 
not reect the frequency at which a gene sequence is present in the genome of 
a cultivar such as Fielder. As a result, the proportion of sequences targeted by 
the dierent sgRNA designed does not reect the real percentages of matching 
sequences present in Fielder, especially since the evaluation was made on 100% 
match while in reality, sgRNA are known to target sequences with slightly lower 
similarity as well (Endo et al., 2015). 
Four CRISPR/Cas9_sgRNA constructs, containing 1 to 5 dierent sgRNAs, were 
designed and used to target α- and/or γ-gliadin gene families, in hexaploid wheat. 
e constructs were stably transformed into bread wheat cultivar Fielder. A total of 
117 regenerated lines expressed Cas9, regardless of which construct they carried. 
e T1 grains generated by these plants potentially contain mutations at a number 
of target sites which are segregating independently. However, it is possible that 
the Cas9-induced mutation is heterozygous in a cell. It is also possible that Cas9 
did not cut the same genes in dierent cells of the T0 plant generating chimerical 
plants or even that Cas9 remained active in the gametes aer meiosis. is means 
that, following segregations events, each grain generated by a T0 plant could have 
a unique assortment of gliadin mutations. For this reason, each grain was cut into 
three parts, the embryo and two identical pieces of endosperm, to run further 
complementary types of analysis (sequencing and advanced proteomics) on the 
identical fractions of endosperm isolated from the same T1 or T2 grain. 
Pre-screening for wheat grains with mutated gliadins
Due to the high complexity of the large gliadin gene families that are only 
expressed in wheat grains, the traditional screening methods such as restriction 
site loss or sequencing are not appropriate for pre-screening and identication of 
potential mutants. Instead, these methods would be relevant for in depth study 
and characterisation of the mutations occurring in interesting mutants identied 
using dierent pre-screening method. Acid-PAGE was successful for identifying 
gliadin protein prole dierences (Cooke, 1987) and we therefore employed it 
for high-throughput pre-screening of the grains from mutant wheat plants. is 
method was rst optimised using CS and associated set of deletion lines and 
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nullisomic-tetrasomic lines. ese lines were previously characterised as missing 
chromosome pairs or arms that carry gliadin genes from specic homoeologous 
genome. ese lines enabled identifying the homoeologous chromosome arms 
and the sub-genome that most likely was altered in a mutant, based on the absence 
or shi in position of the band. 
e optimised Acid-PAGE protocol was then validated, as it was able to identify 
14 lines out of 360 (3.9%) Paragon γ-irradiated lines that showed gliadin proteins 
expression changes compared to Paragon. Lines showed changes in one or two 
gliadin families but never in all three families simultaneously. Irradiation mutation 
is known to trigger large deletions, up to several mega-bases, which can explain 
the deletion of a complete gliadin gene locus. e nature of the homoeologous 
chromosomes altered by γ-ray were inferred based on the results obtained with 
the CS line set, since similarly large deletions are expected in both line sets. e 
percentage of mutations observed on Acid-PAGE was around 4%, for all visible 
changes in the three large gliadin gene families, each counting more than dozens 
of members. 
Changed gliadin proles were observed with each construct, implying that each 
construct contained at least one sgRNA that successfully generated mutations 
in some copies of the targeted α- or γ-gliadin gene family. More importantly, it 
indicates that CRISPR/Cas9 can edit a sucient number of genes within large 
family in polyploid plants to actually generate a dierent phenotype in the 
progeny. e acid-PAGE analysis of the Fielder-CRISPR lines revealed dierences 
in gliadin proles in 70 T1 grains (6.1% of the total number of grains tested) 
harvested from 36 T0 plants (30.8% of the total number of T0 plants expressing 
CRISPR/Cas9 constructs) across all four CRISPR/Cas9_sgRNA constructs used. 
erefore, a single T0 plant that produced T1 mutant grains, gave on average 2 
mutant grains out of 8 grains tested. 
Constructs targeting γ-gliadins sometimes trigger shi of protein bands in the 
untargeted ω-gliadins. is phenomenon could be explain by the deletion of 
ω-gliadins present in between targeted γ-gliadins since both gene families are 
suspected to have some overlap on the short arm of chromosome 1 (Dong et al., 
2016). Moreover, it is known that knocking out some gene in a gluten family triggers 
the compensation by other gene families (Pistόn et al., 2011, Galili et al., 1986).
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Variation in eciency could be observed between the constructs, with construct 
α1_sgRNA being signicantly less ecient. is could be explained by the 
presence of only one sgRNA in this construct while several are present in other 
constructs. It could also be due to a presence of secondary structure in the 
sgRNA – identied aer use, using RNAfold soware - that could decrease 
the target binding eciency. e number of sgRNA in a construct appears to 
slightly increase the ratio of mutant grains obtained, but no direct correlation 
was observed. Indeed, construct α2_sgRNA and construct γ3_sgRNA generated 
19 and 23 mutant grains respectively while construct α2γ3_sgRNA – combining 
both previous sgRNA guides in a single construct - gave only 20 mutant grains, 
which does not show a cumulative eciency. However, the Cas9 expression level 
in dierent plants as well as the actual number of mutations generated at the 
DNA level would be necessary to give a robust answer regarding the variation of 
eciency of the dierent constructs.
Inheritance of gliadin mutations observed in T1 grain endosperm
ree T1 embryos, associated with three T1 endosperm samples with gliadin 
mutations, were planted and T1 plants grown. From each of the three T1 plants, 
8 T2 grain were harvested and run on Acid-PAGE, revealing no mutations. 
An additional 100 T2 grains from T1 α1-14_G1 mutated plants, which the T1 
endosperm showed three missing α-gliadin protein bands associated to 6AS, did 
not reveal mutations either. is suggests that the mutations identied in the T1 
generation do not appear to have been inherited in the T2 generation and that no 
new mutations were observable in the second generation, in contrast to CRISPR/
Cas9 mutations generated in wheat (Wang et al., 2018). 
e rst hypothesis for the lack of inheritability that one would think of is 
segregation issues, especially in case of potential heterozygous mutations, in 
gene families in hexaploid plants. Meanwhile, looking at the biology of the T1 
endosperm and its associated embryo - which is the origin of the future T1 plant -, 
the absence of inheritance of mutations associated with missing bands on the Acid-
PAGE is not straight forward. Wheat endosperm is formed by the fecundation 
of doubled-haploid female (2x ABD_f) central cell by the second haploid male 
gamete (1x ABD_m) while the rst haploid male gamete (1x ABD_m) fecundate 
the haploid female (1x ABD_f) egg cell in order to form the embryo (Wegel and 
Shaw, 2005). Wheat endosperm is therefore triploid (2x ABD_f + 1x ABD_m) 
although carrying the similar genetic material than the diploid embryo (1x 
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ABD_f + 1x ABD_m). Mutations present in the endosperm are identical to the 
one present in the embryo, only the dosage of female mutation is doubled in the 
endosperm. In case of T1 α1-14_G1, for the endosperm to display three α-gliadin 
band missing on Acid-PAGE, corresponding to genes in short arm of chromosome 
6A, this would imply that the mutations were present in both female and male 
gametes. erefore, the associated embryo subsequently growing into T1 plant 
should be homozygous for these mutations on 6AS. As a consequence, all gametes 
formed by T1 α1-14_G1 plant should also carry these mutations and the resulting 
T2 grain should have a triploid endosperm and a diploid embryo, all homozygous 
for these α-gliadin mutations on chromosome 6A, with potential new mutations 
generated aerwards. e T2 endosperms should therefore show at least similar 
double α-gliadin band missing associated to chromosome 6A, which was never 
observed in more than 100 tested T2 endosperms from α1-14_G1 T1 mutant.
e lack of inheritable phenotypes associated with the mutations in T2 grains could 
potentially be explained by epigenetic modication and compensation within the 
targeted gene family. Indeed, mutations leading to suppression of some gliadin 
protein expression in the T1 may have triggered the expression of remaining 
intact copies that were initially not expressed. Such compensation mechanisms 
within a gliadin family could be plausible considering that it already takes place 
between dierent gliadin families (Pistόn et al., 2011; Galili et al., 1986). It could 
explain that the mutant phenotype cannot be visualised on Acid-PAGE despite 
the actual inheritance of the gliadin mutations themselves, and thus the detection 
requires further analysis with dierent methods. However, the T2 grains tested 
were obtained with the less ecient sgRNA and the T2 grains generated with the 
other, more ecient, constructs are yet to be tested.
Comparison with other groups also using CRISPR/Cas9 to target gluten 
genes in hexaploid wheat 
Sánchez‐León et al. (2018), who used a sgRNA, namely sgRNA _α2, having 13 
overlapping bases with our sgRNA_α213 and targeting α-gliadins 6 base-pairs 
upstream, reported a higher success rate with T1 grains from one T0 CRISPR/Cas9 
line being mutated in a similar way, and inheriting those mutations in T2 grains. 
ese dierences of results may be related to a low Cas9 eciency in our case. Cas9 
sequences have quickly been improved to increase the mutation eciency and the 
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Cas9 version we used (dierent from the one used by Sánchez‐León et al. (2018)) 
has been reported as having a low eciency (Ma et al., 2015, Wang et al., 2016). In 
addition, in monocots, most research report the use of maize ubiquitin promoter 
(Sánchez‐León et al., 2018; Ma et al., 2015) while we used the rice actin promotor. 
ose factors could explain not only the low number of T1 mutant grains per T0 
plants obtained but also the low level of gene copies mutated within each mutant 
wheat grain. It could also explain the absence of mutated phenotype inheritance, 
assuming that with a higher eciency and most of the targeted genes mutated, 
compensation of the mutated gene copies becomes much more dicult for the crop. 
Comparison of CRISPR/Cas9 targeted mutations with γ-irradiation 
random mutagenesis 
Using either CRISPR/Cas9 or γ-irradiation method, the mutation eciency 
revealed by the Acid-PAGE is comparable. However, the mutation rate obtained 
using CRISPR should be much higher. Fielder-CRISPR lines tested correspond 
to T1 generation grain potentially heterozygous for mutations while Paragon 
γ-irradiated correspond to M4 generation grain where most mutations are 
homozygous and easier to visualise. In addition, Acid-PAGE will probably not 
reveal amino-acid substitutions or small in-frame indels potentially generated by 
CRISPR/Cas9 since proteins with dierent sequences but having similar molecular 
weight/charge ratio can be represented by a single band on the gel (Anderson and 
Greene, 1997). Moreover, knocking out a gliadin gene may not supress any protein 
band if another similar gene has not been knocked out. Alternatively, 2D-gels 
could give a higher resolution but other methods such as deep DNA sequencing 
are needed to reveal and characterise more subtle types of mutations and to get a 
better idea of the dierences in eciency between both methods.
Interestingly, some T1 CRISPR-Fielder grains showed a similarly altered gliadin 
protein prole as some M4 Paragon γ-irradiated grains (Fig. 6a, 6e and 5a, 5f)). e 
dierence, however, is that in the Fielder-CRISPR grains, only the α- or γ-gliadin 
gene family were targeted and are probably modied whereas in the Paragon 
γ-irradiated grains it is possible that not only gliadin genes but also unrelated 
anking genes were deleted as a side eect. Furthermore, wheat lines with small 
deletions in the epitope region possibly generated by CRISPR/Cas9 would be more 
interesting than multiple gene copy deletions generally generated by γ-irradiation 
for two reasons. First of all, the gliadin copies would remain under a ‘safer’ form 
while retaining the backing properties more easily than if being totally removed 
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using irradiation. In addition, having small deletions might avoid compensation, by 
other potentially immunogenic genes, whose expression is triggered when a gene 
family is partly knocked down. However, following the actual regulation regarding 
gene-editing and mutation breeding, the Fielder-CRISPR wheat could not be grown 
yet due to strict GM regulation while the Paragon γ-irradiated wheat could directly 
be grown and used for breeding programs without any restrictions (Chapter 5). 
Conclusion
is pilot study aimed to mutate the large α- and γ-gliadin gene families in hexaploid 
wheat to decrease gluten immunogenicity for coeliac patients. We succeeded in 
generating wheat grains that contained gliadin protein proles altered for the 
targeted gene family in the bread wheat cultivar Fielder by targeted mutagenesis 
using CRISPR/Cas9 and in Paragon germplasm induced by random mutagenesis 
using γ-irradiation. As many gliadin genes have not been altered, optimisation 
concerning uses of dierent promoter and dierent Cas9 or new Base Editor systems 
needs to be done to obtain wheat plants which are safe for CD patients. 
e pre-screening and identication of the mutations was performed using Acid-
PAGE, which identies mostly the non-sense mutations and large deletions. 
However, the nal purpose is to modify the epitopes into safe versions without 
knocking out the complete gliadin genes, in order to avoid compensation by 
other gliadins and to maintain baking quality. erefore, reliable high throughput 
methods for small in-frame mutation detection will be important. Methods such 
as droplet digital PCR, enrichment and sequencing as well as advanced proteomics 
studies will be needed to identify also these subtle modications and characterise 
them further. is should increase the percentage of plants in which mutations have 
been induced, even further and enable the identication of mutations in T2 plants. 
Segregating out the CRISPR/Cas9 construct from promising lines and subsequently 
self-pollinating these wheat lines to make all mutations homozygous would be the 
next steps. Potentially interesting lines would then need extensive investigation 
including immunological tests using monoclonal antibodies to determine their 
immunogenicity level and rheological studies to evaluate the bread dough quality 
obtained using these generated “hypoimmunogenic-gluten” wheat lines.
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Abstract
Droplet digital PCR (ddPCR) enables the accurate quantication of nucleic 
acids of interest. is technique has been proposed as a rapid and cost-ecient 
alternative for high-throughput screening of gene copy number variation (CNV). 
e sensitivity of ddPCR has yet to be tested for the quantication of the gene copy 
number in large families in polyploid plant species, where the relative dierences 
between copy numbers are smaller. e α-gliadin gene family in hexaploid bread 
wheat varieties and lines was used here as a case study to test the feasibility and 
accuracy of ddPCR for CNV analysis in large (> 50 gene copies) gene families. 
We designed and optimised duplex ddPCR assays that amplify a reference gene 
that occurs as a single copy gene on each of the six homoeologous chromosomes, 
along with α-gliadin genes for which the copy number is to be determined, and 
demonstrate their accuracy for measuring gene copy numbers in four sets of 
genetic material. First, the sum of α-gliadin gene copy number measured with 
the ddPCR assays in diploid and tetraploid wheat accessions corresponded to 
the copy number measured in Synthetic Hexaploid Wheat lines produced from 
them, demonstrating the linearity of the detection up to 95 gene copies. Second, a 
comparison of α-gliadin CNV of a set of deletion and nullisomic-tetrasomic lines 
from variety Chinese Spring enabled determining the number of α-gliadin genes 
present on the three pairs of homoeologous chromosomes 6A, 6B, and 6D. ird, 
ddPCR assays detected a reduction of 18 α-gliadin gene copies between variety 
Paragon and some of its derived γ-irradiated mutant lines. Finally, the comparison 
of two dierent duplex ddPCR assays demonstrated the feasibility to distinguish, 
quantitatively, small indels from larger deletions induced by a CRISPR/Cas9 
construct targeting α-gliadin genes in variety Fielder. We showed that a single 
Fielder-CRISPR line could contain small indels (1-50bp) in up to 10 α-gliadin 
genes and large deletions (>300bp) in 20 α-gliadin genes out of the 87 α-gliadin 
genes present in Fielder. We demonstrate that ddPCR is suitable and sensitive for 
high-throughput screening of gene CNV and gene-editing induced mutations 
in large gene families, in polyploid organisms. We also show a feasible ddPCR 
strategy to distinguish small indels from large deletions generated by CRISPR/
Cas9 sgRNAs, in large gene families. In case of wheat, ddPCR thus represents a 
valuable tool for high throughput screening for lines with low gliadin gene copies, 
to be used in breeding programs toward hypoimmunogenic gluten, representing 
an important step forward for people with Coeliac disease.  
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Introduction
Gene families are composed of several genes that oen vary in terms of sequence 
content and copy number across varieties, inuencing diverse crop traits. Due to 
the high variability, it is challenging to qualitatively or quantitatively assess a gene 
family and predict its impact on the phenotype or performance of a plant. In the 
60’s, gene copy number variation (CNV) was estimated using the southern blot 
technique, which is very tedious (Collier et al., 2017). Since the 2000’s, qPCR was 
used to estimate CNV quickly and using less DNA (Collier et al., 2017). However, 
the measurement accuracy is limited for high gene copy number (Karlen et al., 
2007) and it varies signicantly among replicates (Weaver et al., 2010). Whole 
genome sequencing can be used to have a hint on the gene copy number by using 
the coverage variation. However, data analysis is dicult for large and oen highly 
similar gene families and cannot yet be applied for high-throughput screening in 
case of large polyploid genomes, for instance for gliadin genes in hexaploid wheat. 
Recently, droplet digital PCR (ddPCR), which is more precise than qPCR, has 
been suggested as a reliable alternative for high throughput gene copy number 
quantication (Hindson et al., 2011, Manoj 2016). 
ddPCR is a PCR-based assay, using primers for amplication of specic DNA 
fragments and probes or a uorescent intercalating dye for detection. e power of 
ddPCR relies on the partitioning of the DNA fragments to amplify into water-in-
oil droplets, enabling multiple simultaneous endpoint PCR reactions per sample 
and increasing the reliability and precision of the quantication. In the rst step 
of the ddPCR workow (Fig. 1), the PCR reaction and droplet generating oil are 
loaded into separated wells of an injection moulding cartridge. An emulsion is 
created by applying a vacuum, generating around 20.000 droplets in each sample. 
en the samples are transferred into a thermocycler to undergo a standard PCR. 
Each droplet constitutes a partition in which an individual PCR reaction will 
occur. Some of these partitions, called positive droplets, contain a copy of the DNA 
fragment to amplify and will yield a uorescent PCR product, others do not and 
these form the negative droplets. Aer the amplication, samples are transferred 
to the reader. Here, droplets are aspirated, separated and aligned toward the 
detector where they are detected one by one. Positive droplets are distinguished by 
a strong uorescence signal while negative droplets are distinguished by their low 
intrinsic uorescence due to imperfect quenching. e negative droplets form the 
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background, which is essential to establish a contrast with positive droplets. e 
concentration of DNA fragment to amplify is determined by calculating the ratio 
of positive and negative droplets in the sample. e random distribution of the 
templates across the droplets allows correction and calculation of the condence 
interval of the concentration using Poisson statistics (Basu, 2017). To calculate 
the absolute gene copy number, it is necessary to know the number of genomes 
relative to the amount of DNA used. For more precision, a single copy gene can 
be included as reference. is method can be used for high throughput screening, 
giving accurate and reproducible results in a quick and relatively cheap manner 
(Hindson et al., 2011). Nevertheless, the accuracy of ddPCR for CNV has never 
been tested on organisms having both a large gene copy number and a large 
genome size, such as the α-gliadin gene family (> 50 members) from hexaploid 
wheat (16 Gb genome size).
Figure 1. Main steps of droplet digital PCR workow. 
a) Droplet generation: A vacuum is applied to the well, aspirating the sample and the oil and generating 
around 20.000 surfactant-stabilized droplets. b) Read droplet uorescence: Aer PCR, droplets are extracted 
from each well and individually streamed through a uorescence detector. Adapted from Hindson et al., 
2011.
Hexaploid wheat (Triticum aestivum, 2n = 6x = 42, AABBDD) is a staple food 
crop with grains containing gluten in their endosperm. Gluten includes two major 
storage protein types: the glutenins and the gliadins. Gliadins consist of three gene 
families: α-, γ-, and ω- gliadins. e α-gliadin family was estimated to contain 
between 60 and 150 gene copies in T. aestivum (Anderson et al., 1997; Ozuna et 
al., 2015), located at Gli-2 loci on the short arm of homoeologous chromosome 
6 (Payne, 1987). e γ- and ω-gliadins were estimated to contain around 40 and 
20 gene copies, located at Gli-1 and Gli-3 loci respectively on the short arm of 
homoeologous chromosomes 1 (Sabelli and Shewry, 1991). e number of 
α-gliadins and their sequence composition is relevant for Coeliac disease (CD) in 
humans. is autoimmune reaction is triggered by the ingestion of gluten proteins 
carrying immunogenic epitopes that can be recognised as antigens by the immune 
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system. CD aects around 1-2 % of the human population (Koning, 2012) and 
produces a chronic inammation of the small intestine, leading to other symptoms 
including bowel disorders and malnutrition. Up to date, the only remedy is a strict 
gluten-free diet. Alternatively, “low-gliadin” products would constitute a great 
step forward toward “hypoimmunogenic-gluten” food products for CD patients. 
Assessing the α-gliadin gene copy number of hexaploid wheat using ddPCR is 
therefore of great interest in the context of developing healthier alternatives to 
gluten-free products for CD patients. 
In this paper, we describe the design, optimization and validation of a ddPCR 
protocol for measuring near-absolute and relative α-gliadin gene CNV. We rst 
used a mixture of DNA from three hexaploid wheat cultivars for the protocol 
optimisation. en, we analysed diploid, tetraploid and resulting synthetic 
hexaploid wheat (SHW) DNA, in order to check the linear range of the ddPCR 
detection of α-gliadins. Subsequently, we tested the sensitivity and accuracy of 
the ddPCR for CNV in a range of materials with decreasing number of gene copy 
changes: Chinese Spring (CS), the model cultivar for hexaploid wheat, and a series 
of selected deletion lines and nullisomic-tetrasomic lines, previously characterised 
as lacking parts or complete chromosome arms with multiple α-gliadin genes; 
Selected variety Paragon γ-irradiated lines that are known to have deletions in the 
α-gliadins; and CRISPR/Cas9 lines of variety Fielder, in which it is assumed that 
there are deletions in the α-gliadins as visualized by missing  specic α-gliadin 
bands on Acid-PAGE.
Materials and methods
Plant materials 
Genomic DNA was extracted using a CTAB-based extraction protocol from 
young leaves of various wheat species, varieties and accessions (Table 1). Fielder, 
Paragon and Chinese Spring (CS) hexaploid bread wheat DNA was pooled 
together for performing optimisation experiments. ree synthetic hexaploid 
(AABBDD genome, Ogbonnaya et al., 2013) wheat lines (SHW) developed by 
NIAB (Cambridge, UK) were analysed, along with the three dierent Aegilops 
tauschii lines (DD genome) and two Triticum turgidum (AABB genome) lines 
from which it was generated. CS, ve CS nullisomic-tetrasomic lines (Sears, 
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Table 1. Wheat genotypes studied
Species Lines Description
Aegilops taushii
Ent 392 
Ent 404 
Ent 405 
DD parental lines
Triticum turgidum Biensur Hoh 501 AABB parental lines
Synthtic Hexaploid Wheat 
(SHW)
NIAB SHW 54 Ent 392 (DD) x Biensur (AABB)
NIAB SHW 75 Ent 404 (DD) x Hoh 501 (AABB)
NIAB SHW 76 Ent 405 (DD) x Hoh 501 (AABB)
Triticum aestivum 
cultivar 'Chinese Spring'
(CS)
WT Control
6AS-1
6BS-4/5BS-2
6DS-4
6DS-4/1BS-19
Kansas Deletion lines 
N6AT6D =  6DDDDBB
N6AT6B = 6BBBBDD
N6DT6A = 6AAAABB
N6BT6D = 6DDDDAA
Nullisomic-tetrasomic lines 
Triticum aestivum 
cultivar 'Paragon'
WT Control
P3-75
P6-43
P6-57
P6-59
γ-irradiated lines 
M4 generation
Triticum aestivum 
cultivar 'Fielder'
WT Control
α1-14_G1
α2-1_G10
α2-1_G15
α2-15_G1
α2-19_G9
α2-19_G12
α2-21_G10
α2-26_G14
α2-28_G7
CRISPR/Cas9 lines
α-gliadins targeted 
γ3-1_G6
γ3-12_G4
γ3-13_G7
γ3-17_G8
γ3-18_G2
CRISPR/Cas9 lines
γ-gliadins targeted 
α2γ3-38_G1
α2γ3-38_G4
α2γ3-38_G7
α2γ3-38_G8
CRISPR/Cas9 lines
α- and γ- gliadins targeted 
1966; obtained from Germplasm Resources Unit, JIC, UK) and four CS Kansas 
deletion lines (Endo, 1988; Endo and Gill, 1996; obtained from Kansas State 
University) that had modied gliadin protein proles with bands missing 
(obtained from Wheat Genetic and Genomic Resources Centre, Kansas State 
University, USA), were analysed individually. Four Paragon γ-irradiated lines 
developed by JIC (Norwich, UK; Shaw et al., 2013) and selected for changes in 
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gliadin protein proles (Chapter 2) were also included. Eight Fielder T1 lines 
containing CRISPR/Cas9-induced mutations in α-gliadin protein proles as 
visualized on Acid-PAGE, 5 lines containing CRISPR/Cas9-induced mutations 
in γ-gliadins and 4 lines containing CRISPR/Cas9-induced mutations in α- and 
γ-gliadins (Chapter 2) were tested as well. 
DNA digestion
α-gliadins are clustered as repeated sequences in one region on the homoeologous 
chromosomes 6. Separating the DNA of the consecutive genes is required to avoid 
introducing bias into the ddPCR binary detection system, as both one or multiple 
consecutive copies in a single droplet would produce one positive droplet. 
ApoI was identied as a unique restriction site located within the α-gliadin 
gene sequence and highly conserved across the dierent copies (Fig. 2). Wheat 
genomic DNA was digested using 0.5 μl of ApoI restriction enzyme (NEB), 2 μl 
of 10x NEB buer, 500 ng of genomic DNA and Milli-Q water to adjust to the 
nal reaction volume to 20 μl. e digestion mix was incubated at 37°C for 2 
hours and inactivated at 65°C for 20 min, following the ddPCR protocol of Bio-
Rad (rather than 80°C as recommended by NEB for ApoI-HF). e digestion 
was then diluted ten times in all the samples, to reduce the salt concentration. 
Primer design for ddPCR multiplexing
Primers designed for ddPCR must have a length between 17 and 25 nucleotides, an 
annealing temperature between 50°C and 70°C and an amplicon length between 
50 and 200 nucleotides (Hindson et al., 2011; Bio-Rad 2018). Multiplexing primer 
pairs with varying amplicon length necessitates that all primer pairs should have 
a similar annealing temperature, be designed on highly conserved regions of the 
genes to amplify, and that each amplicon preferably has ~50bp dierence from 
the other amplicons (Bio-Rad, 2018). e degenerated primers for the multiplex 
were therefore manually designed, taking into account only existing sequence 
combinations present in the gliadin database (Chapter 2). Each primer was 
checked for absence of self-complementarity and primer dimer formation with 
other primer pairs using the online tool Multiple Primer Analyzer (ermosher). 
Primer specicity was checked by blasting in Ensembl! Plant against the Triticum 
aestivum database. e absence of ApoI restriction sites between the primer 
binding sites was veried.
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ree primer pairs could be designed fullling all the criteria (Table 2). For the 
TaPFT1 reference gene, the primer pair Ref_181 was designed to amplify all three 
homoeologous variants, giving amplicons of 181bp, based on the Chara sequences 
used by Fitzgerald et al. (2010). For the α-gliadin genes, two dierent primer pairs 
were designed. Primer pair Epi_61 binds immediately upstream of the epitope 
regions at the position targeted by the sgRNA_α213 in most Fielder CRISPR/
Cas9 lines, giving amplicons of 61 bp in nearly all gliadin genes if the Cas9 has 
not induced a mutation. Primer pair UD_136 is complementary to the unique 
domain in the centre of the gene, a region that is not targeted by any sgRNA in 
Fielder CRISPR/Cas9 lines, located more than 240 bp downstream Epi_61 reverse 
primer. It produces an amplicon of 136 bp (Fig. 2). 
Figure 2. Alignment of α-gliadin sequences, localisation of ddPCR primer pairs relatively to sgRNAs targets 
and ApoI restriction site.
In this depiction of a subset of the sequence alignment of over 1200 sequences (Chapter 2), each block 
corresponds to a group of α-gliadin sequences identied across the three homoeologous chromosomes 
6A, 6B, and 6D. It is unknown how many genes and of which group are present and/or expressed in each 
accession or variety used in this study. erefore, the ApoI restriction site was selected as it is located in a 
conserved part of the proteins, and the Epi_61 and UD_136 ddPCR primer pairs were designed as to bind to 
the most conserved parts of the genes, although even with the use of a few degenerate sites it was impossible 
to design primer pairs that would anneal all possible genes. Epi_61 binds close to sgRNA_α213 target site, 
while UD_136 binds at a non-targeted site over 240 bp downstream, in order to be able to discriminate 
between small indels (which will aect only Epi_61) and large deletions over 240 bp (which will aect both 
primer pairs). e picture is adapted from Chapter 2.
 
is design was aimed at enabling a comparison of the number of amplicons 
generated at sgRNA-targeted and non-targeted sites in order to deduce the 
(relative) number of small indels generated by sgRNA_α213 with a local eect, 
compared to the number of large deletions. In the case of CRISPR/Cas9 lines, 
the decrease of amplicon number correlates with the presence of small indels 
or larger deletions, but as we do not know the length of the large deletions this 
does not necessarily indicate a decrease of full-length gene copy number. When 
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used to study deletion lines or γ-irradiated lines, known to contain deletions of 
several megabases, there is a direct correlation between the decrease of amplicon 
number and the decrease of gene copy number present in the plant. 
Table 2. ddPCR primers used for CNV detection
Primer name Primer sequence
(5’- -3’)
Tm 
(°C)
Primer 
length
(bp)
CG% Amplicon 
length 
(bp)
F-Epi_61 GCAACCATTTCCATCACAACA 59.9 21 42.9 61
R1-Epi_61 AAGGCGTCGGCGTTGAT 61.5 17 58.8 61
R2-Epi_61 AAGGtGTCGGCGTTGAT 58.1 17 52.9 61
F1-UD_136 TTGCAACAACACAGCATAGC 59.8 20 63.0 136
F3-UD_136 TTGCAgCAACACAaCATAGC 59.8 20 63.0 136
R2-UD_136 GGTcCGGTAgGTgTTACAaC 61.7 20 55.0 136
R3-UD_136 GGTtCGGTAgGTgTTACAaC 59.9 20 50.0 136
F_Ref_181 GCAGAGTGGAGTGGACATTT 60.1 20 50.0 181
R_Ref_181 CTCTATGGTGGCTGTTGCTA 59.4 20 50.0 181
Primer sequences with only upper-case characters cover the most common haplotype while lower-case 
characters mark haplotypes with a lower frequency. 
e two degenerate primers in the same orientation were mixed 1:1, and forward 
and reverse primers were then pooled in equal volume, representing a degenerated 
primer pair mix with a concentration of 1µM. All degenerated primer pairs were 
then tested individually and multiplexed, using basic PCR with a gradient ranging 
from 55°C to 65°C, on ApoI digested DNA pool from Chinese Spring, Fielder and 
Paragon.  
ddPCR protocol
e ddPCR reaction mixture was prepared using 2-3 μl of degenerated primer 
pair mix (depending on the primer combination) at 1 µM, 12 μl of ddPCR 
EvaGreen Supermix (Bio-Rad), 10 ng of 1:10 diluted digested DNA and Milli-Q 
water in a nal volume of 23.6 μl per sample. Of this mix, 20 μl was transferred 
into a sample well of a DG8 Cartridge for QX200 droplet generator™ and 70 μl 
of Droplet Generation Oil for EvaGreen chemistry (Bio-Rad) was loaded into 
the corresponding oil well of the cartridge, for each sample. e cartridge was 
sealed with a rubber gasket (Bio-Rad) and transferred into the QX200 droplet 
generator (Bio-Rad). A nal volume of 40 μl of droplet-partitioned samples, 
containing approximately 20,000 droplets, was generated for each sample. 
Each 40 μl sample was transferred into a 96-well plate (Bio-Rad), sealed and 
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transferred onto a regular ermocycler (Bio-Rad). e PCR protocol used was: 
5 min at 95°C, 40 cycles of 30 sec at 95°C and 60 sec at 56°C, followed by one 
step of 5 min at 4°C and a nal step of 5 min at 90°C followed by innite hold 
at 2°C. e ramp rate for the entire run was 2°C/s. Aer the PCR, the plate was 
transferred in the QX200 reader (Bio-Rad) for reading and counting positive 
and negative droplets.
Data acquisition
Droplet count was performed sample per sample by the QX200 reader (Bio-
Rad) linked to the QuantaSo SowareTM (Bio-Rad) for data acquisition and 
posterior analysis. e soware was run on “absolute gene copy number” with 
detection channel adapted for EvaGreen QX200 ddPCR orescence. Default 
parameters were used, except for the “Experiment Type” that was set to “Copy 
Number Variation 6” and “the ploidy” of the sample was entered for the reference 
for each well of the 96-well plate. e rst “target” was set as unknown and the 
second one as reference. Samples with fewer than 10.000 droplets were excluded. 
In the output, each droplet from a sample is represented by a dot and each dot is 
plotted according to its uorescence amplitude. Dots therefore clustered in clouds 
or populations based on their uorescent amplitude, which is determined by the 
presence or absence of specic DNA template to amplify in each droplet. 
Analysis of ddPCR output
Aer acquiring the data in the QuantaSo SowareTM (Bio-Rad), the 
representation of the amplitude of the droplets signal as a 1D dot-plot was used 
to check whether there was clear distinction between the background (negative 
droplets without the specic DNA fragment to amplify) and the specic DNA 
fragment amplied (positive droplets with signal amplitude related to the size of 
the amplicon associated to each fragment to amplify) (Fig. 3a). e thresholds 
of discrimination between background and amplicon groups were adjusted 
when necessary. e representation of the ampliude of the droplets signal as 
a 2D dot-plot was used to identify four dot-clusters associated to droplets 
containing no amplicon, Epi_61 or UD_136 amplicons, Ref_181 amplicons and 
multiple-amplicons, based on their respective signal amplitude correlated with 
their length (Fig. 3b). Once the populations are dened, Poisson statistics are 
applied and yield an absolute measure of the dierent amplicon concentration, 
necessary to calculate the gene copy number present in the sample. e 95% 
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condence intervals given by the soware (Hindson et al., 2011) are used, and 
the standard deviation of the condence intervals dierence was calculated.
Figure 3. Example of the multiplex assay using two primer pairs, Epi_61 and Ref_181. 
a) 1D plot view. b) 2D plot view. Eect of amplicon length on the signal amplitude of droplets with (1) no-
template, (2) Epi_61, (3) Ref_181 and (4) Epi_61+ Ref_181.
Results
ddPCR optimisation experiments
Four experiments were carried out using pooled gDNA of the varieties Chinese 
Spring, Fielder and Paragon and digested by ApoI in order to test the possibility of 
multiplexing the reference gene primer pair with the α-gliadin genes primer pairs, 
to dene the optimal primer annealing temperature, to determine the optimal 
amount of digested gDNA, and to optimize the distinction of the amplicons, using 
dierent primer concentrations. 
Multiplexing primer pairs
Multiplexing primer pairs generating dierent amplicons is oen challenging 
in ddPCR. Hence, we rst tested and compared the three primer pairs Epi_61, 
UD_136 and Ref_181, individually and together. Two duplex experiments 
were performed, combining either Epi_61 or UD_136 with Ref_181, and a 
triplex experiment combining all three primer pairs. e same quantity of each 
degenerated primer pair mix at 1µM was used in each experiment (triplex thus 
has 3 time more primers concentration). Standard ddPCR protocol was followed, 
but using 10 ng of gDNA and an annealing temperature of 60°C. 
Each primer pair tested individually resulted in good DNA fragment amplication 
and a clear distinction from the background signal (Fig. 4d). e longer the 
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amplicons the higher the signal amplitude of the droplets. Epi_61 or UD_136, 
that both generate α-gliadin gene amplicons, showed a much larger cloud of 
dots than Ref_181. is is related to a high variability of signal amplitude per 
droplet caused by the large sequence length variation of this gene family. When 
duplexing the reference with one of the α-gliadin primer pair, it was possible to 
distinguish both amplicons from each other and from the multiple amplicon-
containing droplets with an artefact signal (Fig. 4a, b, d). e absolute amplicon 
copy numbers obtained in simplex and duplex experiments were not signicantly 
dierent. When triplexing the reference with both α-gliadin primer pairs, the 
signal amplitude of the droplets overlapped (Fig. 4d, last column), which impeded 
distinguishing the dierent amplicons from one another quantitatively (Fig. 4c). 
erefore, we decided to use duplexing of the reference primer pair and one of the 
α-gliadin primer pairs throughout the study.
Figure 4. Simplex, duplex and multiplex assays. 
a) and b) 2D views of the two duplexing primer combinations (gliadin (blue) and Ref_181 (green)). 
c) 2D view of multiplexing Epi_61, UD_136 and Ref_181. d) 1D plot of all simplex, duplex and multiplex 
combinations. (1) Negative droplets, (2) α-gliadin positive droplets, (3) reference positive droplets and (4) 
multiple amplicons-containing droplets. 
Optimal annealing temperature
To determine the optimal annealing temperature for duplex ddPCRing of 
reference and either α-gliadin primer pairs, a thermal gradient experiment was 
performed with eight dierent annealing temperatures (Fig. 5). e standard 
ddPCR protocol was used with 10 ng of gDNA. e best separation of the dierent 
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amplicon groups was observed with an annealing temperature between 55°C 
and 57°C, for both Epi_61 + Ref_181 and UD_136 + Ref_181 duplexing assays 
(Fig. 5). 56°C was selected as optimal annealing temperature for further reference 
and α-gliadin duplex ddPCR experiments.
Figure 5. 1D plot view of the annealing temperature thermal gradient. 
Representing the negative droplets (1), amplicon positive droplets (2), reference positive droplets (3), double 
positive droplets (4) and undetermined droplets (?). Each sample annealed at 64, 63.3, 62.2, 60.5, 58.4, 56.7, 
55.6 and 55 º C, from le to right, duplexing with a) Epi_61 and Ref_181 or b) UD_136 and Ref_181.
Optimal DNA input
In ddPCR, the amount of input DNA is determined by the optimal copy number 
of DNA fragment to amplify, also called “sweet spot”. e sweet spot stands for 
around 1,500 DNA fragment copies per µl or 30,000 copies for 20 µl of reaction. We 
calculated that 10.4 ng of DNA per reaction corresponds to the theoretical sweet 
spot, based on the estimated hexaploid wheat genome mass (34.66 pg, according to 
Kim et al., 2015; Garcia et al., 2013) and the estimated α-gliadin gene copy number 
(100 copies, according to Ozuna et al., 2015), while including sucient single copy 
reference gene in the reaction. To conrm this sweet spot, ddPCR experiments 
were performed for the range of 2 ng to 50 ng of digested DNA per sample. It was 
possible to distinguish enough reference gene amplicon and to remain within the 
detection limit of the droplet reader using any tested concentration. Nevertheless, 
extremely low or high DNA concentration hampered the visualization of the 
output and the distinction of amplicons in duplex experiments (not shown). e 
α-gliadin gene copy number measured using duplex ddPCR was stable between 
10 and 30 ng of DNA input per assay (Table 3). e amount of digested wheat 
gDNA was therefore set to 10 ng per 20 µl of ddPCR reaction.
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Table 3. Comparison of α-gliadin gene copy number measured with duplex ddPCR with dierent amounts 
of DNA input.
DNA (ng) α-gliadin gene copies
50 50.9
40 54.3
30 58.2
20 61.5
10 58.2
5 56
2 41
Optimal primer concentration
e general primer concentration used was 100 nM of each primer pair. Increasing 
the concentration of the primer rises the amplitude of the respective amplicons 
and can be used for optimizing the dierence between the amplicon signals. 
When multiplexing UD_136 and Ref_181, the distinction between both amplicon 
groups was insucient in some genotypes with high α-gliadin amplicon size 
variability. Increasing the Ref_181 primer pair concentration to 150 nM improved 
the discrimination of the populations (Fig. 6a) without signicantly altering the 
copy number detected (Fig. 6b). Meanwhile, increasing primer concentration rises 
the signal amplitude of the background. Subsequently, a Ref_181 concentration of 
150 nM instead of regular 100 nM was used for those genotypes in which the 
Ref_181 signals overlap with those of the UD_136 α-gliadin amplicons.
Figure 6. Primer concentration optimization. 
a) 1D plot view of the eect of increasing Ref_181 primer pair concentration. Representing negative 
droplets (1), UD_136 positive droplets (2), Ref_181 positive droplets (3) and multiple-amplicons positive 
droplets (4). Increasing the Ref_181 concentration increase the separation between UD_136 and Ref_181 
positive droplets. Increasing Ref_181 concentration also increases the amplitude of the negative droplets. b) 
α-gliadin gene CNV was independent of the Ref_181 primers concentration tested. Error bars indicate the 
Poisson 95% condence intervals for each copy number determination.
Technical replicates
Technical replicates were used within a plate and across plates during the 
optimisation run. Replicates within a plate showed no signicant dierences, 
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although some failed for technical reasons. Replicates across plates showed higher 
variation than within a plate, which were sometimes signicant. Although this 
could be corrected for using a “landmark sample” present in all plates, we decided 
to limit the comparisons to samples on the same plate for higher accuracy. 
Measuring the α-gliadin gene copy number in wheat for the three 
homoeologous chromosomes
e duplex ddPCR reveals the α-gliadin amplicon number present in a hexaploid 
wheat line. is amplicon number directly correlates with the α-gliadin gene 
copy number in case of wheat lines, unless they would contain small indels 
induced in the amplicon region (see below). With the ddPCR method we can thus 
determine the total number of α-gliadin genes in bread wheat, but using selected 
genetic material we should also be able to determine the number of genes on 
each three pairs of homoeologous chromosomes 6 (written as 6AA, 6BB, 6DD, to 
emphasise that the numbers concern the chromosome pairs and not the individual 
chromosomes). For this we compared the number of α-gliadin genes in Synthetic 
Hexaploid Wheat (SHW) and their parental lines, as well as in variety Chinese 
Spring and various deletion and nullisomic-tetrasomic lines derived from it. 
Synthetic Hexaploid Wheat lines
Synthetic Hexaploid Wheat (SHW) lines have been created by crossing tetraploid 
Triticum turgidum (AABB) with diploid Aegilops tauschii (DD) followed by 
embryo rescue and spontaneous chromosome doubling to obtain hexaploid 
synthetic lines (AABBDD) (Ogbonnaya et al., 2013). e α-gliadin gene copy 
number of the ve parental lines and their three resulting SHW lines were 
analysed using duplex ddPCR. e α-gliadin gene copy number was 14-17 in the 
diploid DD genome accessions, 70-76 in the tetraploid AABB genome, and 86-95 
in the hexaploid SHW lines. Generally, the sum of gene copy number measured 
in the tetraploid parent and the diploid parent lines was not signicantly dierent 
from the copy number measured in the resulting SHW plant. is consistency in 
gene copy number measured reects the accuracy and the robustness of ddPCR 
for gene CNV studies in large gene families in polyploids (Table 4).
Chinese Spring Wheat deletion lines
Chinese Spring (CS) deletion lines (Endo, 1988; Endo and Gill, 1996) carry a 
homozygous large deletion in one pair of homoeologous chromosome 6 (short arm),
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Table 4. Comparison of measured and expected CNV of the SHW lines (AABBDD).
SHW lines
name
Measured in 
Parent AABB
Measured in
Parent DD
Measured in
SHW AABBDD
Sum of measured
Parental AABB + DD
NIAB SHW 54 76 15.5 95 91.5
NIAB SHW 75 70 17.2 86 87.2
NIAB SHW 76 70 13.5* 87 83.5
Measured α-gliadin gene copy number in parental AABB and DD lines and their corresponding AABBDD 
SHW lines compared to the sum of α-gliadin gene copy number measured in both parental AB and D lines. 
*CNV calculated using the average Ref_181 concentration of the two other DD lines as the reference gene 
did not amplify in Ae. tauschii Ent 405, presumably due to reference sequence variations.
where α-gliadin genes are located. e 6DS-4/1BS-19 line was generated by 
a cross between 6DS-4 and 1BS-19 deletion lines which lacks γ- and ω-gliadin 
genes on the short arm of chromosome 1. Using duplex ddPCR, 61 α-gliadin gene 
copies were found in hexaploid (AABBDD) CS, while all deletion lines showed a 
signicant reduction in α-gliadin gene copy number compared to CS (Table 5), 
with 42 to 52 copies remaining (Fig. 7). 
e 15 genes missing in the 6DS deletion are consistent with the number estimated 
in the diploid DD genome donor of the SHW lines (Table 4). We estimate from 
the data that in 6AS-1, 6BS4/5BS-2 and 6DS-4 deletion lines respectively 23, 17 
and 15 α-gliadin genes were missing (Table 5). e addition of these genome-
specic α-gliadin genes is 55 copies while 61 copies were measured in CS. is 
dierence could be explained by variations of the condence interval or by copies 
still present at glia-2 loci, if the deletions did not include all genes.
Remarkably, deletion line 6DS-4/1BS-19 lacks 11 gene copies more than 6DS-4. If 
the identication of the line is correct, it would suggest 11 α-gliadin-like sequences 
on 1BS (Table 5).
Figure 7. α-gliadin gene copy number in CS and in four CS deletion lines.
Duplex PCR using Epi_61 and Ref_181 primer pairs on hexaploid CS and CS lines carrying a deletion in 
one of the homoeologous chromosome 6.  Error bars indicate the Poisson 95% condence interval. Stars 
indicate signicant amplicons reduction compared to Paragon based on standard deviation of condence 
intervals dierence.
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Chinese Spring Wheat nullisomic-tetrasomic lines
CS nullisomic-tetrasomic lines (Sears, 1966) were made by removing one pair of an 
homoeologous chromosome and replacing it by one pair of another homoeologous 
chromosome. We used the lines that miss one pair of homoeologous chromosome 
6 but have, instead, two pairs of one of the other homoeologous chromosomes 
6. For better readability, we renamed the nullisomic-tetrasomic lines based on 
the homoeologous genomes they contain. For instance, the line Nullisomic for 
6A but Tetrasomic for 6D is originally called N6AT6D and contains 6DDDDBB 
which we renamed 6DDB. Using ddPCR, CS revealed to have 61 α-gliadin gene 
copies, consistent with the deletion lines study. In the nulli-tetra lines, gene copies 
were estimated to be 47 in 6DDB, 50 in 6BBD, 66 in 6AAB and as many as 111in 
6DDA (Fig. 8). 
Figure 8. α-gliadin gene copy number in CS and in four related CS nullisomic-tetrasomic lines. 
Duplex PCR using Epi_61 and Ref_181 primer pairs on CS lines lacking one of the homoeologous pairs 
of chromosome 6 and possessing two pairs of another homoeologous chromosome. Error bars indicate 
the Poisson 95% condence. Stars indicate signicant amplicons reduction compared to Paragon based on 
standard deviation of condence intervals dierence.
e α-gliadin copy number associated to each homoeologous chromosome in CS 
was calculated by solving the three functions with three variables resulting in the 
total copy number measured for three dierent combinations of nulli-tetra lines 
(Calculation 1).  
DDB = 47   BBD = 50   AAB = 66
B = 47 –  2D  D = 50 – 2B  66 – B = 2A
B = 47 –  2 * (50 - 2B) D = 50 – 2 * (47 – 2D) 66 – 17.6 =2A
B = 47 – 100 + 4B  D = 50 – 94 + 4D  24.2 = A
(100-47) / 3 = B  (94 – 50) / 3 = D
17.6 = B   14.6 = D
Calculation 1. Calculation of α-gliadin gene copy number in each homoeologous genome.
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In nulli-tetra line 6DDA – that contains 6DDDDAA -, the reference did not 
amplify well, most likely due to a mutation in the reference sequence. erefore 
the average reference copy number of the other three lines was used and 52 
α-gliadin gene copies were calculated. is is consistent with 6AA + 6DD + 6DD 
= 53.4 α-gliadin gene copies, based on Calculation 1 values. 
No signicant dierences were found between the results obtained with nulli/
tetra CS lines and CS deletion lines (Table 5), meaning that the full complement of 
genes on the glia-2 loci was deleted from the specic homoeologous chromosome 
in the deletion lines. e 15 copies obtained for the DD genome using the nulli-
tetra lines was similar to the number obtained using the 6DS-4 deletion line 
containing only deletion in the DD genome. However, it did not match with the 
26 copies from 6DS-4/1BS-19 double deletion line. 
Table 5. α-gliadin gene copies per genome estimated in CS nulli/tetra and missing in CS deletion lines 
compared to CS
Diploid genome Nulli-Tetra lines Deletion lines
AA   24.2   23.2
BB   17.6   17.1
DD   14.6                15.3 (25.6*)
AA + BB + DD 
(CS WT estimated)
  56.4   55.6
AABBDD 
(CS WT measured)
61 61
* Includes additional deletion in chromosome 1 short arm.
Quantication of the intact α-gliadin gene copy number aer random 
or targeted mutagenesis
Mutagenesis was used to mutate or delete α-gliadin genes, in order to reduce the 
immunogenicity for people with coeliac disease (Chapter 2). Using Acid-PAGE, 
lines were selected in which the α-gliadin prole was modied, most frequently in 
the form of bands that are absent. However, this is a qualitative method, and it does 
not see small insertions and deletions that only change a few amino acids. With 
ddPCR method we set out to determine the quantity of the mutations and deletions 
induced, both in lines from random mutagenesis – obtained using γ-irradiation 
- and in lines produced with targeted mutagenesis – generated using CRISPR/
Cas9-. In the case of the Paragon γ-irradiated lines, where the deletions may be 
megabases in size, the decrease in α-gliadin amplicon number is correlated with 
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the decrease of the α-gliadin full-length gene copy number. In contrast, in case of 
the Fielder-CRISPR lines, where mutations oen consist of relatively small indels 
(up to a few hundred bases), the decrease of amplicons generated correlates to 
the presence of mutations or deletions and can but does not necessarily indicate 
a decrease of the full-length gene copy number. e term amplicon number is 
therefore used here, instead of gene copy number.  
Random mutagenesis: Paragon γ-irradiated lines
Four Paragon γ-irradiated lines that showed loss of bands in the α-gliadin protein 
prole on the Acid-PAGE, were tested for α-gliadin gene copy number loss. Two 
duplex ddPCR assays were implemented using the internal reference (Ref_181) 
and either the primer pair located on (Epi_61) or downstream (UD_136) the 
α-gliadin epitope region. 
All four Paragon γ-irradiated lines showed a signicant reduction of α-gliadin 
gene copies (Fig. 9). In comparison to the 61 α-gliadin gene copies measured 
in Paragon, P3-75 and P6-57 showed a 16-18 copy number reduction while P6-
43 and P6-59 carried as many as around 30 copies less. ere are no signicant 
dierences between results obtained with both ddPCR primer pairs in Paragon, 
which indicates that they do not dier in specicity with regard to producing 
amplicons in this multigene family. e absence of signicant dierences between 
both primer pairs in irradiated lines indicate a similar reduction of amplicons 
both at epitope and conserved region of the α-gliadin genes, which is likely caused 
by full gene or loci deletion.  
Figure 9. ddPCR results of α-gliadins gene copy number in Paragon wild type and γ-irradiated lines.
Two multiplex ddPCR assays, with Epi_61 or UD_136 α-gliadin primer pairs and Ref_181, were performed 
on Paragon and 4 of the γ-irradiated lines pre-screened for α-gliadin protein prole alterations. e absolute 
α-gliadin gene copy number estimations with the two primer pairs were not signicantly dierent within 
all samples. Error bars indicate the Poisson 95% condence intervals. Stars indicate signicant amplicons 
reduction compared to Paragon based on standard deviation of condence intervals dierence. 
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Targeted mutagenesis: Fielder CRISPR/Cas9 lines
Targeted mutagenesis using CRISPR/Cas9 was done with sgRNAs that focussed 
on regions near or in coeliac disease epitopes, or upstream of these epitopes. 
For a total of 18 Fielder CRISPR/Cas9 lines that showed an altered gliadin 
protein prole on Acid-PAGE, the α-gliadin gene copy number was determined 
quantitatively using ddPCR with two dierent primer pairs, one near the epitope 
region (Epi_61) and one 240 nt downstream (UD_136) (Fig. 10). Both would 
detect a complete loss of the gene, but the rst one is also expected to be aected 
by small indels and medium deletions as it is near the target site from the two 
sgRNAs targeting α-gliadins, present in most tested plants.
Figure 10. Distance from sgRNA target sites to Epi_61 or UD_136 primer pairs in α-gliadin gene.
e scheme represents an α-gliadin gene, the sgRNA target sites and the position of Epi_61 and UD_136 
ddPCR primer pairs. a) α1 construct with only sgRNA_ α87; b) α2 and α2γ3 construct sgRNA_ α213 and 
sgRNA_ α324 targeting α-gliadin genes. e distance between each sgRNA target site and the two ddPCR 
primer pairs is reported. ese distances correspond to the minimal length of a deletion induced by sgRNAs 
that would prevent at least one primer to anneal to the DNA, causing amplicon number reduction compare 
to the wild type. Relative amplicon number reduction detected by duplex ddPCR assays is therefore 
interpreted as number of deletions from a minimal size. e primer pair adjacent to a sgRNA target site 
will detect small indels as well as larger deletions while the primer pair distant from the sgRNA target site 
will only detect large deletions. e dierence of amplicon number reduction between UD_136 and Epi_61 
gives the number of smaller mutations. However, in lines harbouring the α2 and α2γ3 constructs (panel b), 
UD_136 detects large deletions but these may occur with (when initiated from sgRNA_ α213) or without 
(sgRNA_α324) aecting the Epi_61 amplicon. A subtraction of the two amplicons may thus underestimate 
the number of small indels.   
Unlike in Paragon, the number of gene copies detected in Fielder was slightly 
dierent for the two amplicons: 87 with Epi_61 and 82 with UD_136. is may 
be due to SNPs in the primer annealing positions for UD_136 in some of the 
gliadin genes. e number of gene copies of the samples were subsequently 
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standardized to 87 copies in Fielder for both primer pairs. e standardization 
was also applied to all the CRISPR lines by adding 5 copies from the number 
obtained with UD_136. 
Among the Fielder-CRISPR lines tested, one was transformed with sgRNA_α87 
only (α1 construct), targeting α-gliadins far upstream the epitope region. e 
target site is around 130 bp of the Epi_61 and 430 bp upstream UD_136 ddPCR 
primer annealing sites (Fig. 10a). e signicant reduction of 26 amplicons 
detected with Epi_61 duplex ddPCR and 14 amplicons with UD_136 duplex 
ddPCR showed that more than 1/3 of the initial 87 α-gliadin copies in Fielder 
underwent a large deletion of at least 130 bp, half of which have a deletion larger 
than 430 bp.  
Eight Fielder-CRISPR lines were derived from plants transformed with both sgRNA_
α213 and sgRNA_α324 (α2 construct), which both target α-gliadin epitopes. e 
Epi_61 primer pair annealing sites are located at the sgRNA_α213 target and 50 
bp upstream of sgRNA_α324, therefore amplicon number variation detected with 
the Epi_61 duplex ddPCR concerns both small indels as well larger deletions (Fig. 
10b). e UD_136 primer annealing site is located 300 bp downstream of that of 
sgRNA_α213 and 190 bp downstream of sgRNA_α324, therefore amplicon number 
variation in UD_136 duplex ddPCR would only reect large deletions (Fig. 10b). 
ese eight lines containing sgRNA_α213 and sgRNA_α324 showed a signicant 
reduction of 17 to 24 Epi_61 amplicons detected compared to the 87 present in 
Fielder, suggesting 20% of the α-gliadin copies having mutations that can be small 
indels or larger deletions. A lower but still signicant reduction of 7 to 13 UD_136 
amplicon was observed in six of the eight lines, indicating the presence of 12% 
of large deletions in these lines. e signicant reduction of amplicons detected 
with Epi_61 and UD_136 duplex ddPCR indicates that about 1/2 of the α-gliadin 
mutations are relatively small indels. 
Four CRISPR lines were derived from plants transformed with the α2γ3 construct, 
which included an additional three sgRNA targeting γ-gliadin epitopes. All four 
lines revealed a signicantly lower amplicon number measured by both duplex 
ddPCR compared to plants with the α2 construct. Epi_61 amplicons decreased 
as much as 32 to 38 copies, while UD_136 amplicons decreased 19 to 23 copies 
(Fig. 11). e signicant reduction of amplicons detected with Epi_61 and 
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UD_136 duplex ddPCR indicates that roughly 40-50% of the deletions may be 
large, while the remainder may be smaller indels. 
Figure 11. ddPCR results of α-gliadin gene amplicon number in Fielder and CRISPR/Cas9 lines with 
targeted α-gliadins.
Two multiplex ddPCR assays, with Epi_61 or UD_136 α-gliadin primer pairs and Ref_181, were performed 
on Fielder and 13 of the CRISPR/Cas9 lines with sgRNA targeting α-gliadins (α1 and α2 constructs) or 
both α- and γ-gliadins (α2γ3 construct), having been pre-screened for α-gliadin protein prole alterations 
on Acid PAGE. Error bars indicate the Poisson 95% condence intervals. Black stars indicate signicant 
amplicons reduction compared to Paragon and grey stars indicate signicant dierence between amplicons 
reduction obtained with both primer pairs, based on standard deviation of condence intervals dierence.
Five additional Fielder-CRISPR mutant lines were analysed that contained 
the γ3 construct, composed only of the three sgRNAs targeting γ-gliadins. 
Even though no α-gliadins were targeted, the α-gliadin amplicon number was 
signicantly lower for both α-gliadin ddPCR primer pairs in all lines, with no 
signicant dierences between both primer pairs in most cases (Fig. 12). An 
average decrease of 20 α-gliadin Epi_61 amplicons was observed in the mutant 
lines, which is ~20% of the total α-gliadin copy number found in Fielder. Line 
γ3-1_G6 lacked 29 and 24 α-gliadin amplicons when using Epi_61 and UD_136 
primer pairs, respectively. ese reductions of the number of amplicons is close 
to the 30 copies reduction observed with Epi_61 and the 20 with UD_136 seen 
in line α2γ3-38_G1 (Fig. 11), in which both α- and γ-gliadins were targeted.
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Figure 12. ddPCR results of α-gliadin gene amplicons number in Fielder and CRISPR/Cas9 lines with 
targeted γ-gliadins.
Two multiplex ddPCR assays, with Epi_61 or UD_136 α-gliadin primer pairs and Ref_181, were performed 
on Fielder wild type and 5 of the CRISPR/Cas9 lines targeting only γ-gliadins and no α-gliadins (γ3 
construct), having been pre-screened for α-gliadin protein prole alterations. Error bars indicate the 
Poisson 95% condence intervals. Black stars indicate signicant amplicons reduction compared to Paragon 
and grey stars indicate signicant dierence between amplicons reduction obtained with both primer pairs, 
based on standard deviation of condence intervals dierence.
Discussion 
e implementation of ddPCR is well established for accurate, reliable and fast 
gene copy number variation studies. However, the feasibility of this method was yet 
to be proven for CNVs in large gene families, or for quantifying the total number 
of gene copies in complex polyploid organisms. Challenges exist with regard to 
the linearity of the detection and to the sensitivity to detect the relatively smaller 
dierences in copy number when the absolute number is large. We developed the 
methodology here for the α-gliadin family - previously estimated at approximately 
100 copies -, in hexaploid (AABBDD) bread wheat. e linearity was assessed 
using sets of genetic material with chromosome deletions or replacements, the 
sensitivity was approached by analysing plants derived from random and targeted 
mutagenesis. e size of deletions and hence the nature of the gene edits was 
assessed by using two dierent amplicons in the α-gliadins.
ddPCR optimisation: internal reference, multiplexing and near-absolute 
copy number quantication
For ddPCR of α-gliadin genes in hexaploid wheat, we calculated that 10 ng of 
gDNA would be the “sweet spot”, based on information known for single gene 
copy in humans. is result was conrmed experimentally using a range of input 
gDNA concentrations. To reinforce the accuracy of CNV, we have included the 
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TaPFT1 as an internal reference. It is an orthologue of the Arabidopsis thaliana 
Phytochrome Flowering Time 1 gene, which is present once per homoeologous 
chromosome 5, meaning 6 times per hexaploid wheat genome (Fitzgerald et al., 
2010). e Ref_181 primer pair was designed on a region conserved across the 
three homoeologous genomes. e results indicate that the internal standard gene 
approach works well for wheat, so that this primer pair is advisable for use in 
ddPCR assays in wheat. However, it must be kept in mind that some accessions 
may present SNPs in the sequences at the primer annealing positions, impeding 
the amplication. is was corrected using the average amplicon number of other 
samples, which appeared to work well. It could also be corrected with degenerated 
primers aer identifying sequence variants.
Multiplexing α-gliadin primer pairs with a reference primer pair increases the 
accuracy of a ddPCR assay by enabling normalisation and direct amplicon 
comparisons within and across samples. It also decreases the costs. However, 
multiplexing requires much stricter experimental design than basic reactions, in 
order to be able to always clearly distinguish the multiple amplicons in the assay 
from each other and from the internal reference. Although uorescently tagged 
probes are the most ecient for multiplexing assays, they are not compatible with 
highly variable gene sequences such as the α-gliadin family. We therefore used 
intercalating uorescent dye assays to detect the α-gliadin gene sequence variants 
amplied with degenerate primer pairs. e use of dierent annealing temperatures 
to distinguish amplicons was discarded, as degenerated primers already have slightly 
dierent annealing temperatures. Increasing the concentration of one of the primer 
pairs (McDermott et al., 2013) increased both amplicons and background signal, 
increasing the probability of signal overlap. erefore, we varied amplicon length 
to be able to multiplex the TaPFT1 reference gene and the α-gliadin studied genes. 
As our attempt of triplexing the reference primer pair with two dierent α-gliadin 
primer pairs failed because of overlap in amplicon signal amplitudes, probably 
due to some variation in length of both α-gliadin genes, we settled on duplexing 
the Ref_181 internal reference with either of two α-gliadin primer pair Epi_61 or 
UD_136. e presence of the internal reference in both reactions increased the 
accuracy of the measurement while it also enabled the direct comparison of both 
α-gliadin amplicon numbers in the paired duplex reactions.
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e higher accuracy generated by duplex ddPCR of an α-gliadin amplicon 
together with the reference amplicon was negatively aected by the occurrence 
of droplets containing multiple-amplicons. When working with amplicon 
size dierences, like signal dierences, it is dicult to dene the content of 
the multiple-amplicons droplets correctly. Since the signal of the multiple-
amplicons droplets overlapped with that of the reference droplets, they have 
been counted as references. is bias was present in all samples, thus did not 
signicantly aect the relative gene copy number comparisons. To estimate the 
absolute copy number bias generated by this phenomenon, samples in which 
multiple-amplicons could be distinguished were rst counted as such and then 
as references. e consequence was an absolute α-gliadin gene copy number 
reduction by 4-5 copies (which is in the order of ~5%). In addition, the high 
sequence variation among α-gliadin genes within a single locus and within a 
genotype, makes it dicult to amplify all copies with sequence variants. Although 
degenerated primers were designed to match the most α-gliadin variants using 
a multiple alignment of over 1200 sequences from various Triticeae species and 
accessions (Chapter 2), these primers may not amplify all sequence variants 
present in the sample. Together, the signal overlap of droplets containing 
multiple-positive or reference amplicon and the high variability of α-gliadin 
gene sequences indicate that the duplex ddPCR may give an underestimation of 
the absolute α-gliadin gene copy number present in the wheat accession studied. 
Duplex ddPCR to determine gene copy numbers per homoeologous 
chromosome pair
e linearity and the detection limit of the method were rst tested by duplex 
ddPCR reactions on Synthetic Hexaploid Wheat (SHW) and their respective 
parental lines. e diploid Ae. tauschii species (DD genome) revealed 14-17 
α-gliadin gene copies, depending on the accession. e tetraploid T. turgidum 
(AABB genomes) varieties showed 70-76 α-gliadin gene copies. e small 
dierences among genotypes were expected. Based on these results, the theoretical 
α-gliadin gene copy number of the SHW (AABBDD) based on the sum of that in 
the respective diploid (DD) and tetraploid (AABB) parental lines was calculated. 
e number was experimentally determined by duplex ddPCR on the actual SHW 
lines. Similar results of 87-95 α-gliadin gene copies were observed using both 
methods (Table 6), conrming the accuracy of duplex ddPCR and demonstrating 
the linearity of the duplex ddPCR up to almost 100 gene copies without saturating 
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the signal detection of the droplet reader. It also shows that the absolute α-gliadin 
gene copy number could be determined, if there would be certainty that the 
primers designed amplify all the sequence variants present in that genotype. 
e linearity and sensitivity of the duplex ddPCR method were further tested 
on CS and related deletion and nullisomic-tetrasomic lines, which have 
dierent α-gliadin gene compositions as the gliadin loci on the homoeologous 
chromosomes 6 are missing or present twice. e method was sensitive enough 
to detect a decrease in copy number of 5-25 genes relative to 61 α-gliadin gene 
copies in wild type hexaploid CS (AABBDD), which is consistent with the 60 
copies estimated in CS using Southern blot (Anderson et al., 1997). e reduction 
of α-gliadin copies in each deletion line enabled us to estimate the number of 
gene copies present on each pair of homoeologous chromosomes, and this was 
also conrmed with calculations based on the nullisomic-tetrasomic lines. A 
total of 24, 18 and 15 α-gliadin gene copies where determined for homoeologous 
chromosome pair 6 AA, 6 BB and 6 DD, respectively, using both methods. e 
number of copies per homoeologous chromosome was, for a long time, an open 
question, as even a genome sequence may not be accurately assembled in these 
regions with tandemly duplicated genes with highly similar sequences.
Dual duplex ddPCR to identify, quantify and distinguish between indels 
and large deletions
e validation of duplex ddPCR for α-gliadin CNV in hexaploid wheat was 
performed using Paragon lines randomly mutagenized with γ-irradiation, 
and Fielder CRISPR/Cas9 lines, gene edited using sgRNAs targeting α- and/or 
γ-gliadin gene families. All lines used had an altered gliadin protein prole on 
Acid-PAGE (Chapter 2). Two connected duplex ddPCR assays were employed, 
which amplied dierent parts of each α-gliadin genes, to identify, quantify and 
distinguish between small indels and large deletions.
e four Paragon γ-irradiated lines tested showed a signicant reduction of 16-30 
α-gliadin gene copies using both duplex PCR compared to the 61 copies found in 
the Paragon. Even when considering that some α-gliadin genes may not have been 
amplied by the ddPCR primer pairs, the γ-irradiation has caused a 25% to 50% 
reduction in the α-gliadin gene copy number. e α-gliadin gene copy numbers 
reduction measured using the two primer pairs were the same, conrming the 
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occurrence of large deletions that aected both primer pairs and, very likely, the 
whole gene. e reductions in copy number were as large as or higher than the 
number of α-gliadin genes on a single homoeologous chromosome pair in CS (6 
AA=24, 6 BB=18, 6 DD=15) which is consistent with the deletion of at least one 
complete set of α-gliadin genes on one of the homoeologous chromosomes. is 
is plausible since γ-irradiation generates mostly deletions of large DNA fragments 
(Morita et al., 2009). 
In case of the Fielder-CRISPR lines, the interpretation of the two connected duplex 
PCR assays is more complex. e concept is based on the fact that small indels 
would only aect the amplication by the primer pair on target or adjacent to the 
sgRNA target site while larger deletions would decrease the amplicons number 
generated by both adjacent and distant primer pairs. e size of large deletions 
is then estimated as being at least of the distance between the sgRNA target site 
and the annealing position of the closest primer of a pair (Fig. 10). One Fielder-
CRISPR line tested contained sgRNA_α87 (α1 construct) targeting α-gliadins at 
the beginning of the gene sequence. It showed that 1/3 of the initial 87 gene 
copies revealed large deletions of at least 130 bp, half of which were larger than 
430 bp. e eight Fielder-CRISPR lines with sgRNA_α213 and sgRNA_α324 (α2 
construct) showed on average 17 small indels or medium-sized deletions (10 
- 50 bp). In addition, in six of the eight lines, large deletions (> 190 bp) were 
observed, in up to 13 of the 87 α-gliadin genes. e dierential eect of both 
assays appears to work well, as the results were consistent across all lines. On 
average, small indels (20%) are usually more abundant than large deletions (8.5 
%). Four Fielder-CRISPR lines contained the previous two sgRNAs targeting 
α-gliadins together with an additional three sgRNAs targeting γ-gliadins (α2γ3 
construct). ese lines all showed on average an additional decrease of 14 small 
deletions and 16 large deletions, compared to the lines where only α-gliadins 
were targeted. us, the presence of sgRNAs targeting γ-gliadins inuences 
α-gliadin amplicons number. A similar result was found for ve additional 
Fielder-CRISPR lines that only contained the previous three sgRNAs targeting 
γ-gliadins and no guide RNAs that targeted α-gliadins (γ3 construct). In these ve 
plants, around 20% of α-gliadin small indels or large deletion where detected. In 
line γ3-1_G6. In this particular line, containing only sgRNA targeting γ-gliadins, 
the mutations measured is close to the one observed in α2γ3-38_G1 (Fig. 10) 
where both α- and γ-gliadins were targeted. is result implies that α-gliadin 
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mutations in this α2γ3-38_G1 lines might only be due to the presence of sgRNA 
actually targeting γ-gliadins.
e fact that sgRNAs targeting γ-gliadins aect similarly the α-gliadin Epi_61 
and UD_136 amplicon number is surprising. One possible explanation is that 
the ddPCR primers partly amplify γ-gliadins, despite the specicity of the primer 
sequences checked using genome Blast. Indeed, due to duplexing constrains, the 
primer annealing temperature used in the duplex ddPCR was only 56°C, but on 
gel only one specic band of the expected length of 61 bp and 136 bp respectively 
are seen aer amplication with annealing temperature between 50°C and 60°C. 
Another explanation is sgRNA o-target, where γ-gliadin-targeting sgRNAs 
would wrongly target α-gliadins, despites the absence of complementarity of the 
sgRNA with other gliadin gene families checked using genome Blast. 
Independent evidence for an eect of γ-gliadins on chromosome 1 comes from the 
comparison between CS deletion lines 6DS-4 and 6DS-4/1BS-19. e latter one, 
obtained from crossing 6DS-4 missing α-gliadin with 1BS-19 missing gliadins 
from other families, unexpectedly showed less α-gliadin copies than in its 
parental line 6DS-4. e only known dierence between the lines is an additional 
deletion in chromosome 1B, short arm, and this suggests the presence there of 
sequences that are amplied by Epi_61 and UD_136 primer pairs. Furthermore, 
a Blast of the primers into Ensembl plant T. aestivum online database gave only 
two hits on chromosome 1 with 95% homology but these were not signicant (E 
value = 2.00). However, many hits were found in scaolds that had not been not 
assigned yet to any chromosome, with signicant E-values as low as 8.4 10-3. ese 
results suggest the possible presence of α-gliadins-like sequences on chromosome 
1, short arm near glia-α1 loci encoding for γ-gliadins. is is not unrealistic 
from an evolutionary point of view, since α-gliadins were originally located on 
chromosome 1, short arm before being translocated to chromosome 6, short arm 
(Payne et al., 1982; Shewry et al., 1984). A hypothesis for the mechanism observed 
here is that large deletions of γ-gliadins lead to losses of intercalated or adjacent 
α-gliadin-like genes.
To test whether the hypothetic presence of α-gliadin-like sequences on 
chromosome 1BS occurs for each homoeologous genome, CS deletion lines that 
related to deletions on chromosome 1 and that show gliadin protein prole changes 
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on Acid-PAGE, should be analysed using duplex ddPCR with the α-gliadin Epi_61 
primer pair. Another way of verifying the theory would be using duplex ddPCR 
with primer pairs amplifying γ-gliadins. A reduction of γ-gliadins amplicons in 
Fielder-CRISPR lines containing the α2 construct targeting only α-gliadins may 
also lead to deletion of surrounded γ-gliadin genes on chromosome 1. 
Based on our experience and in view of the diversity of γ-gliadins, duplex 
ddPCR to measure γ-gliadin genes or amplicon copy number variation should be 
designed using a slightly dierent approach than for α-gliadin. Indeed, γ-gliadin 
gene sequences are so much more diverse than α-gliadins (Salentijn et al., 2012; 
Chapter 2) that several primer pairs should be designed, each specic to one group 
of sequence patterns. is set of primer pairs, used in CS deletion lines, would 
give precise information regarding the sequence patterns on the homoeologous 
genomes, and this would assist the genome assembly in these complex regions.
Regarding the development of hypoimmunogenic wheat, ddPCR was proven to 
be a valuable pre-screening tool. In hexaploid wheat lines, this method enabled us 
to (1) assess near-absolute α-gliadin gene copy number in CS, (2) estimate their 
repartition over the homoeologous genomes AA, BB and DD, (3) detect α-gliadin 
gene copy number reduction in CS deletion lines and Paragon γ-irradiated lines 
as well as (4) quantifying and distinguishing small indels and larger deletions 
generated in α-gliadin genes by CRISPR-Cas9 constructs in Fielder lines. erefore, 
wheat lines identied by ddPCR to contain a lower number of intact gliadin genes 
could be combined, by simple crossing or generation of synthetic hexaploid 
wheat, to produce lines with a reduced level of gluten immunogenicity. ese lines 
should be further tested with deep sequencing and advanced proteomics methods 
in order to characterise the mutations generated, their expression and predict 
their immunogenic potential based on the sequence of detected epitopes. Further 
in-vitro immunogenic tests including ELISA and T cells stimulation should be 
done to prove the gluten hypoimmunogenicity of the newly generated bread 
wheat lines. 
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Conclusion
Gene copy number variation (CNV) in large gene families can represent an 
important feature for plant phenotypes. In this study, we developed two duplex 
ddPCR assays, each amplifying a reference gene with a known copy number per 
genome and one amplicon in the genes for which the gene copy number was to 
be determined. ese ddPCR assays proved to be accurate and reliable to assess 
near-absolute α-gliadin gene copy number in hexaploid wheat up to almost 100 
gene copies. Duplex ddPCR assays on sets of deletion and nullisomic-tetrasomic 
lines could quantify relative gene copy number variation and therefore enables to 
calculate the gene copy number associated to homoeologous chromosome pairs. 
In addition to gene copy number variation, ddPCR proved to be able to quantify 
α-gliadins gene-edited within the gene family and to distinguish between small 
indels and large deletion induced by the sgRNA-Cas9, in hexaploid wheat. Indeed, 
we showed that a single Fielder-CRISPR line could contain small indels (1-50bp) 
in up to 10 α-gliadin genes and large deletions (>300bp) in 20 α-gliadin genes out 
of the 87 α-gliadin genes present in Fielder. ese positive results, generated in a 
large gene family of a hexaploid plant, attest further the potential of ddPCR assays 
for high throughput gene-editing screening as shown by Gao et al. (2018) for 
single genes in tetraploid Medicago sativa. We conclude that ddPCR is a suitable 
method for pre-screening of gene-edited plants when gene families or multiple 
genes are targeted, and one that can be used for high-throughput screening. 
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Abstract
Genetic variation studies of large gene families in polyploid crops are challenging. 
A genomic reduction step such as target gene enrichment makes it possible to use 
sequencing to characterize all gene members more eectively. Here we report on 
the development of an in-solution gluten exome capture system called GlutEnSeq 
for Gluten gene Enrichment and Sequencing, which fully covers the sequence 
variation present in thousands of available prolamin gene sequences originating 
from various Triticeae species and cultivars. We assessed the ecacy of this 
capture system, followed by Illumina sequencing, to localise and characterise the 
mutations generated in gliadin gene families of hexaploid wheat. e on-target 
regions were determined based on the Chinese Spring (CS) reference genome 
RefSeq v1.0. Gluten gene sequences were generally enriched around 10,000-fold. 
For validation, the loss of gluten genes in CS deletion line 1BS-19/6DS-4 deletion 
was detected in the form of the absence of gluten gene coverage on chromosome 
1B and Un (the α-gliadin Gli-2 loci from chromosome 6D are not yet anchored in 
the CS reference genome but instead are part of the Unknown chromosome). Two 
γ-irradiated lines of cultivar Paragon, known to be aected in their gliadin protein 
prole, were shown to contain homozygous deletions for the α-gliadin Gli-2 
locus on 6A and the γ-gliadin Gli-1 locus on 1B, respectively. Four CRISPR/Cas9 
gliadin gene-edited lines of the cultivar Fielder revealed homozygous deletions of 
the γ-gliadin Gli-1 locus on 1B and heterozygosity for the α-gliadin Gli-2 locus 
on 6A. We also detected a decrease of gluten gene sequence coverage within 
parts of some gluten genes on 6A, 6B and 1B in some lines, most likely associated 
with heterozygous medium-sized deletions within the genes. GlutEnSeq thus 
enables identifying the homoeologous chromosome pair on which homozygous 
or heterozygous mutations occurred, such as large deletions across multiple 
consecutive genes or medium-size mutations within individual genes, in hexaploid 
wheat. e bioinformatics pipeline will be optimised to also enable ecient 
characterisation of small indels responsible for lack of coverage within individual 
gluten genes, in order to fully analyse the Fielder-CRISPR mutant lines for their 
decrease in gluten immunogenicity for Coeliac patients. 
Key words: GlutEnSeq, Enrichment and sequencing, Gene editing, CRISPR/Cas9, 
Mutation breeding, γ-irradiation, Deletion lines, Wheat, Polyploid, Gene family, 
Gluten, Prolamins, α-gliadin, γ-gliadin, Epitope, Coeliac Disease. 
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Introduction
Bread wheat (Triticum aestivum) is a hexaploid crop (2n=6x=42) with 7 pairs of 
chromosomes for each of the homoeologous genomes A, B and D. e genome 
size of hexaploid wheat is approximately 16 Gb (Arumuganathan and Earle, 1991; 
IGWS, 2014), which is more than ve times larger than the human genome. 
e hexaploid wheat genome consists of only 2% of protein coding sequences 
(Paux et al., 2006) whereas over 80% are repetitive sequences (Li et al., 2004, 
Wicker et al., 2011), of which 70% are retroelements (class I; Clavijo et al., 2017). 
erefore, the size and the complexity of the wheat genome makes it a challenging 
puzzle to assemble the genome sequences (Wul and Moscou, 2014). e rst 
hexaploid wheat genome assembly of the reference cultivar Chinese Spring (CS) 
was released in 2012 (Brenchley et al., 2012) but it was very fragmented and 
incomplete, with only 5 Gb -one third of the genome- successfully sequenced 
and roughly assembled. Since then, new assemblies have been released, based on 
dierent sequencing technologies and bioinformatic tools. In 2017, Zimin et al. 
published an assembly of 15 Gb, representing 96% of the genome, with a much 
better resolution.
Due to the large size of the wheat genome and the diculty to assemble it, screening 
a wheat population for variation in complex gene families is currently not feasible 
using whole genome shotgun sequencing (WGS). Although using RNA sequencing 
(RNAseq) would reduce the genetic information to be sequenced, the amount of 
data generated is still high and dicult to handle. Furthermore, not every gene 
from a gene family is expressed, and expression also varies during development 
and/or under inuence of environmental conditions. To circumvent these issues, 
Jupe et al. (2013), while studying a large and complex family of disease resistance 
genes (NB-LRRs) in potato, developed an exome capture-based approach called 
REnSeq for Resistance genes Enrichment and Sequencing. 
Based on the REnSeq approach, we developed an exome capture system that we 
have called GlutEnSeq (Gluten gene Enrichment and Sequencing), in order to 
study the complex gluten gene families. Gluten consists of two types of proteins, the 
glutenins and the gliadins. Glutenins are divided into two groups, High Molecular 
Weight (HMW) and Low Molecular Weight (LMW) glutenins, estimated to have 
20 and 35 gene copies respectively (Forde, 1985; Sabelli and Shewry, 1991) while 
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gliadins are divided into three groups, α- γ- and ω- gliadins and estimated to have 
60-100, 39 and 16 gene copies respectively, in hexaploid wheat (Sabelli and Shewry, 
1991; Anderson et al., 1997; Ozuna et al., 2015). e exact gene copy number 
varies among cultivars (Anderson et al., 1997). Genes within each gene family are 
clustered at specic loci, present on the three homoeologous genomes A, B and 
D. HMW-glutenins are located at the Glu-1 loci on the long arm of chromosomes 
1. LMW-glutenins, γ- and ω- gliadins are clustered at loci Glu-3, Gli-1 and Gli-3 
respectively, on the short arm of chromosomes 1. However, α-gliadins are located 
at Gli-2 on the short arm of chromosomes 6. Within one gene, there are repetitive 
domains, made of simple and complex repeat motifs. Within a gene family, 
various groups can be distinguished based on sequence similarity. In addition, a 
large portion of them may be pseudogenes (up to 90% of the α-gliadin genes, as 
estimated by van Herpen et al., 2006).
Our aim was to develop GlutEnSeq as a tool to facilitate the study of genetic 
variation in all gluten gene families simultaneously, and applicable for various 
species (wheat, barley, rye, or relatives). Here we focus on hexaploid wheat, with 
the intention to characterise mutations generated by γ-irradiation or CRISPR/
Cas9 in gliadin gene families, working towards the development of wheat lines 
with hypoimmunogenic gluten for Coeliac patients.  
Materials and methods
Development of solution-based gluten genes exome capture system
e exome capture system is based on in‐solution sequence hybridization, 
to selectively enrich a DNA sample for gluten gene-like sequences. It has been 
developed using the MYbaits® technology of Arbor Bioscience (formerly 
MYcroarray; Ann Arbor, Michigan) in which multitudes of micro-beads are 
coated with biotinylated single-stranded RNA probes designed to capture DNA 
fragments containing gluten gene-like DNA sequences. 
e probes, also referred to as baits, were designed based on all sequences from 
gluten genes (i.e. glutelins and prolamins) and anking regions (e.g. promoters) 
from any Gramineae containing gluten-like proteins (97 species), as were 
available on NCBI in June 2015. Some gene sequences cloned and sequenced 
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in house were added. A total of 7,468 sequences of gDNA and (since the genes 
of interest do not have introns) cDNAs and ESTs from genes and pseudogenes 
were used to design the MYbaits® solution-based gluten exome capture system. 
Integrating all gluten gene sequences enabled the creation of a complete exome 
capture library that can be used as a resource for projects focusing on glutenins 
as well as gliadins, for any of the species included. In addition, sequences from 
the wheat Phytochrome and Flowering Time 1 (TaPFT1) gene were integrated in 
the exome capture system design to be used as endogenous reference sequences. 
One copy of TaPFT1 is present per haploid genome on chromosome 5, and the 
gene copies include homoeologous genome-specic SNPs in both Chinese Spring 
and in cultivar Chara (Fitzgerald et al., 2010). is gene can therefore be used for 
data normalisation, giving a better estimation of the enrichment, the sequence 
coverage and the absolute gluten gene copy number sequenced.
Several successive steps were necessary to optimize the MYbaits® gluten exome 
capture design, and these steps were performed by Arbor Bioscience based on 
our criteria. e initial design of the baits was made by splitting each of the input 
sequences into 120 nucleotide sub-sequences using a moving window approach 
with steps of 40 nucleotides, giving over 65,000 bait sequences with 3x tiling 
density, to cover the integral sequences multiple times and to ensure that all gene 
copy variants would be captured. Bait sequences targeting wheat and having 100% 
sequence homology to another bait sequence were considered redundant and 
removed to avoid over-representation of some bait sequences. In case of other 
Gramineae species the threshold for discarding redundant bait sequences was 
set at 90% sequence homology, due to exome capture design restrictions. Baits 
usually capture DNA fragments with as low as 70-80% sequence homology (Jupe 
et al., 2013). e bait sequence coverage was checked by BLASTing each designed 
bait sequence against all initial full-length sequences. Bait sequences containing 
signal peptide-like sequences were discarded to avoid capturing o-target genes 
also expressed in the grain endosperm. All bait sequences were also BLASTed 
against the Triticeae Repeat Element Database (TREP on http://wheat.pw.usda.
gov/ITMI/Repeats/, which contains 1,717 transposon sequences) and bait 
sequences showing 1 or more BLAST hits with a Tm>40C were discarded in order 
to avoid capturing unwanted transposon-containing sequences. However, bait 
sequences from the gluten-specic repetitive regions were retained. Redundant 
complementary bait sequences were identied by performing a bait-sequence-
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to-bait-sequence BLAST. Bait sequences complementary to other bait sequences 
were discarded. 
Plant materials
In total seven mutated hexaploid wheat lines from three dierent cultivars, 
showing altered gliadin protein prole on Acid-PAGE compared to their wild 
type parents (Chapter 2), were selected for GlutEnSeq. Chinese Spring (CS) and 
its 1BS-19/6DS-4 deletion line (Endo, 1988; Endo & Gill, 1996; obtained from 
Kansas State University), missing α-gliadin gene copies from chromosome arm 
6DS and gliadins from chromosome arm 1BS, showing α- and ω-gliadin bands 
missing, were used. Cultivar Paragon and two Paragon γ-irradiated lines P3-75 
and P5-20 (obtained from JIC, Norwich, UK; Shaw et al., 2013), selected for 
altered expression of α-gliadin and γ-gliadin proteins, respectively, were also used. 
Fielder and four Fielder-CRISPR gliadin mutant lines generated using sgRNA 
targeting of α-gliadins and/or γ-gliadins (Chapter 2) were tested as well. Line α1-
14_G1 contains one sgRNA targeting α-gliadins and showed the absence of two 
α-gliadin protein bands on Acid-PAGE gels. e γ3-20_G6 line contains three 
sgRNA targeting γ-gliadins and it showed protein bands missing for γ-gliadins 
and bands shied for ω-gliadins. e α2γ3-38_G4 and α2γ3-39_G7 lines contain 
two sgRNA targeting α-gliadins and three sgRNA targeting γ-gliadins, and they 
showed fainter α-gliadin bands and missing γ-gliadin bands, respectively. 
Library preparation and enrichment for Illumina MiSeq 2*250 paired-
ends sequencing
DNA was extracted from leaves of the ten mutated seedlings (generation M4 for 
Paragon and T1 for Fielder-CRISPR mutant lines), using a CTAB-based protocol. 
DNA samples were sent to Arbor Biosciences which performed all the steps from 
library preparation, capture and enrichment with GlutEnSeq to Illumina MiSeq 
2*250 paired-end sequencing using one sequencing lane (for a total of 12 samples).
Bioinformatic analysis of enriched gluten sequences
Analysis of the sequences resulting from gluten gene enrichment followed by 
Illumina sequencing was conducted using the wheat genome reference assembly 
of the International Wheat Genome Sequencing Consortium (IWGSC) RefSeq 
v1.0, before its full annotation was released (IWGSC, 2018). Gluten gene families 
are known to have varying copy number in dierent wheat cultivars (Anderson 
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et al., 1997). In addition, gluten genes contain low complexity repeat domains 
made of consecutive “CCA” or “CAG” codons, which translate into glutamine (Q) 
repeats that are characteristic of gluten proteins. e length of these glutamine-
coding domains varies between gene copies, within and between wheat varieties. 
For example, the length of PolyQ domain 1 in α-gliadins (General Introduction) 
ranges from 24 bp to 210 bp (between 8 and 70 consecutive repeats of glutamine 
codon), as based on a multiple sequence alignment (Chapter 2). Since these 
short sequence repeats are also abundantly present throughout in the genome as 
trinucleotide microsatellite repeats, our rst task was to dene our actual target 
regions within the reference genome framework. 
e target regions within the reference genome were identied by mapping back 
the bait sequences to the reference genome using two slightly dierent approaches: 
A ‘high stringency’ approach wherein 10 copies of each of the bait sequences 
and 10 copies of all baits sequences with every possible single nucleotide change 
were mapped back to the reference, and a ‘low stringency’ approach wherein a 
number of random changes R was introduced in 10 copies of each bait sequence 
for each R in the range of 10-29 (inclusive). For clarity, this means that in the ‘high 
stringency’ approach, each 120-nucleotide long bait sequence was represented 
using a dataset of 1+120*3=361 sequences with small variations, and in the ‘low 
stringency’ approach, each bait sequence was represented by a dataset of 200 
sequences with larger variations. Read mapping of both the ‘low stringency’ and 
‘high stringency’ datasets was performed separately using “bwa mem” (Li, 2013) 
with default settings and post-processed using ‘samtools sort’ (Li et al., 2009). 
Aer read mapping, genome sequence coverage graphs were obtained using 
“bedtools genomecov” (Quinlan and Hall, 2010), and converted to bed les using 
a coverage threshold of 1 using a custom perl script. Another custom script was 
subsequently used to expand the regions in the bed les by 500bp le and right and 
to merge them when appropriate to accommodate the fact that properly captured 
DNA fragments were expected to exhibit up to 500bp overhang beyond the actual 
probe sequences. Subsequently, regions in the bed les were ltered using a custom 
script to remove regions shorter than 1200 bp aer expansion, as such regions were 
surmised to arise due to short sequence motifs present throughout the genome. 
Aer this, lines in both bed les were tagged as ‘1’ or ‘2’ as either ‘low stringency’ 
or ‘high stringency’ using the unix ‘awk’ command-line utility. en, they were 
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combined into a single bed le using the ‘bedtools merge’ (Quinlan and Hall, 2010) 
utility, using the option to sum elds in this le, producing a bed le with regions 
tagged as either ‘1’, ‘2’ or ‘3’ for regions found using either the ‘low stringency’ 
approach only, the ‘high stringency’ approach only, or using both approaches, aer 
some minor manual editing. is bed le containing the nal set of target regions 
was subsequently used in downstream analyses, either directly or in a modied 
form, for visualisation purposes, for which the regions were expanded slightly by 
200bp on either side and with coordinates converted to compact the regions to 
visualize into a set of adjacent blocks using a custom script. Similar coordinate 
conversions were applied, as appropriate, to other les to maintain consistency 
in visualisations. In addition to visualisation purposes, the bed le containing 
the combined (‘high stringency’ and ‘low stringency’) regions was used to extract 
histograms of the on/o target coverages using a custom script.
Reads obtained from each variety were mapped back against the reference genome 
using ‘bwa mem’ (Quinlan and Hall, 2010) using default options, post-processed 
using ‘samtools sort’ and ‘samtools rmdup’ (Quinlan and Hall, 2010) before 
being converted into nucleotide coverage graphs using ‘bedtools genomecov’. For 
visualisation purposes, regions from these genome coverage graphs were extracted 
and their coordinates converted to place-dened target regions in adjacent blocks 
using a custom perl script. Custom perl scripts were used to generate the nal 
GNUPlot (Racine, 2006) scripts and annotation datasets that were used in the 
visualisations of data.
Results
Solution-based gluten exome capture: nal design
To nalise the gluten exome capture design, the specicity of the bait sequences 
toward their target gene family was checked based on genome-wide hit counts. 
Each bait sequence was BLASTed against the entire Chinese Spring hexaploid 
wheat reference genome (Ensembl! version release 29 of Triticum_aestivum.
IWGSC1.0+popseq.29.dna_sm.toplevel.fa.gz,). e stringent “1 or more BLAST hit 
with a Tm>40C” cut o was applied. To get an accurate estimate of bait specicity, 
the number of hits in the wheat genome obtained by a bait sequence was plotted 
against the number of bait sequences that showed a specic number of hits in the 
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wheat genome. It enabled selecting the most specic bait sequences (Fig. 1). is 
value should correspond to the number of targets found in one diploid genome, 
which, multiplied by three, was comparable to the estimated gene copy number in 
the targeted family, in a hexaploid genome. 
Figure 1. Distribution of γ-gliadin-targeting baits matching dierent number of sequences in CS wheat 
genome. 
e number of BLAST hits in the CS genome obtained by a bait sequence was plotted against the number of 
bait sequences that show a specic number of hits in the wheat genome. It enables selecting the most specic 
bait sequences. Here, in the case of baits targeting γ-gliadins, most of the bait sequences hit 13 sequences 
in the wheat genome. is means that bait sequences having between 1 and 20 hits in the wheat genome 
should be specic. If we assume that most primer pairs specically catch 13 or 14 gene copies in only one 
of the three homoeologous chromosomes, the total gene copy number estimate is around 3*13=39, which 
corresponds to gene copy number estimations made using RFLP (Sabelli and Shewry, 1991).
Aer this step, the number of bait sequences was 40,559. It was reduced by 
applying a more stringent cut-o regarding the bait sequence specicity to 39,997 
(Table 1), to t the 40,000 baits design oered by Arbor Biosciences.
Table 1. Repartition of the baits targeting each gene family present in the MYbaits® gluten exome capture
Genes Initial sequences
used
Unique 120bp
baits generated
Specic  
baits remaining
Final baits 
HMW-glutenins   947 10.567 4.361
No 
data concerning  the 
nal number of baits 
per family
LMW-glutenins 1.876 12.120 9.275
α-gliadins 2.622 24.576 22.937
γ-gliadins 1.073 9.802 6.421
ω-gliadins    282 2.641 1.124
TaPFT1 ref       16 83 72
Precurser       15 75 n/a
Promotors/Flaking 637 n/a n/a
TOTAL 7.468 59.864 44.190 39.997
is table summarizes the evolution of the representation of the dierent gene families during the process of 
designing the exome capture system. e nal number of bait sequences for each family is not known since 
the steps discarding signal peptide and transposon containing bait sequences were performed aer merging 
the gene family les for simplicity. 
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GlutEnSeq specicity and eciency
To assess the ecacy of GlutEnSeq as a method for characterisation of mutations 
induced in gluten genes, hexaploid wheat lines tested as mutant lines were 
pre-screened for gliadin protein prole alteration comparing to the wild type, 
using Acid-PAGE (Chapter 2). Based on these results, it was possible to infer 
the chromosome and sometimes even the homoeologous genome on which 
the mutations occurred. For twelve lines, DNA samples were captured and 
enriched with GlutEnSeq and sequenced using Illumina MiSeq 2*250 paired-end 
sequencing. We describe here the analysis of 10 of these samples. 
As a rst step in the analysis, the bait target regions were identied in the Chinese 
Spring reference genome, leading to the identication of 573 target regions in the 
reference genome, 12 of which were identied using only the high-stringency 
target region identication method and 292 which were only identied using the 
low-stringency target region identication method (Table 2). On-target regions 
refer to regions where the baits from the exome capture system map on CS 
reference genome, some of which are on the target chromosomes (i.e. 1 and 6 
expected to contain gluten genes) and others map to remaining chromosomes (2, 
3, 4, 5 and 7) whereas o-target regions refer to the rest of the genome. Note that 
not all contigs have been mapped to the chromosome scaolds of RefSeq v1.0, as 
a part is included as Un (Unknown).
Based on the identied on-target regions, the Chinese Spring reference genome 
was subdivided into 4 compartments: 1) O-target regions, 2) On-target regions 
found using both low- and high-stringency target identication methods, 3) On-
target regions only identied using the low-stringency method and 4) On-target 
regions only identied using the high-stringency method (these were relatively 
rare). e sequence reads of the dierent lines studied here were mapped back to 
the Chinese Spring reference genome, aer which nucleotide coverage tables were 
obtained. Coverage histograms were extracted for each of the four compartments, 
which were used to compute average coverage gures for each of the compartments 
as shown in Table 3. 
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While a signicant proportion of the sequence data was o-target, in particular 
for Chinese spring and CS deletion line 1BS-19/6DS-4 where it was systematically 
below 600-fold, the general on-target enrichment was above 1000-fold while the 
on-target enrichment on targeted chromosomes was above 6000-fold. Overall, the 
enrichment worked well, with at least a factor 3 increase of coverage in on-target 
regions versus o-target regions, even though the fraction of on-target nucleotides 
is relatively low since on-target regions constitute only a very small part of the 
total genome (data not shown).
GlutEnSeq coverage prole
Sub-selection of sequence coverage data (obtained from the read mapping 
data) around only the identied target regions (i.e., essentially removing the 
o-target regions from the data) resulted in what we refer to as condensed on-
target coverage proles or, for short, “coverage proles” for each of the accessions 
under study. Below, these coverage proles are compared to each other in various 
combinations, as appropriate – CS versus a CS deletion line (Fig. 2), Paragon 
versus Paragon γ-irradiated lines (Fig. 3) and Fielder versus Fielder CRISPR 
gliadin-edited lines (Fig. 4).
In these coverage proles (Fig. 2, 3 and 4) three main types of peaks can be 
observed: Very narrow, very high peaks most likely corresponding to incidental 
repeats, low level peaks most likely corresponding to noise caused by mis-
hybridization or mis-mapping of reads, and broader peaks essentially covering 
most of a target region, most likely corresponding to our actual genes of interest. 
Coverage variation within and between these latter peaks may correspond to 
variations in hybridization eciency or in copy number. e physical origin of 
each region in a condensed coverage prole is depicted beneath each coverage 
prole, giving information on the genomic position of the dierent target regions. 
e target regions are color-coded according to their respective compartment: 
red for regions only identied using the low-stringency method, blue for regions 
identied using only the high-stringency method and grey for regions identied 
using both methods.
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GlutEnSeq to study gliadin-induced mutations in hexaploid wheat 
CS and gliadin deletion line 
Figure 2 shows coverage proles for CS and CS deletion line for two chromosomes, 
1B in Figure 2a and 6D/Un in Figure 2b. Several target regions in this gure 
exhibit a broad coverage peak, which we associate with proper mapping of target 
gene sequences. Oen these target regions are grouped in a small physical region, 
reinforcing the possibility that each region in a group represents a single gene in a 
gluten genes cluster.
Figure 2. Gliadin sequence coverage prole and Acid-PAGE of Chinese Spring and a Chinese Spring deletion 
line.
Panel a) and b) display superimposed coverage proles of CS (grey) and CS deletion line 1BS-19/6DS-4 (red) 
for chromosome 1B and Un, respectively. e coverage proles show the number of sequenced nucleotides 
covering the target regions, which the exome capture system enriched for. Absence of red peaks hence 
indicates the absence of coverage in the target regions in the deletion line. e track below the gure shows 
the physical position of each target region on the CS reference genome (chromosome 1B and Un, where 
Un is not properly assembled). e coverage proles themselves are a condensed representation of only the 
target regions, leaving out most of the o-target regions of the genome. In the track below the gure, grey 
lines represent target regions identied using both high- and low-stringency methods, red lines represent 
target regions identied using only the low-stringency method. Panel c) shows the Acid-PAGE gliadin 
protein prole of CS (outer lanes) in comparison to the CS deletion line (in the two central lanes, in duplo). 
e deletion line lacks protein bands of each of the three gliadin families, as indicated with red arrows.
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Almost no bait sequences were mapping to chromosome 6D although it carries 
many α-gliadins. However, the U chromosome that combines all non-anchored 
contigs had a lot of bait sequences mapping to it (Fig. 2b). 
e coverage prole of CS deletion line 1BS-19/6DS-4, which lacks a part of 
chromosome 1B short arm that carries γ- and ω-gliadin genes as well as part of 
chromosome 6D short arm that carries α-gliadin genes, is shown superimposed 
on the coverage prole of CS. An absence of coverage in the large gluten gene 
regions in chromosome 1B and Un was observed in the CS deletion line (Fig. 2a, 
2b). e absence of coverage in the CS deletion line on chromosome 1B and Un 
correlates with the characterisation of the deletion line. e lack of coverage on 
Un in the deletion line and the lack of target regions on 6D in CS lead us to infer 
that the α-gliadins from 6D are not yet anchored in 6D, but present on Un. No 
dierences in coverage prole between CS and the CS deletion line were observed 
on other chromosomes. e Acid-PAGE of this deletion line visualises the impact of 
removing parts of gluten loci on the proteins produced in then endosperm (Fig. 2c).
Paragon and γ-irradiated gliadin mutant lines
Two Paragon γ-irradiated lines were selected as they lacked some gliadin bands 
on Acid-PAGE. Line P5-20 lacks bands associated to γ-gliadins (which are 
located on chromosome 1 short arm) while line P3-75 lacks bands related to 
α-gliadins (located on chromosome 6 short arm; Fig. 3b, 3d). A coverage prole of 
Paragon together with the two Paragon γ-irradiated mutants P5-20 and P3-75 of 
chromosomes 1B and 6A was generated (Fig. 3a, 3c). 
e comparison between sequence coverage proles of Paragon and mutants 
shows the absence of coverage in a large part of the gluten locus on chromosome 
1B for the P5-20 mutant line (Fig. 3a). In case of line P3-75, there is no coverage 
for the complete Gli-2 locus on chromosome 6A for α-gliadins (Fig. 3c). ese 
results correlate with the bands missing on the gels. 
Paragon line P5-20 and CS deletion line 1BS-19/6DS-4 lack the same peaks in 
their coverage proles and have similar alteration of γ-gliadins on the protein gels, 
although they show dierent changes in the ω-gliadins.
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Figure 3. Gliadin sequence coverage prole and Acid-PAGE of Paragon and two Paragon γ-irradiated lines
Panel a) and c) display superimposed sequence coverage proles of Paragon (grey) and Paragon γ-irradiated 
lines P3-75 (red) and P5-20 (dotted green line) for chromosome 1B and 6A, respectively. e absence of 
green peaks in Chr1 and red peaks in Chr6 indicate the absence of coverage of gluten genes and α-gliadin 
genes in lines P5-20 and P3-75 respectively. Panel b) and d) are the Acid-PAGE gliadin protein proles 
of Paragon (outer lanes) in comparison to the Paragon mutant (central lanes, in duplo). e deletion line 
displays protein bands missing in corresponding gliadin families.
Fielder and Fielder-CRISPR gliadin mutant lines
Four Fielder-CRISPR lines were selected as they lacked some gliadin bands on 
Acid-PAGE. Line α1-14_G1 contains one sgRNA targeting α-gliadins and showed 
the absence of two α-gliadin protein bands from the gel. Line γ3-20_G6 contains 
three sgRNA targeting γ-gliadins and showed protein bands missing for γ-gliadins 
and bands shied for ω-gliadins. e α2γ3-38_G4 and α2γ3-39_G7 lines contain 
two sgRNA targeting α-gliadins and three sgRNA targeting γ-gliadins, and they 
showed faint α-gliadin bands (Fig. 4d) and missing γ-gliadin bands (Fig. 4b), 
respectively. 
Coverage proles were generated for Fielder together with two Fielder-CRISPR 
mutants, α1-14_G1 and γ3-20_G6 (data not shown) and together with two other 
Fielder-CRISPR mutants, α2γ3-38_G4 and α2γ3-39_G7 (Fig. 4a, 4c). 
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e comparison between coverage proles of Fielder and the gene-edited mutants 
shows the absence of coverage in a large part of the gluten locus on chromosome 
1B in line α2γ3-39_G7 (Fig. 4a), which is similar to the CS deletion line (Fig. 
2a) and P5-20 Paragon γ-irradiated line (Fig. 3a). e Acid-PAGE prole is in 
accordance with this result (Fig. 4b) and is similar to the one of P5-20 (Fig. 3b) 
where a band is missing in the γ-gliadins. 
In case of line α2γ3-38_G4, the coverage across the complete Gli-2 locus on 
chromosome 6A is approximate half the coverage observed across the same locus 
for Fielder (Fig. 4c). is is in correlation with the gliadin protein prole where 
the α-gliadin bands are present but less bright than in Fielder (Fig. 4d).
Figure 4. Gliadin sequence coverage proles and Acid-PAGE of Fielder and two Fielder-CRISPR lines.
Panel a) and c) display superimposed sequence coverage proles of Fielder (grey) and two Fielder CRISPR 
lines: α2γ3-38_G4 (red) and α2γ3-39_G7 (dotted green line) for chromosome 1B and 6A, respectively. For 
line α2γ3-39_G7, the absence of green peaks in Chr1 indicates the absence of coverage of gluten genes 
while for line α2γ3-39_G7 the lower height of red peaks in Chr6 indicates a decrease of coverage by half 
for α-gliadin genes. Panel b) and d) are the Acid-PAGE gliadin protein proles of Fielder (outer lanes) in 
comparison to the Fielder-CRISPR mutant (central lanes, in duplo). e deletion line displays protein bands 
missing in corresponding gliadin families.
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In the γ3-20_G6 line, coverage for some genes from chromosome 1B and 6B 
show an approximately two-fold reduction (data not shown). ese results are 
consistent with the Acid-PAGE where bands are faint in α-gliadins, one band is 
missing in γ-gliadins and bands shied in ω-gliadins.
For line α1-14_G1 the coverage proles are hard to interpret. It seems that on 
chromosome 6A, less coverage is present in the middle part of some α-gliadin 
genes (data not shown). is result would correlate with the Acid-PAGE where 
two bands associated with α-gliadin genes are extremely faint. 
Discussion
GlutEnSeq was developed to identify and characterise mutations generated 
in gluten gene families from hexaploid wheat species in order to select 
hypoimmunogenic wheat lines for Coeliac patients. e development of a gluten 
gene enrichment method was necessary due to the large size of the wheat genome 
and to the complexity of the gluten gene families. 
GlutEnSeq development and enrichment eciency
e choice of including all gluten gene families from various gluten-containing 
species in the design of the capture system was made to enable studying several 
gluten families together and to be able to use the same capture design for dierent 
studies in wheat or other species, such as glutenin studies for bread dough quality 
or secalin studies for rye with low Coeliac immunogenicity. e choice to retain 
glutamine-rich repetitive sequences specic to gluten genes was made to bind 
as many gluten sequences as possible, since these sequences were not similar 
to retro-transposon sequences. Retaining these repetitive sequences may lead 
to enrichment for some o-target sequences or biased the homogeneity of the 
enrichment eciency (Henry et al., 2014), and indeed many repeat-containing 
sequences were present in the enriched samples, which eectively decreased the 
sequencing depth of gluten gene target sequences. 
e success of the enrichment obtained using GlutEnSeq was determined by 
looking at the ratio between average sequence coverage in on-target and o-target 
regions, resulting in an ‘enrichment ratio’. On-target regions refer to regions where 
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the baits from the exome capture system map on CS reference genome, many of 
which are on the target chromosomes (i.e. 1, 6 and Un containing gluten genes) 
and others map to remaining chromosomes (2, 3, 4, 5 and 7). Together this is a 
small proportion of the genome. O-target regions refer to the rest of the genome. 
For all but two samples (CS and 1BS-19/6DS-4), the enrichment ratio on target 
chromosomes was around 10,000-fold on average, except of course for regions 
in mutants where target gene copies were missing. On the other chromosomes, 
where additional potential target regions were found in our bait sequence analysis, 
the enrichment ratio was below 4000-fold. is result supports the hypothesis 
that these are actually o-target regions coincidentally captured due to conserved 
sequence motifs shared with gluten genes, e.g. from other genes of the prolamin 
superfamily, which occur on all wheat chromosomes (Juhász et al., 2018). 
e CS and 1BS-19/6DS-4 samples had a much lower enrichment ratio (an 
average of 200) than all other samples. e exact cause of this is unknown, but 
it was noted that sequence library prep for these accessions was done separately 
from the others, and the insert size distribution of the resulting sequences was 
dierent (data not shown). Evidently, this lower enrichment ratio is also reected 
in the fact that for these accessions the vast majority of the sequenced nucleotides 
(>95%, data not shown) was located in o-target regions for these accessions. 
Nevertheless, because the target represents only a small fraction of the genome, 
the remaining average coverage in the target regions (15x for CS and 5.5x for 1BS-
19/6DS-4) still allowed qualitative assessments. 
Bait mapping and mis-assignment of 6D α-gliadin locus sequences
Few baits mapped to chromosome 6D in all 10 lines, even though this chromosome 
contains the 6D α-gliadin locus (van Herpen et al., 2006). Instead, a cluster of 
baits was found to map to the unplaced sequences in the reference which are 
combined into pseudo-chromosome “Un”. Juhász et al. (2018, Suppl. S2) also 
noted that a part of chromosome “Un” in RefSeq v1.0 contains several α-gliadins 
not yet anchored in 6D. In line with this, CS deletion line 1BS-19/6DS-4, which is 
known to lack the 6D α-gliadin locus, lacks coverage for several on-target genes 
on chromosome “Un”. 
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Comparison between gliadin sequences in wheat cultivars and mutated 
lines
GlutEnSeq proof of concept to assess gluten gene loss was achieved by comparing 
the gluten mapping prole of CS with its deletion line 1BS-19/6DS-4, which lacks 
parts of chromosomes 1BS and 6DS that carry gliadin genes. e deletion line 
showed partial absence of sequence coverage for chromosomes 1B and Un (which 
contains the 6D α-gliadin locus). is conrm that this approach can be used 
to determine which homoeologous gluten loci has been mutated. In theory, the 
absence of reads mapping to a locus can have two dierent reasons: either the 
sequence was completely absent from the sample or the sequence was too dierent 
to map to the reference in the correct locus. For that reason, GlutEnSeq should 
also be used for the reference cultivar that was used for mutagenesis. When no 
reads map to a full locus, while they are present in the cultivar before mutagenesis, 
it is most likely that large deletions occurred at the genomic level. In contrast, 
when only reads mapping in the middle of the gene are absent, it is possible that 
only small mutations were generated within the gene.
GlutEnSeq was validated using Paragon and two of its γ-irradiated mutants, 
selected for altered gliadin proles. Both mutants revealed lack of sequence 
coverage in a large part of the gluten loci, conrming a large DNA fragment 
deletion in 6AS for P3-75 and 1BS for P5-20. It is known that using γ-irradiation 
can cause large deletions. In addition, the genes missing are consistent with the 
gliadin bands missing on the protein gels (Chapter 2), namely α-gliadins in P3-75 
and γ-gliadins in P5-20. 
GlutEnSeq was then applied to Fielder and its CRISPR/Cas9 mutants, which 
display dierences in the protein proles on Acid-PAGE. Absence of sequence 
coverage for a series of gliadins on 1B was detected in CRISPR line α2γ3-39_
G7, similarly to the absence observed in the CS deletion line and in one of the 
Paragon mutants. Line α2γ3-39_G7 contains sgRNA constructs targeting both 
α- and γ-gliadins and the phenotype shows that γ-gliadin bands are missing on 
the gel. We can therefore conclude that CRISPR/Cas9 with multiplex sgRNA can 
generate large deletions in genes that are present in tandem repeats, as reported 
in rice (Zhou et al., 2014). Moreover, the CRISPR/Cas9-induced deletions were 
homozygous in the T1 generation used here for GlutEnSeq. 
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Line α2γ3-38_G4, which contains the same CRISPR/Cas9 construct, showed an 
approximately two-fold decrease in sequence coverage along the full series of 
α-gliadin genes on 6A. Two hypotheses are possible. e rst one is that the full 
Gli-2 locus has been removed, but from only one of the two copies of chromosome 
6A, and the T1 grain is still heterozygous for this deletion. e second hypothesis 
is the T1 grain is homozygous for a deletion, but this deletion only aected about 
half of the genes in the locus, and the reads obtained from the remaining genes of 
this locus were mapped back to all genes in the CS reference sequence. On the gel 
no gliadin band is missing in α2γ3-38_G4 but three bands are fainter. ese are 
the same bands as were completely missing in γ-irradiated mutant P3-75, which 
was homozygous for the 6A locus deletion. erefore, it is most likely that α2γ3-
38_G4 is heterozygous for the deletion of α-gliadin Gli-2 locus on chromosome 
6A. A study of the T2 seeds from this line will be needed to conrm this.
In the α1-14_G1 mutant line, in which one α-gliadin band is missing and two 
other are faint (data not shown), fewer reads seem to map to the middle part of 
four α-gliadin genes on chromosome 6A. In this case, we are probably not dealing 
with a deletion of a large part of the α-gliadin Gli-2 locus but instead with smaller 
mutations within several of the α-gliadin genes. erefore, CRISPR/Cas9-induced 
medium size mutations in several genes within a locus may trigger similar gliadin 
protein prole changes on the Acid-PAGE as when the full locus is gone, if the 
deletions knock out gene expression, e.g. by generating premature stop codons. 
Several studies have shown that CRISP/Cas-induced small deletions may produce 
stop codons and abolish gene expression, in various species. Sánchez-León et al. 
(2018) detected them as a result of several small deletions in α-gliadin genes in 
wheat. Whether our line α1-14_G1 contains gliadins with new stop codons, will 
be determined by zooming in on the reads for those regions, but it may explain 
the diculties to observe the mutations in the T2 grains.
Limitations of GlutEnSeq 
One limitation of GlutEnSeq is that, although the baits are designed on the basis 
of gluten sequences from many species, the initial mapping is made to the CS 
reference genome. As a consequence, sequence reads obtained from genes that 
are not present in the CS reference genome cannot be mapped to their proper 
location. If a suciently similar sequence is present in the CS reference genome, 
then such reads may accidentally be mapped to the incorrect locus, otherwise 
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such sequences may remain completely unmapped. is signicantly complicates 
analysis of mutants of a strain for which no proper reference sequence is available: 
if reads do not map or map to the wrong locus, then conclusions about structural 
variations may be wrong. One example of the dierence among wheat cultivars is 
the number of α-gliadin genes that we estimated using ddPCR (Chapter 2), where 
CS and Paragon have around 60 genes, but Fielder has more than 87 genes. 
In addition, we chose for the data analysis to start by visualising the power of 
GlutEnSeq in terms of revealing large deletions in gluten loci or medium-sized 
mutations in individual gluten genes. is analysis, however, does not allow the 
identication and characterisation of subtle indels that may be responsible for 
gene knock-out and newly functional gene sequences. In-frame indels in gliadins 
may supress their immunogenicity for CD patients while remaining functional for 
bread dough rheology. Additional ways of analysing the data set (inspired from 
MutRenSeq (Steuernagel et al., 2017)) are therefore necessary in order to reveal 
the full potential of GlutEnSeq for characterising small gluten mutations, despite 
the level of complexity associated to wheat gluten gene families.  
Conclusions
Genetic variation studies of large gene families in polyploid crops are oen 
challenging and require a genomic complexity reduction step such as target gene 
enrichment and sequencing. Here we developed an in-solution gluten exome 
capture system called GlutEnSeq for Gluten gene Enrichment and Sequencing, 
which enable doing various studies of the large gluten gene families present in 
Triticeae. We assessed the ecacy of the method to localise and characterise the type 
of mutations generated in gliadin gene families of hexaploid wheat, with the aim to 
develop bread wheat varieties with hypoimmunogenic gluten for Coeliac patient.
e in-solution gluten exome capture system successfully enriched hexaploid 
wheat DNA samples in gluten genes by around 10,000-fold. GlutEnSeq enabled 
identifying homoeologous chromosome pairs in which large deletion occurred 
across gluten gene clusters, such as in CS deletion lines, Paragon γ-irradiated 
lines but also in some Fielder-CRISPR lines, by analysing dierences in gluten 
gene coverage prole. In the lines made with targeted gene editing, it was possible 
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to distinguish between lack of coverage of a full gluten gene locus – most likely 
associated with complete deletion of gluten gene loci – and changes in coverage 
within genes, as expected for small indels and medium-sized deletions. It was also 
possible to distinguish between homozygous and heterozygous deletions based 
on variations in gluten coverage proles compared to what was observed in the 
original cultivar, Fielder. 
So far, gluten gene coverage prole variation enabled us to infer whether mutations 
were large deletions of gluten gene loci or medium-sized mutations occurring 
within a gluten gene. Further developments, on the bioinformatics side, are being 
made to enable characterisation of small indels responsible of lack of coverage 
within individual gluten genes, in order to fully analyse the Fielder-CRISPR edited 
lines for their modication of gliadin genes, and the associated decrease in gluten 
immunogenicity for Coeliac patients.
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Abstract
Coeliac Disease (CD) is an auto-immune reaction to gluten in 1-2% of the 
human population. A gluten-free diet, excluding wheat, barley and rye, is the 
only remedy. is diet is dicult to adhere to, partly because wheat gluten is 
added to many processed products for their viscoelastic properties. In addition, 
gluten-free products are less healthy and expensive. Wheat products containing 
only hypoimmunogenic gluten proteins would be a desirable option. Various 
gluten peptides that trigger CD have been characterized. A single wheat variety 
contains around hundred gluten genes, producing proteins with varying 
numbers of epitopes. Gene editing using CRISPR/Cas9 can precisely remove 
or modify the DNA sequences coding for immunogenic peptides. Wheat with 
hypoimmunogenic gluten thus exemplies the potential of gene editing for 
improving crops for human consumption where conventional breeding cannot 
succeed. We describe here, in relation to breeding hypoimmunogenic wheat 
varieties, the inconsistencies of applying GM regulation in Europe for gene-
edited plants while mutation breeding-derived plants are exempted. We explain 
that healthy products derived from this new technology may become available 
in the US, Canada, Argentina and other countries but not in Europe, because of 
strict regulation of unintended GM risk at the expense of reduction the existing 
immunogenicity risks of patients. We argue that regulation of gene-edited plants 
should be based on scientic evidence. erefore, we strongly recommend 
implementing the innovation principle. Responsible Research and Innovation, 
involving stakeholders including CD patient societies in the development of gene-
editing products, will enable progress towards healthy products and encourage 
public acceptance. 
Key words: Coeliac disease, Gluten, Wheat, Mutation breeding, New Plant Breeding 
Technique, Policy, Public acceptance, Innovation principle, GM Regulation, Genetic 
Modication, Risk assessment.
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Wheat gluten and coeliac disease
Bread wheat (Triticum aestivum) is a staple crop consumed worldwide. e 
properties that make wheat our suitable for bread-making are conferred by 
gluten, the glutenin and gliadin storage proteins present in the grain. High 
molecular weight (HMW) glutenins provide dough with elasticity, which is 
the most important property for bread quality, while gliadins provide viscosity 
(Shewry et al., 2009). 
Wheat gliadins, and to a lesser extend low molecular weight (LMW) glutenins, 
carry immunogenic peptides that can cause Coeliac Disease (CD) in 1-2% of 
the human population (Fasano, 2006). CD leads to an inammation of the small 
intestine, which aects nutrient absorption and causes diverse symptoms (Husby 
et al., 2012). 
A gluten-free (GF) diet, excluding wheat, barley and rye, is the only way CD 
patients can avoid symptoms. It is dicult to adhere to as wheat gluten is added to 
many food products (Atchison et al., 2010). Furthermore, current GF products are 
low in proteins and nutrients, high in salt and contain many additives to emulate 
the rheology of gluten-based dough (Caponio et al., 2008; Capriles and Arêas, 
2014; Belz, 2016; Horstmann et al., 2016). Hence, healthier but safe products for 
CD patients are needed.
Breeding towards hypoimmunogenic wheat: a complex 
challenge
Breeding wheat without immunogenic epitopes (Gilissen et al., 2014) would be 
a denitive solution for CD patients (Shewry and Tatham, 2016). Developing 
“hypoimmunogenic gluten” wheat varieties that retain baking quality is, however, 
very challenging. Firstly, gluten proteins are encoded by ve gene families 
containing many immunogenic epitopes. Within these families, α-gliadins on 
chromosomes 6 trigger CD strongly, followed by γ-gliadins, ω-gliadins and LMW 
glutenins on chromosomes 1. Secondly, bread wheat is allohexaploid, with three 
sets of chromosomes referred to as genome A, B and D. Each of these genomes 
contains all gluten gene families. As a result, a single bread wheat variety has a 
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combination of gliadins and glutenins, some without any CD epitopes, others with 
one or more immunogenic epitopes (Van Herpen et al., 2006; Tye-Din et al., 2010; 
Salentijn et al., 2013). No cultivated wheat or wild relative has been identied 
that contains only CD safe gluten epitopes (van den Broeck et al., 2010a; 2010b). 
Consequently, conventional breeding alone cannot produce hypoimmunogenic 
varieties.
Gil-Humanes et al. (2010) used RNA interference to reduce the expression of the 
gliadin gene families by 97%, abolishing stimulation of T cells from CD patients 
while no major issues were reported regarding seed germination or dough quality 
(Gil-Humanes et al., 2014). Becker et al. (2012) reduced the expression of up to 20 
α-gliadins, but other storage proteins became more abundant. As the transgenic 
RNAi construct remains in the wheat genome to silence the genes, these plants are 
subject to GM regulation, which in the EU is expensive, takes a long time, and has 
an uncertain outcome (Laursen, 2016). In practice this precludes investments in 
what initially will be a niche product.
Another approach is mutation breeding. Exposure to γ-irradiation has been used 
to randomly remove large regions of chromosomes in wheat, among which the 
gluten genes on chromosomes 1 and 6 (van den Broeck et al., 2009). Selected 
mutations in separate plants can be combined by crossing and selecting, as was 
done for “ultra-low gluten” barley (Tanner et al., 2016). We screened a γ-irradiated 
population of variety Paragon (JIC, Norwich, UK) to identify relevant deletions 
in hexaploid bread wheat. Paradoxically, mutation breeding is regulated as 
conventional breeding based on a history of safe use, although it randomly alters 
or removes many other genes besides the intended ones. 
CRISPR/Cas9 editing of gliadin genes towards 
hypoimmunogenic gluten
Gene editing (Baltes and Voytas, 2015), a prominent New Plant Breeding 
Technique (NPBT), can be used to develop wheat with hypoimmunogenic gluten 
(Sánchez‐León et al., 2018; Jouanin et al., 2018). A Cas9 nuclease is directed by a 
guide RNA to a target region within the genome and generates a double strand 
break. Inaccurate DNA repair by the plant may result in mutations at the target 
site. As a pilot project, we focussed on mutating epitopes in α- and γ-gliadin 
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genes - which are the most immunogenic - separately and simultaneously using 
CRISPR/Cas9. We transformed immature embryos of the bread wheat variety 
Fielder with constructs with Cas9 and multiplex guide RNA constructs, and 
regenerated plants. Due to the contiguity of the gliadin genes on the chromosome, 
gene copies located between two DNA breaks may be lost from the genome as well. 
Sánchez‐León et al. (2018) successfully targeted α-gliadins with CRISPR/Cas9, 
generating small deletions. e Cas9 construct is to be out-crossed in subsequent 
generations (Schaeer and Nakata, 2015; Sprink et al., 2015). Alternatively, Cas9 
can be delivered through transient expression or as ribonucleoprotein  (Zhang et 
al., 2016; Liang et al., 2017).
First, we tested grains of the plants produced for changes in gluten composition 
by acid-polyacrylamide gels, and determined the number of mutated or deleted 
gliadin genes using droplet digital PCR. Some γ-irradiated lines showed identical 
gliadin prole changes to gene-edited lines (Fig. 1). Sequencing data enabled 
determining the type of mutations generated, while proteomics analysis can 
identify changes in amino acid composition of modied gliadin proteins. ese 
data will enable predicting whether a mutation in an epitope decreases its 
immunogenicity, as crucial residues have been determined experimentally (Mitea 
et al., 2010) and the anity of the human receptors has been fully characterized 
(Petersen et al., 2014; 2016). 
Second, gluten from selected lines should be tested for immunogenicity and 
dough rheology. ese tests are designed in collaboration with gastroenterologists, 
immunologists, food scientists and CD patient associations. ey comprise 
in-vitro studies using epitope-specic T-cell clones isolated from CD patients 
(Anderson et al., 2000) and bread quality tests. Sánchez-León et al. (2018) made 
CRISPR/Cas9 mutant wheat lines with altered α-gliadin proles and a reduction 
in immunogenicity, which retained acceptable dough quality. 
As a third and nal step, in-vivo studies are needed where gluten from mutant grains 
would be given to voluntary CD patients to conrm hypoimmunogenicity. en, 
hypoimmunogenic wheat will be ready to be cultivated in a separate production 
chain, carefully controlled from eld to packaging to avoid contamination with 
regular wheat, barely or rye, similar to a gluten-free oat chain (Smulders et al., 
2018). It will likely be sold under a specic hypoimmunogenic gluten label. 
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Figure 1. CRISPR/Cas9 gene editing (a) and γ-irradiation mutation breeding (b) generated similar changes 
in wheat γ-gliadin protein proles (Chapter2). 
Lanes are Acid-PAGE gliadin proles from control lines (on the le), a T1 Fielder grain, stably transformed 
with a CRISPR/Cas9 construct, and a M4 Paragon mutant line. Similar amounts of protein extract were 
loaded.
Gene-edited plant varieties: regulation, safety, acceptance 
and policy in Europe
We describe here, in relation to hypoimmunogenic wheat, the inconsistencies 
of applying GM regulation for gene-edited plants in Europe while mutation 
breeding-derived plants are exempted. e EU regulation is based on the process 
used, not on the product generated, and follows the precautionary principle. 
Other countries have a product-based system (Canada) or a mixed product/
process-based system (USA, Argentina).
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e origin of GM regulation for gene editing plants in Europe
Competent Authorities of several EU countries, including the Swedish Board of 
Agriculture, as well as the European Food Safety Authority (EFSA, 2015) are in 
favour of adopting gene-edited products (Sprink et al., 2016a) with conventional 
breeding regulations or adapted regulations (Whelan and Lema, 2015). EFSA 
found a very low level of intended or unintended risks associated with site-directed 
mutated products (EFSA, 2012). Furthermore, the former Chief Scientic Advisor 
to the President of the European Commission (Simon, 2013) and the European 
Academies Science Advisory Council (EASAC, 2015) supported the regulation 
of gene editing plants as non-GM. However, the EC postponed a decision, mainly 
due to pressure from NGOs (Lawler, 2015). Recently, the European Court of 
Justice ruled that according to the text of the Directive 2001/18/EC, such products 
should be regulated as GM (ECJ, 2018a; 2018b).  
Inconsistent regulation of mutated plants in Europe
Random versus targeted mutations
Mutation breeding deploys chemical mutagens or radiation. Because mutations 
occur randomly, large mutant populations must be screened to nd a plant that 
contains the desired mutation, and each plant will contain many other mutations. 
ese plants and products are considered as GM but exempted from GM regulation 
in most countries, including the EU (Directive 2001/18/EC, Annex 1B), due to a 
history of safe use and consumption since the 1930’s. Over 3200 commercial crop 
varieties have been produced using mutation breeding (Ahloowalia et al., 2004; 
Bado et al., 2015). 
Gene editing uses a nuclease to generate a double-strand break at a desired target 
site in the genome, and plants are selected in which a mistake during repair led 
to a mutation of the target site. O-targets may occur at a low frequency, much 
lower than in mutation breeding. In a product-based approach, the fact that plants 
obtained via gene editing are similar to those obtained using mutation breeding, 
means that they will follow the regulation of conventionally bred plants due to 
history of safe use (Fig. 1). In contrast, in a process-based approach, as used by the 
EU, it has to go through the process of GM risk assessment. 
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Detrimental eects on costs and opportunities
GM regulation of gene edited plants in Europe implies time-consuming (6 years) 
and costly ($35M) GM safety tests and administrative processes (McDougall, 
2011), with uncertain outcome as the nal permission is still a political decision. 
GM regulation erases the core advantages of gene editing as a quick, precise and 
cheap method to develop high added-value plants to meet the needs of consumers 
and society. 
In the US, were both mutation breeding and gene editing are exempted from GM 
regulation, the latter will be preferred since it is more precise, faster and versatile 
as it can produce homozygous mutations in several gene families simultaneously 
target (Fig. 2). Consequently, European companies move their research facilities 
to the US (Burger and Evans, 2018), and European researchers move to US start-
ups focusing on gene editing, such as Calyxt, which develops reduced-gluten 
wheat for the US market. As hypoimmunogenic wheat will initially be a niche 
product, the costs of GM regulation will be too high for small and medium-
sized companies in Europe. us, regulation of gene editing as GM will impede 
innovation, competitiveness and access to healthier food in Europe.
Detection, labelling and eects on trade
It is oen impossible to distinguish products obtained using gene editing from 
those with mutation breeding or from ‘natural’, spontaneous mutations (Sprink 
et al., 2016b). e absence of distinctness will hamper control and labelling 
of gene editing-derived products, especially when it concerns material from 
outside Europe where gene-edited varieties are exempted from GM regulation. 
It represents a major issue. If Europe does not accept gene-edited products due 
to their lack of compliance with GM regulation applied in EU, this would block 
the import of any product that is not GM-labelled and tested. Indeed, any non-
GM labelled product could potentially be produced with gene-editing, since there 
is no obligation of labelling gene-edited products in the US. As a consequence, 
world trade could be disrupted (Cheyne, 2012). 
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Figure 2. Comparison of the main technical and regulatory steps in the US and EU for breeding 
a hypoimmunogenic wheat variety using mutation breeding and gene editing.
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Some gene-edited plants had similar targeted mutations as plants produced with 
γ-irradiation (Fig. 1) and they cannot be distinguished by their gluten prole. In case 
of hypoimmunogenic wheat, a separate production chain is always required to avoid 
contamination with regular immunogenic wheat. e traceability is guaranteed, 
and products will be labelled as hypoimmunogenic, so it would be relatively easy to 
label them as derived from gene-edited wheat, even in the US. For other products 
this will not be the case, as no separate production chain is necessary.
Food safety, environmental safety and food security tests under GM 
regulation
For each new technology one undertakes a cost, benet and risk analysis. 
According to the European Food Safety Authority (EFSA, 2012), the scientic 
facts gathered so far show no higher food safety risks of gene-edited plants than 
mutation breeding plants that have a history of safe consumption. Furthermore, 
gene editing leads to plants with fewer o-targets modications, making them 
at least as safe as conventionally-bred ones (Lucht, 2015). is implies, from a 
risk assessment perspective, that gene-edited plants should be regulated as 
conventionally bred ones (EPSO, 2015). 
Food safety testing
e GM food safety risk assessment tests are related to the presence of foreign 
genes in the plants. ese tests have not uncovered issues for over two decades 
(SNSF, 2012) and are not adapted for gene editing due to the absence of foreign 
genes introduced. In case of hypoimmunogenic wheat varieties, food safety issues 
will already thoroughly have been tested for coeliac patients, to ensure that epitope 
content is suciently low. However, to comply with the GM regulation for food 
safety, a rat feeding study has to be performed to test whether animals (that do 
not have CD) would develop unknown symptoms from eating hypoimmunogenic 
compared to regular wheat. On top of time, costs and animal welfare issues, there 
is no relevance for these tests.
Environmental safety testing
Regarding environmental risks, under GM regulation, gene-edited plants have 
to follow strict containment rules. With regard to outcrossing, wheat is a self-
pollinated species, and there are no wild populations. Outcrossing to other 
varieties would introduce hypoimmunogenic gluten, which is safer for human 
18060-Aurelie_Jouanin_PM.indd   160 02-01-19   12:19
Gene editing policy and wheat with hypoimmunogenic gluten
161
5
health, while bread quality would barely be aected. Gluten proteins are storage 
proteins in the grain and loss of gluten storage proteins did not lead to decreased 
tness in gluten-free barley (Tanner, personal communication).
Food security
Considering food security, regulating gene editing as GM in Europe impedes the 
goals of increasing food production with fewer inputs (Ishii and Araki, 2016) for 
all types of agriculture, including integrated and organic farming (Andersen et al., 
2015). As the economy of many developing countries relies on food exports to the 
EU, regulating gene editing as GM in the EU consequently has a negative impact 
on the availability of the technology for local markets in these countries, aecting 
their food security (Heap, 2013).
Public acceptance and Responsible Research and Innovation
e public needs to be better informed about new food technologies, to enable 
educated choices about food consumption. Scientists should contribute to this 
knowledge transfer and creation of awareness. However, the complexity of science 
oen confuses people’s risk perception, decreasing their trust in scientic facts and 
increasing their fears, that they base on inaccurate information or wrong concepts 
from non-scientic sources (Lucht, 2015). is contributes to empower NGOs 
that inuence the regulation-making process by claiming to protect consumers’ 
safety on no scientic grounds. 
In a context where scientic communication has proven to be insucient, the 
Responsible Research and Innovation initiative (RRI) (Owen et al., 2012) should 
be implemented as complementary approach. Targeted consumers should be 
asked for their interest in a potential product beneting them and their trust in 
the methods used, in order to assess product acceptance prior its development, 
and they should remain involved during the whole process. 
CD patients are the prime consumers for gene-edited hypoimmunogenic wheat. 
Following this RRI initiative, the idea of developing such a product has been 
discussed with CD patient associations early on. ey understand the complexity 
of the challenge and appreciate the eort of scientists to develop a solution, even 
if the initial results are not perfect, as oen when developing products concerning 
health issues (Schenk et al., 2011). 
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Gene-edited hypoimmunogenic wheat ts into a strongly growing market of GF 
food for coeliacs and other consumers (Sapone et al., 2012). In addition, it may 
contribute to preventing genetically predisposed children of developing CD, as 
quantity of exposure matters (Koning, 2012). us, there is a clear prospective 
gain in health which is held back in Europe by the GM regulation of gene editing. 
CD patients, relatives and others beneting from gene-edited products should 
stand up and help the scientic community to convince politicians to adopt a 
science-based regulation of gene-edited plants and derived products.
Policy making: “innovation principle” instead of “precautionary 
principle”
Considering the incoherence of applying GM regulation in EU to gene-edited 
products that may be identical to conventional varieties and anticipating its 
consequences in terms of food and environmental safety, food security, as well 
as associated economic issues, we strongly suggest the EC to review its position 
on the matter. So far, “the precautionary principle” (EC, 2000) is being applied 
solely, although technically this principle, meant as a provisional measure to avoid 
discernible risks based on scientic evidence, is not valid anymore considering 
the history of safe use of GM (no evidence of hazards for 20 years (SNSF, 2012)). 
We argue that the “innovation principle” (EPSC, 2016) should be used instead 
where relevant risk assessment would be designed on a case-per-case base, to 
enable beneting of gene-edited products while complying with relevant risks 
management. is would constitute an appropriate regulation for the future of 
food security, healthy food, as well as protection of the environment and economy.
Conclusions and recommendations
Gene editing has made it possible to remove CD epitopes from wheat gluten. It is 
expected that in America, derived-products from such wheat will be on the market 
soon. Due to their absence of compliance with GM regulation, these products will 
remain illegal in the EU, as long as gene-edited products will be regulated as GM, 
following a process-based approach. 
In addition, these niche products would not be developed in EU either due to 
the lack of protability associated to expensive GM regulation tests and labelling. 
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ese GM tests, based on an precautionary principle, are required to detect 
unintended eects associated to transgenes, which are not present in the product. 
We argue that, instead, gene-edited plants should be regulated as plants made 
with mutation breeding, on a product-based approach, and follow the innovation 
principle. is principle values benets associated with the product while 
scientically complying with trait-specic risk management. It should be part of 
a Responsible Research and Innovation initiative involving targeted consumers 
as stakeholders, to ensure their acceptance throughout the gene-edited product 
development process.
Food safety, environmental safety and food security in Europe will directly be 
aected by the regulation of gene editing as GM, and we expect politico-economic 
issues related to non-GM regulation of gene editing in other countries. erefore, 
we strongly advise the EC to review its position on NPBT regulation by considering 
the present case and the regulatory advices provided. 
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Overall goals and ndings regarding gliadin gene editing 
in wheat
Why develop wheat varieties with hypoimmunogenic gluten?
Bread wheat contains two groups of gluten proteins. On the one hand, the 
glutenins - High Molecular Weight (HMW) and Low Molecular Weight (LMW) 
glutenins - which can form a network, provide elasticity and thus are essential 
for good bread dough quality (Weegels et al., 1996; Shewry et al., 2009). On the 
other hand, the gliadins (α-, γ-, and ω-gliadins) which can contribute viscosity to 
the network. All include immunogenic epitopes causing Coeliac disease (CD), an 
autoimmune reaction, aecting 1-2% of the human population worldwide, but 
the gliadins include the major epitopes (Mäki et al., 2003; Rewers, 2005; Catassi et 
al., 2014; Vriezinga et al., 2015). e only remedy to prevent CD is a gluten-free 
(GF) diet excluding wheat, barley and rye, which is very dicult to adhere to since 
gluten is added to many processed food products for its visco-elastic properties. 
In addition, GF products contain various substitutes to improve product quality 
that are less healthy, the products are more dicult to nd and more expensive 
than regular food products (Caponio et al., 2008; Capriles and Arêas, 2014; Belz, 
2016; Horstmann et al., 2016). ere is therefore a need to create healthier, wheat-
based products that would nevertheless be safe for CD patients. 
Why use gliadin gene editing?
One option to generate wheat-based products safer for CD patients, which is 
already being explored since decades, is the development of food processing 
strategies that modify or degrade gluten – especially gliadins – while retaining the 
nutrients and most of the other characteristics (Chapter 1). So far, no food strategies 
were yet found to produce wheat-based products that are safe for CD patients. 
For instance, during sourdough preparation the bacteria produce proteinases that 
degrade gluten proteins, but they only digest up to 95% of the gliadins (Loponen 
et al., 2007) and the nal taste is not appreciated by most people. erefore, there 
is a need to implement, in parallel, breading strategies towards wheat with lower 
gliadin content or with safe gliadin epitopes (Ribeiro et al., 2018). However, 
bread wheat is allohexaploid with three homoeologous genomes A, B and D, each 
containing the ve gluten gene families accounting from 20 to 150 genes in total 
(Sabelli and Shewry, 1991; Anderson et al., 1997; Ozuna et al., 2015). Despite 
the presence of some genes without gliadin epitopes, conventional breeding 
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alone cannot succeed in generating wheat varieties with hypoimmunogenic 
gluten, let alone varieties with entirely safe gluten for CD patients. erefore, 
genetic modication (GM) has been deployed to silence gliadin genes with RNAi 
aected (Gil-Humanes et al., 2010) while random mutation breeding can be used 
to remove gliadin loci from bread wheat (Chapter 2, 3, 4). Despite their relative 
success rate, implementation of these two methods face dierent types of hurdles: 
the rst one, being a GM method, must follow substantial, expensive and time-
consuming regulations before being allowed in the market, whereas the second 
one generates a large number of o-target mutations and is resource-consuming, 
as it requires identifying and combining the deletions of all gluten loci into a 
single wheat plant (Chapter 5). As a result, the use of gene editing through the 
CRISPR/Cas9 system – for which the regulation was not clear at the start of this 
PhD project - represented a promising alternative in order to precisely modify or 
delete gliadin epitopes or gliadin genes to prevent CD.  
Can gene editing modify gliadin families in hexaploid wheat and how to 
analyse the mutations?
At the start of my PhD project, gene editing with CRISPR/Cas9 had not yet 
been used to target and produce knockout mutations in large gene families in 
polyploids, although it was reported to be successful in small gene families in – 
diploids - animals (Wang et al., 2013a) or for mutating a single copy gene across all 
six homoeologous loci in hexaploid wheat (Shan et al., 2013). erefore, two main 
technical questions were addressed. e rst one was about the feasibility of using 
CRISPR/Cas9 for large gene families with diverse sequences. e second one was 
regarding the choice of screening and analysis methods, with the aim to identify 
and characterise the gliadin mutations generated in order to pre-evaluate the level 
of gluten immunogenicity of the mutant wheat lines before clinical testing. Ideally, 
the screening methods should be amendable for high-throughput screening.
Generating gliadin gene-edited wheat and screening for gliadin protein 
prole changes using Acid-PAGE
I designed four CRISPR/Cas9 constructs containing multiple guide RNAs (sgRNA) 
targeting α-, γ-gliadins or both simultaneously at dierent positions within the 
genes, that were transformed into the hexaploid bread wheat cultivar Fielder 
(Chapter 2). I rst used acid polyacrylamide gel electrophoresis (Acid-PAGE) as 
a method to screen for mutant Fielder-CRISPR wheat grains with modications 
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in the gliadin protein proles. Acid-PAGE is an established method for visualising 
gliadin protein patterns, and it has been used for many years to detect dierences 
between cultivars (Cooke, 1987). Screening for potential mutant lines was labour-
intensive. It did enable identifying the mutant lines in which some gliadin proteins 
were absent, conrming the feasibility of using CRISPR/Cas9 to edit gliadin gene 
families in a manner that eventually modies the gliadins present in wheat grains 
(Chapter 2). e absence of specic proteins can either be due to the deletion of 
the complete gliadin gene locus or the generation of small or medium-sized o-
frame indels in many gliadin genes. Small, in-frame mutations leading to gliadin 
proteins with amino-acid changes cannot be identied using this method. 
Quantication of small mutations and large deletions in gliadin genes using 
ddPCR
Genomic analyses were performed on the lines grown from grains that showed 
altered gliadin protein proles, in order to gather more knowledge regarding 
the generated mutations occurring, both in expressed and non-expressed genes. 
In Chapter 3, droplet digital PCR (ddPCR) was used to detect small mutations 
and to quantitatively distinguish them from large mutations (Gao et al., 2018), 
as CRISPR/Cas9 can generate both, especially when target genes are tandemly 
organised and multiplexed sgRNAs target the simultaneously several position 
of a gene (Qi et al., 2013; Zhou et al., 2014). We developed two duplex ddPCR 
assays which together showed that a single Fielder-CRISPR line could contain 
small indels (1-50bp) in up to 10 α-gliadin genes and large deletions (>300bp) 
in 20 α-gliadin genes out of the 87 α-gliadin genes present in Fielder (Chapter 3). 
is method revealed that in most Fielder-CRISPR gliadin mutant lines CRISPR/
Cas9 generated more large deletions in α-gliadins than small indels in these genes. 
However, large deletions may aect individual genes or can span several of the 
tandemly arranged α-gliadin genes, thus removing all genes present at a gliadin 
locus at once. 
Distinction between large deletions in individual gliadin genes and across 
gliadin loci using GlutEnSeq
To test further whether the large deletions were associated with individual gliadin 
gene deletions or with full gliadin loci deletions, next generation sequencing was 
used. However, as the wheat genome is massive in size and full of repeats it is 
currently not possible to easily perform whole genome resequencing and analysis. 
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Consequently, a complexity reduction step is necessary (Jupe et al., 2013), and for 
this I developed a gluten genes enrichment and sequencing approach, which was 
called GlutEnSeq (Chapter 4). In most cases, the coverage prole of the Fielder-
CRISPR gliadin mutant lines revealed the deletion of a full gliadin locus on one of 
the homoeologous chromosome (A, B or D), in some lines in homozygous form, 
in others possibly heterozygous. e analysis of the GlutEnSeq data does not yet 
reveal the gliadin sequence changes generated by small mutations. Although most 
of them are expected to generate frameshis, which would be expected to lead to 
rapidly degraded mRNA or truncated proteins, it is necessary to identify them and 
evaluate the immunogenic potential of their epitopes in case of stable expression. 
Further bioinformatic analyses of the sequence reads produced by the GlutEnSeq 
is required to properly characterise the small mutations induced in gliadin genes.
Characterisation of new gliadin protein sequences end new epitope generated 
using LC-QTOF-MSMS
Other methods that may be used to characterise and assess the immunogenicity of 
newly generated and expressed gliadin sequences, include advanced proteomics 
(Sánchez‐León et al., 2018; van den Broeck et al., 2015). Liquid-chromatography 
(LC) associated with quadruple time of ight (QTOF) and tandem mass-
spectrometry (MSMS) on a gluten protein extract is a state-of-the-art approach 
to detect and identify specic gliadin peptides. I have been involved in a pilot 
experiment to qualitatively identify known CD epitope present in Fielder but 
absent in the Fielder-CRISPR gliadin mutant lines, using an untargeted approach. 
However, the amount of information generated had not yet been adequately 
analysed to generate results reliable enough to be presented in this thesis. 
Ultimately, one would also want to identify the alternative peptide and infer its 
sequence based on its MSMS spectrum. is approach would reveal the protein 
sequences of the gliadins expressed in the grain and would enable inferring their 
potential level of immunogenicity based on the knowledge of gliadin epitopes and 
their interaction with the human immune cell receptors.  
CRISPR/Cas9 ecacy to edit gliadin families in wheat and outcomes of the 
screening methods used
CRISPR/Cas9 has been shown to generate, in the progenies of some transformed 
plants, mutations in up to 1/3 of the total α-gliadin gene copies present in 
hexaploid bread wheat variety Fielder (this thesis). Among these mutated genes, 
18060-Aurelie_Jouanin_PM.indd   169 02-01-19   12:19
General discussion
170
an estimated 1/3 carried small indels while the remaining 2/3 were aected by 
large deletions, probably by the deletion of the full gliadin locus from one of the 
homoeologous chromosomes, in a homozygous or heterozygous manner. ese 
mutations generated a dierent gliadin protein composition in the grains of the 
Fielder-CRISPR plants. 
All the methods developed and used during my PhD project give complementary 
information, which is all required to properly assess the gliadin mutants in wheat. 
However, evaluating the strengths of each of them now that they have been 
developed, and based on the experiences while using them, future projects should 
implement them in a dierent order (Fig.1). 
Figure 1. Optimised pipeline to screen for and analyse CRISPR/Cas9-induced mutations in wheat gliadins.
To optimise the identication of CRISPR/Cas9-induced mutations in gliadin genes and characterise them, 
the four methods should be used in the following order: 1) ddPCR enables high throughput quantication 
of small mutations and large deletions in gliadins, 2) Acid-PAGE enables the visualisation of absence of 
gliadin protein expression, 3) GlutEnSeq enables the genomic characterisation of deletions and soon of 
the edited sequences, and 4) LC-QTOF-MS enables identication of modied gliadin protein peptides and 
eventually their sequences. 
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e ddPCR, which is a fast, easy to use and relatively cheap method to screen DNA 
extracts of grains, in a 96-wells format that only takes a couple of hours to analyse, 
should be used as a high-throughput pre-screening method for identifying gliadin 
gene mutations (Fig. 1). is would considerably reduce the number of mutant grains 
to be screened using Acid-PAGE, which is a time-consuming method to evaluate 
the major impact of the mutations at the protein level (Fig. 1). GlutEnSeq, time-
consuming but expensive as well, could then be performed on the most interesting 
plants to gather information on the size-range of the deletions and on the sequences 
of the remaining genes, enabling estimating the reduction of immunogenicity 
compared to the initial variety used (Fig. 1). is also enables estimating what 
would remain to be edited in a next round. Finally, LC-QTOF-MSMS, which is by 
far the most complex method applied in this pipeline, should be performed on the 
most interesting mutant lines only, to get an exact idea of the gluten extract content 
in term of gliadin epitopes, and to predict its immunogenic level (Fig. 1). 
Once lines have been developed that are devoid of the major toxic epitopes -in 
one or more rounds of gene editing-, the next steps would be to extract gluten 
and perform tests with epitope-specic monoclonal antibodies (as far as these 
are available). en, T cells specic for immunogenic gliadin epitopes would be 
used for additional testing before to set up an in vivo test oered to CD patients 
who volunteer to test whether the new wheat varieties have no or a very low 
immunogenic eect on them (Anderson et al., 2000). In parallel, dough rheology 
tests have to be performed in order to guarantee a good bread dough quality for 
bread baking despite the modication of the total gluten content in wheat grains. 
Reecting on the gene editing method used towards 
hypoimmunogenic gluten
Is CRISPR/Cas9 still the best gene editing method to obtain 
hypoimmunogenic gluten in wheat? 
CRISPR for generating targeted mutations
When my PhD project started, CRISPR associated with the Cas9 endonuclease 
or nickase, to generate double stand breaks in the target DNA to induce non-
homologous end joining type of DNA repair, were the only advanced CRISPR 
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systems available in plants. As revealed by the dierent screening and analysing 
methods developed during this PhD project, the outcome of CRISPR/Cas9 with 
multiplexed sgRNA for editing gliadin genes in wheat turned out to produce some 
small deletions, as was expected, but the most successful lines included large 
deletions, usually of an entire α-gliadin locus with tandemly repeated genes. is 
type of full-locus deletions are similar to the ones obtained using γ-irradiation, 
only more precise since they have been induced in a directed manner. us it 
can be expected that anking non-gliadin genes have not been aected in the 
gene-edited lines, while the large deletions induced by γ-irradiation, when they 
remove a gliadin locus, would remove considerably more genes, in a random 
fashion. In addition, multiplexing sgRNA enables targeting several gene families 
simultaneously, which speeds up the possibility of combining the deciency of 
multiple gluten loci. 
However, fully removing gluten loci is oen triggering a phenomenon called 
compensation, visible as overexpression of some of the remaining gluten genes, which 
may carry other immunogenic epitopes or impede bread dough rheology. Sánchez-
León et al. (2018) were quite successful in editing α-gliadins, in terms of reduction of 
protein produced, but they observed compensation in the form of a higher synthesis 
and accumulation of ω-gliadins, which, in some of their lines, actually increased 
the estimated immunogenicity for Coeliac patients. One solution is to remove them 
all: once all nine gliadin gene loci are removed, gliadin compensation can no longer 
occur, preventing any unwanted increase of immunogenicity. Only glutenins, which 
are most important for bread dough quality and -generally- devoid of major CD 
epitopes, would remain. e potential loss of viscosity due to the absence of gliadins 
could be compensated with naturally Coeliac-safe gliadin-like proteins, for instance 
from oat – called avenins – in order to restore bread dough quality, if necessary 
(Londono et al., 2013; Smulders et al., 2018). 
e literature shows that worldwide researchers are developing alternative 
approaches using the CRISPR system, with higher eciency, providing more gene 
editing opportunities. Below, I discuss the application of a couple of them towards 
hypoimmunogenic gluten. However, with new developments being published 
almost every month, these options may quickly become outdated, only meaning 
that the goal of engineering wheat to be safe for Coeliac patients, is probably closer 
at hand than we currently expect. 
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CRISPR for gene correction or replacement
CRISPR associated with a Cas9 endonuclease or nickase enzyme, or associated 
with the Cpf1 endonuclease, generates DNA cuts with overhangs which facilitate 
targeted template insertion - using homologous recombination -, in order to 
correct (SDN-2) or replace (SDN-3) DNA sequences. is methods was proven to 
work in monocots (Sun et al., 2016). In case of gliadin gene families, this strategy 
would be very promising, as the loci generated would produce gliadin proteins, but 
these would be safe proteins as they are already naturally existing in low amounts 
in some wheat varieties. For α-gliadins such safe variants have been identied 
in Gli-2 locus on chromosome 6B. is would have advantages, for screening 
lines, for subsequent safety testing, and for public acceptance of the resulting 
products. For instance, in one implementation one could target all gliadins, and 
templates corresponding to gliadins with these naturally existing CD-safe epitope 
variants would be provided alongside, and these could be integrated to replace all 
or some of the immunogenic variants. is approach avoids the possibility that 
novel epitopes are created, and it would be relatively straightforward to screen 
the resulting plants, as the desired changes are designed and dened beforehand. 
Technical issues may occur, related to the fact that we are dealing with multiple 
copies in a gene family that would need to be resolved. It could be that the original 
immunogenic sequence cut out in one gene integrates in the next one instead of 
the safe template, and safe templates could be cut out again by the Cas9. 
CRISPR for base editing
Recently, CRISPR systems have been developed with a deactivated nuclease, 
which is then used as “transporter” for another active enzyme having dierent 
properties. One of these alternative enzymes can be a deaminase. For instance, 
CRISPR-dCas9-cytidine deaminase enables deamination and thus conversion of 
target base C into a T (and, on the other strand, A into G), with the same sequence 
specicity as other CRISPR applications, but without generating a double-strand 
break in the DNA. It has recently proven successful in wheat (Zong et al., 2017). A 
fusion with an adenosine deaminase generated an adenine base editor (changing G 
into A) (Kim, 2018). Such systems may be used for DNA codon modication into 
a codon coding for a dierent amino acid or a premature stop codon. An amino-
acid change in the gliadin epitopes could abolish their immunogenicity while a 
stop codon would knock-out the gene and prevent stable or any translation of the 
gene into a gliadin protein. is option would represent a much more controlled 
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induction of mutations, enabling desired generation of mutations for predicted 
safe epitopes generation, and avoiding gluten compensation by other gene 
families. However, the detection of such subtle changes and the verication of 
their occurrence in each immunogenic epitope would represent a large challenge. 
is issue may be tackled with the capture array developed here in combination 
with Illumina sequencing, but it would require a tailored and optimised analysis 
pipeline to digest the amount of data eciently and suciently precise. Moreover, 
although safe on the basis of existing knowledge of how the disease develops, 
there is no certain way of predicting the actual eect of newly generated epitopes 
on CD or on induction of the disease in susceptible people who do have yet to 
develop the disease.
CRISPR for gene silencing or overexpressing
A similar system, using CRISPR-dCas9-methyltransferase, enables the 
methylation of targeted cytosines in promotor regions of genes, which may 
prevent gene transcription and therefore it is a way to silence gene expression 
(Putcha, 2016). Using this system, we may be able to silence only gliadin genes 
with hypoimmunogenic epitopes, therefore limiting the risks of compensation 
by increased expression of other genes, and maintaining bread dough quality. 
For this to be possible it would require that we can identify distinct promotor 
sequences that would be dierent between (some) safe and immunogenic genes. 
Most likely, when some or all gliadin genes could be silenced, this would bring 
about the same results as when using active Cas9 to remove gluten loci, only more 
dicult to screen for. 
Following the idea of working on the regulatory elements (Putcha, 2016) of 
gliadin genes rather than the gene themselves, another alternative would be over-
expression of a transcription factor (TF) –using acetyltransferase - that represses 
gliadin expression, or silencing a TF activating their expression. Moehs et al. 
(2018) combined stable mutations in three Lys3a-like transcription factors to 
reduce gluten gene expression by 50%. However, the transcription factors found so 
far similarly inuence the expression of both gliadins and glutenins genes and are 
therefore not ideal candidates since the aim is to keep the glutenins expression – at 
least HMW-glutenins – and decrease the immunogenic gliadin expression. Wheat 
without gluten does not have any trace le of its unique rheological properties 
that we do not want to lose. is is the reason why engineering wheat that is safe 
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for CD patients is more complicated than for barley, which is mainly used for 
making alcoholic beverages, where gluten properties are not required.
Combining dierent CRISPR methods
Looking at the dierent CRISPR methods, each of them presents advantages, 
inconveniences and uncertainties for editing gliadin genes toward wheat with 
hypoimmunogenic gluten. An idea would be to combine several of these methods, 
subsequently, to generate the safest wheat variety for CD patients while retaining 
sucient baking quality. As an example, in a single wheat plant, the α-gliadin 
gene family being on chromosome 6 and having the least diversity and being the 
best characterised, could have their immunogenic epitopes replaced by known 
safe ones using the Cas9/template approach while the complex γ- and ω-gliadin 
genes families – overlapping on chromosome 1 – could be deleted. As a result, 
no gliadin toxic epitope would remain but some gliadin proteins would still be 
produced to confer some viscosity for bread dough quality.
In case it would be impossible to generate wheat varieties without any gliadin 
immunogenic epitope, a solution could be to make dierent varieties lacking 
dierent types of epitopes. ey would be hypoimmunogenic or safe for dierent 
categories of CD patients. However, this scenario would imply very complex food 
production separations, labelling, testing and systematically genetically screening 
CD patients to inform them of their set of dominant T cells and the type of 
epitopes they recognise.
Is stable transformation of CRISPR constructs still the best method to 
edit wheat gliadins? 
Alternatively to the integration of the CRISPR constructs within the plant DNA, a 
ribonucleoprotein CRISPR/nuclease complex can be used to introduce the sgRNA 
and the nuclease inside plant cell nucleus, in order to perform gene editing (Woo 
et al., 2015). e method is applicable by transfection of the complex into plant 
protoplasts, where it is directed to the nucleus using specic signal peptides to edit 
target genes before the rst cell division, and it is degraded quickly. Although it is 
usually a very attractive solution, especially for correcting genes using templates, 
the CRISPR ribonucleoprotein complex may not be suitable for gliadin editing 
in wheat for two reasons. First, due to the short life time of the complex, it is 
less likely that all targeted copies would be modied. Second, regeneration of 
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plants from protoplasts remains challenging in monocots such as wheat, whereas 
regeneration of stably transformed immature embryos to form plantlets is more 
ecient.
e future of gene editing wheat varieties for hypoimmuno- 
genic gluten 
How far are we from a commercial release of gene-edited hypo-
immunogenic gluten wheat?
From a technical point of view
Developing wheat lines with safe gliadin epitopes remains a challenge due to the 
complexity and the size of the gluten gene families, their aptitude to compensate 
for the decrease of expression of some gliadins (Galili et al., 1986; Pistόn et al., 
2011) and the uncertainty, on a long term, of the degree of hypoimmunocity of 
the newly generated varieties. Despite these issues, gene editing methods are 
being improved in terms of eciency and accuracy making the objectives of 
hypoimmunogenic gluten more realistic. An intermediate goal is wheat lines with 
at least a great reduction of epitopes related to certain gliadin families if not all 
gliadin families (Chapter 1). ese lines may not be suciently safe for sensitive 
CD patients, but they would reduce the induction of the disease in susceptible 
people (children as well as grown-ups), because dosage (how much toxic gluten 
do you eat) correlates with the induction of the disease (Koning, 2012).
A concrete example comes from Barro’s group in Spain, where regular CRISPR/Cas9 
was applied on hexaploid bread wheat lines – with similar sgRNA for α-gliadin – in 
the same period as this PhD research was carried out. ey succeeded in generating 
lines with low α-gliadin content, lower immunogenicity for some T cells, and a 
decent bread dough quality following rheology studies (Sánchez‐León et al., 2018). 
is academic group is collaborating with a US company called Calyxt, which is 
focusing on the development and commercialisation of gene-edited plants and is 
currently working on commercialisations of these gluten hypoimmunogenic wheat 
lines (Barro, personal communication). Hence, the rst gene-edited wheat lines 
with hypoimmunogenic gluten and derived products might appear in products on 
supermarket shelves in the US within a few years’ time.
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From an immunological point of view
All wheat that is consumed up to now, contains many gluten genes with several 
epitopes. Immunologists have studied the immune reactions in patients, and they 
have identied several highly immunogenic epitopes, based on the observation 
that many patients have T cells that react to these epitopes (Arentz–Hansen et 
al., 2002). ese epitopes are called “major epitopes”. ey have been very well 
characterized and they are the prime target of my gene-editing approaches to 
remove immunogenic epitopes from gluten (Sollid et al., 2012). In addition, 
patients also have many T cells that recognise other gluten peptides, but these 
dier among patients. ese are referred to as “minor” epitopes. ey are less 
well characterized, and as the diversity is large, it may be that we do not know 
them all. One hypothesis is that they are secondarily generated, meaning aer 
the disease has been induced and intestinal inammation has occurred. If so, it 
may be that some Coeliac patients cannot tolerate hypoimmunogenic wheat if it 
still has one of the minor epitopes to which they react. Meanwhile, this wheat 
without major epitopes would be safe for susceptible children and other people in 
which the disease has not yet developed, as the epitopes that induce the disease, 
are absent. However, an alternative possibility is that these “minor epitopes” are 
as immunogenic as the “major” ones, just less ecient because less abundant, 
and thus wheat with only minor epitopes would also be able to induce CD. Once 
hypoimmunogenic wheat would be common, its consumption may still induce 
the onset of the disease, although, most likely, later in life. erefore, although safe 
on the basis of existing knowledge of how the disease develops, there is no certain 
way of predicting the actual eect of only “minor epitopes”, or newly generated 
epitopes, on CD or on induction of the disease in susceptible people who do not 
have developed the disease yet (Lundin, Personal communication). It is therefore 
important that the introduction of hypoimmunogenic wheat varieties into the diet 
of patients, is monitored.
From a regulatory point of view
For more than ten years, in most countries, no clear regulations were dened 
regarding new plant breeding techniques (NPBT), a suite of techniques to which 
gene editing using TALENs or CRISPR systems are counted. As a matter of fact, 
gene editing requires foreign DNA or proteins to be inserted in plant genomes or 
plant cells, as a temporary step to perform editing of target genes, and are then 
crossed out or naturally degraded, so that they are absent in the resulting gene-
edited plant and derived products. e issue is thus, whether to regulate gene-
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edited plants – and derived products –using a process-based or a product-based 
approach. A process-based approach would consider the temporary GM step 
necessary to induce the targeted mutation and they would therefore fall under 
GM regulations (Chapter 5). On the contrary, a product-based approach would 
consider the absence of foreign entities in the nal gene-edited plant, and that it 
would carry similar mutations as plants obtained through spontaneous mutations 
or produced using mutation breeding with mutagenizing agents –e.g. γ-irradiation 
or EMS -, which are exempted from GM regulations and follow conventional 
breeding rules because of a history of safe use. ey have been exempted by 
putting them on Annex 1B of the GMO Directive 2001/18/EC.
While in 2017 and 2018, several countries in North and South America decided 
not to regulate gene editing and some other NPBT techniques as GM (e.g. 
Argentina, USA) – or to decide on a case per case basis as in Canada -, the 
European Commission (EC) announced and postponed a decision several times. 
In the end they have not made any announcement on the matter. On July 25th 2018, 
the European Court of Justice, in a case brought before them from France, ruled 
that, according to the text of the Directive 2001/18/EC, gene editing is considered 
as GM technique and that is not exempted from GM regulation but should be 
subjected to regulation in the European Union (ECJ, 2018a; 2018b). Consequently, 
gene-edited wheat lines with hypoimmunogenic gluten and derived products 
can be easily developed and commercialised in the American continent and in 
countries adopting similar gene editing regulations but they will not be accepted 
in Europe without fullling all GM related tests and labelling. is will mean in 
practice that gene-edited varieties in general, and niche products in particular, 
will not be produced, as the regulatory process itself already costs a lot of money 
(estimates range from a few million to 100 million euro per event (McDougall, 
2011)). Moreover, even if the regulatory process would be successfully concluded, 
European countries could still reserve the right to reject the cultivation within 
their respective territories. erefore, the two remaining sources of hope for CD 
patients in the EU is a change of gene-editing regulation or a successful wheat 
line based on combining γ-irradiation-induced large mutations deletions of all 
nine gliadin gene loci (Chapter 5). Such a line would most likely not have a good 
baking quality, and it could harbour more deleterious mutations, notably in the 
form of several deleted genes that used to be adjacent to the gluten loci – but it 
would not be regulated in the EU.
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What would be required in the production chain using wheat with 
hypoimmunogenic gluten? 
If hypoimmunogenic wheat varieties make it to the market, there are 
two options for wheat breeding companies, farmers and food processing 
companies. e rst option is to have two production chains, meaning two 
sets of completely separated facilities for hypoimmunogenic wheat and 
regular wheat at the breeding companies, in the production farms, at the 
processing factory, all the way to packaging and labelling, to avoid any risks 
of contamination with other grains containing immunogenic gluten epitopes. 
e other option would be to only work with hypoimmunogenic gluten-
containing grains throughout the whole chain, which would decrease even 
more the risks of contamination. Most likely the separate chain solution is the 
one chosen initially, as only few hypoimmunogenic varieties would exist. In 
case the products are well accepted and the market grows, because consumers 
prefer safe wheat over regular wheat, even if they are not Coeliac patients 
themselves, more products will be made with hypoimmunogenic gluten. At 
some point they may be considered as the new standard for gluten.
In the long run, this would slowly imply the replacement of regular wheat 
varieties by hypoimmunogenic ones, abolishing the need for separate 
production chains, although strict precautions should remain in place to avoid 
contamination with related species, still containing immunogenic gluten 
epitopes.
How to shi from gluten to immunogenic epitopes detection in food 
products?
Currently, products labelled as GF have to contain less than 20 ppm of gluten 
(Saturni et al., 2010), which is tested using R5 antibody tests. However, in case 
of hypoimmunogenic gluten on the market, what has to be measured is not only 
the gluten content (as GF products will remain to produced) but also the amount 
of immunogenic epitope present in the total gluten extract of wheat-containing 
products. So far, no method exists to achieve this task. Antibodies specic for 
immunogenic epitopes could potentially be developed, but it has turned out to be 
very dicult to develop highly specic antibodies for these sequences with a high 
degree of similarity. Only one antibody is commercially available that recognises 
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the deamidated form of a CD epitope. It was developed by the group of Prof. 
Koning at Leiden University in the Netherlands.
Proteomic methods distinguishing gliadin protein epitope sequences could be 
developed and implemented for pure grains, but for food product extracts it 
would be more dicult to implement protein-based assays to test for the absence 
of immunogenic gluten epitopes. An alternative for grains would be to implement 
genomics assays, using the GlutEnSeq system followed by a comparison of 
the tested wheat sequences with known gluten immunogenic epitopes, or by 
recognising the varieties used. An absence of immunogenic epitopes at the DNA 
sequence level would ensure the absence of immunogenic epitope in the gluten 
protein used to make food products. is solution, could not be repeated on food 
products due to a too small amount of gluten gene DNA in food products, which 
would require a high level of precaution against contamination by immunogenic 
gluten downstream the genomic tests performed on the grains.  
What about public acceptance of gene-edited hypoimmunogenic gluten 
wheat?
In terms of public acceptance, it has been shown that people suering from 
a food-related disorder are usually supporting the development of healthier 
products for their disorder, regardless of the methodology used (Schenk et al., 
2008, 2011). us, there are high chances that CD patients welcome food products 
with hypoimmunogenic gluten generated using gene editing technology (Chapter 
5). For non-CD people who do not consume GF products, the chances are that if 
their fellow CD-suerers accept gene-edited products, they would encourage their 
development but may not want to consume them themselves at rst. Once more 
and more products would be labelled as containing hypoimmunogenic gluten, 
the non-CD consumer may start considering it as the new standard. Progressively 
all products could be made of hypoimmunogenic gluten and current high 
immunogenic wheat would no longer be commercialised at least in some parts of 
the world. In addition, the regulation used in dierent countries regarding gene-
edited products is likely to impact on the public acceptance of products containing 
gene-edited hypoimmunogenic gluten. 
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Would wheat hypoimmunogenic gluten protein families be safe for 
everyone?
For individuals without wheat- or gluten-related discomforts
People not subject to any adverse eects triggered by wheat or gluten should 
not experience any dierences consuming hypoimmunogenic gluten than when 
consuming regular (high-immunogenic) wheat or gluten, especially if the strategy 
used is complete removal of gliadin loci. However, in case of hypoimmunogenic 
gluten generated with gliadin epitopes editing, predictions cannot be made whether 
on a long term, epitopes so far safe would not suddenly reveal immunogenic 
potential due to the increase of their frequency in diet and consumption by larger 
numbers of people. 
For CD patients
In case of a wheat variety with hypoimmunogenic gluten, several issues exists. 
Firstly, the term “hypoimmunogenic” is used because an absolute “safe” variety 
cannot be guaranteed. In case of a variety where all α-, γ-, and ω-gliadin loci have 
been fully removed, the variety would be relatively safe for patients carrying T 
cells recognising the epitopes present in these families. However, a low percentage 
CD patients react to some LMW-glutenins epitopes and HMW-glutenins (the key 
family for baking quality). erefore, LMW-glutenins should also be removed 
or edited to ensure a better hypoimmunogenicity. As for the HMW-glutenins, 
it might be possible, giving the variety of gene editing tools now available, to 
modify very subtly its sequences, prevent its immunogenicity while retaining a 
similar amount expressed, having similar 3D congurations to retain all its baking 
properties. 
Secondly, there is an issue about minor epitopes in gliadins, that would not all 
be removed when only a subset of gliadins, with major epitopes, are removed 
(see above). To which extent this will be a problem for a subset of the existing 
patients, or for the induction of the disease in healthy people with a susceptible 
background, remains to be determined once the varieties exist.
For individuals with non-coeliac wheat sensitivity
Non-coeliac wheat sensitivity (NCWS) or non-coeliac gluten sensitivity (NCGS), 
are terms that actually refers to individuals presenting symptoms while eating 
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wheat, which are not caused by gluten (Lundin and Alaedini, 2012). A better 
adapted terminology would be non-gluten wheat sensitivity, NGWS. ese 
individuals – as well as irritable bowel syndrome (IBS) suerers - are not sensitive 
to wheat gluten but to other components present in wheat. e exact nature of 
these compounds is subject to research and debate, but it is currently not known.
To these persons, ingestion of hypoimmunogenic or highly immunogenic gluten 
would not make a dierence. Since the actual wheat grain components that trigger 
the disorder are not clearly identied yet, it is not possible to engineer wheat safer 
for NCWS suerers. GF products are currently safe for them, it can be expected 
that the market for GF products will not disappear once hypoimmunogenic 
(“safe-gluten”) products appear. In theory, one could provide them with healthier 
products by using similar ingredients as in current GF products but adding 
puried gluten extracts rather than additives to restore the viscoelasticity required 
for baking quality.  
For individuals with allergies
In addition to CD and NCWS, several allergies are triggered by gluten, although 
the number of people suering from these allergies is much lower. For these 
people, a wheat variety lacking or having modied gliadins would be safer, 
regardless of the presence or absence of other gluten families. erefore, a gene-
edited wheat hypoimmunogenic for all gliadin families would benet them. 
Wheat also contains several other allergens (Juhász et al., 2018). In theory all or 
a subset of these allergens could also be removed. Technically, this might even be 
easier than removing CD epitopes from gluten, as fewer genes are involved, but 
the market would be much smaller as well.
Would it be better to breed for baking quality in “safe” 
cereals?
Looking at the various adverse conditions triggered by wheat, one could wonder 
whether breeding for baking quality in alternative cereals and pseudo-cereals 
considered safe -e.g., buckwheat, sorghum, amaranth, quinoa, etc. - would be a 
better option. However, most of these plants currently represent niche products 
without much breeding history. Breeding programs, which take half a dozen 
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years for well-known crops – would have to be started almost from scratch, which 
could take several decades and very few companies would make such investments, 
without guaranties on a market share and return on investment in case of success. 
Moreover, it would imply modifying the whole food processing chain and convert 
consumers to new types of food products, which is a real challenge. In addition, 
plants that are now considered safe while being niche products may suddenly also 
trigger some health issues once consumed on a larger scale by more individuals. 
e uncertainty related to these crops are pretty similar to the ones rising about 
gene-edited hypoimmunogenic wheat. However, the knowledge and methods 
necessary to develop hypoimmunogenic or hypoallergenic wheat with gene 
editing are already available, minimising the time scale necessary to generate safe 
and healthy food product for people suering from CD and other gluten-related 
disorders.  
Did wheat breeding increased the gluten immunogenicity 
over time? 
ere is a widespread belief that modern wheat breading increased gluten 
immunogenicity and is therefore responsible for the current burst of CD 
cases. However, studies comparing gliadin epitopes presents in some current 
commercial wheat varieties and wild relatives show that some wild wheat relatives 
contain higher amounts of immunogenic epitopes or few epitope variants more 
immunogenic than in some modern wheat varieties (Schaart et al., in prep). 
Other studies have found very little changes in overall gluten immunogenicity of 
varieties over the last 50 years, although the level of immunogenicity is highly 
dierent between varieties (van den Broeck et al., 2010a; Kasarda, 2013; Ozuna and 
Barro, 2018). Breeding is therefore not a very likely reason for the steep increase 
in diagnosed CD cases. A better understanding of CD mechanism, the wider 
awareness of its existence and its symptoms by both physicians and consumers, as 
well as the development of more detection methods, has contributed to an increase 
of the number of CD diagnosed (Murray et al., 2003). Nevertheless, the incidence 
of CD itself also appears to be on the rise (Lohi et al., 2007). e evolution of 
the diet over time and across the world, together with many other factors, has 
probably contributed to this increase in the incidence of CD (Chapter 1). In this 
situation, hypoimmunogenic wheat may not change some of these underlying 
processes, but it would help CD and NCWS patients.
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Concluding remarks
Wheat varieties with hypoimmunogenic gluten represent a need for individuals 
suering from Coeliac Disease. Developing such varieties is challenging due to 
the polyploidy of wheat and the complexity of gluten gene families. However, 
this pilot project revealed the potential of gene editing technology to achieve 
this goal. Meanwhile, additional years will be necessary, for improving gene 
editing eciency and screening methods, in order to generate a wheat variety 
hypoimmunogenic for most CD patients. In addition, the wheat-chain will need 
some adaptations and new methods to distinguish “gluten-safe” food products 
from “gluten-free” ones.
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anthocyanin-related genes in roses of dierent colours, under the supervision 
of Virginia Gitonga and Dr. Frans Krens. She, then, did a 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under the supervision of Dr. Franck Lhuissier and Dr. Michiel de Both on 
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Germany. 
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do a PhD and advised to apply for the ITN-Marie Curie PhD project that was 
focusing on applying mutagenesis techniques on bread wheat to decrease gluten 
immunogenicity for Coeliac Disease patients, Aurélie successfully got the position 
in 2014. She became, thus, part of the “Max-imising the potential of CROP 
researchers” (Max-CROP) Program funded by the European Commission via 
the 7th Framework Program. is International Training Network - PhD project 
was conducted between the Pre-breeding & Genetics department of the National 
Institute of Agricultural Botany, NIAB, Cambridge, UK – as industrial partner - 
and at the Plant Breeding department of Wageningen University – as academic 
partner -. e PhD supervision at NIAB was undertaken by Dr. Fiona Leigh, 
Dr. Emma Wallington and Dr. James Cockram while it was handled at WUR 
by Dr. Jan Schaart and Dr. René Smulders, Prof. Richard Visser being the PhD 
Promoter. Additionally, Dr. Lesley Boyd (NIAB) was the coordinator of the Max-
CROP program and Dr. Luud Gilissen (Bioscience, WUR) was the PhD external 
supervisor. e present thesis book reports all the work done during these four 
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1) Start-Up Phase date cp
▶ First presentation of your project
“Deployment of mutagenesis technics targeting gliadin gene families 
to eliminate Celiac Disease epitopes from bread wheat” (Plant Breeding 
department, WUR, Wageningen, NL)
19 Jan 2015 1,5
▶ Writing or rewriting a project proposal
“Deployment of mutagenesis technics targeting gliadin gene families to 
eliminate Celiac Disease epitopes from bread wheat”
28 Jan 2015 6,0
▶ Writing a review or book chapter
▶ MSc courses
Programming in Python (INF-22306) (WUR, Wageningen, NL) Sep-Oct 2014 3,0
Advanced Bioinformatics (BIF-30806) (WUR, Wageningen, NL) Nov-Dec 2014 3,0
▶ Laboratory use of isotopes
Subtotal Start-Up Phase 13,5
2) Scientic Exposure date cp
▶ EPS PhD student days
EPS PhD student days: 'Get2gether' 2015 (Soest, NL) 29-30 Jan 2015 0,6
EPS PhD student days: 'Get2gether' 2016 (Soest, NL) 28-29 Jan 2016 0,6
▶ EPS theme symposia
EPS ema 4 symposium: "Genome Biology"  2014 (WUR, Wageningen, 
NL)
03 Dec 2014 0,3
EPS ema 2 symposium: "Interactions between Plants and Biotic Agents"  
2018 (UvA, Amsterdam, NL)
24 Jan 2018 0,3
▶ National meetings (e.g. Lunteren days) and other National Platforms
▶ Seminars (series), workshops and symposia
Symposium: All Inclusive Breeding, Integrating high throught put science 
(WUR, Wageningen, NL)
16 Oct 2014 0,3
Symposium: Omics Advances for Academia and Industry - Towards True 
Molecular Plant Breeding (WUR, Wageningen, NL)
11 Dec 2014 0,3
Workshop: Marie Curie ITN Max-CROP report 1 + Crop production & 
Genetics (NIAB, Cambridge, UK)
10-12 Feb 2015 0,8
Workshop: Marie Curie ITN Max-CROP report 2 + Crop pathology & 
Plant-pathogen interactions (WUR, Wageningen, NL)
06-08 May 2015 0,6
Workshop: REnSeq (JIC, Norwich, UK) 11-12 Jun 2015 0,3
Workshop: New Plant Breeding Technologies and other advances in plant 
genetic research for Africa (NIAB, Cambridge, UK)
09-10 Jul 2015 0,6
Symposium: BioRad ddPCR (Cambridge, UK) 25 Sep 2015 0,3
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Workshop: GMOs Risk Assessment & Communication of Evidence 
(Vienna, AT)
05-08 Oct 2015 0,9
Workshop: Towards a sustainable future for wheat genomics: Plant 
genomics databases training (TGAC, Norwich, UK)
20-21 Oct 2015 0,6
Workshop: Health Grain Forum (Wageningen, NL) 16-17 Nov 2015 0,6
Workshop: Marie Curie ITN Max-CROP report 3, Mid-term assesment 
(NIAB, Cambridge, UK)
24 Nov 2015 0,3
Symposium: Monogram 2016 + Bioinformatics workshop (Cambridge, 
UK)
12-14 Apr 2016 0,7
Workshop: Whealbi, SNP discovery & analysis using next generation 
technologies training (JHI, Dundee, UK)
19-20 May 2016 0,6
Workshop: Marie Curie ITN Max-CROP report 4 (NIAB, Cambridge, UK) 21 Nov 2016 0,3
Workshop: Community Resource for Wheat transformation (NIAB, 
Cambridge, UK)
18 May 2017 0,3
Workshop: Your Plant science (NIAB, Cambridge, UK) 20-21 Nov 2017 0,6
Mini-Symposium EPS: Polyploidy, genetics & breeding (WUR, 
Wageningen, NL)
14 Jun 2018 0,2
▶ Seminar plus
▶ International symposia and congresses
Final conference of GMOs Risk Assessment & Communication of 
Evidence (Potsdam, DE)
09-10 Nov 2015 0,6
5th Plant Genomics & Gene Editing Congress_Europe (Amsterdam, NL) 16-17 Mar 2017 0,6
e Rank Prize Funds mini-symposia on e Role of Wheat in Diet, 
Health and Disease (Grasmere, UK)
24-27 Apr 2017 0,9
International Conference "Plant Transformation & Biotechnology IV" 
(Vienna, AT)
29-30 Jun 2017 0,6
International Conference "Plant Genome Editing & Genome Engineering" 
(Vienna, AT)
03-04 Jul 2017 0,6
Nestlé Conference: Planting seeds for the future of food II (Nestlé HQ, 
Vevey, CH)
06-07 Jul 2017 0,6
International Celiac Disease Symposium 2017 (New Delhi, IN) 08-10 Sep 2017 0,9
4th Conference of Cereal Biotechnology and Breeding, EUCARPIA Cereal 
(Budapest, HU)
06-09 Nov 2017 0,9
13th International Gluten Workshop, CIMMYT (Mexico city, MX) 14-17 Mar 2018 1,2
▶ Presentations
Poster: Science week (Cambridge, UK) 14 Mar 2015 1,0
Talk: Health Grain Forum Workshop (Wageningen, NL) 16-17 Nov 2015 1,0
Poster + Flash talk: Monogram 2016 (Cambridge, UK) 12-14 Apr 2016 1,0
Poster: 5th Plant Genomics & Gene Editing Congres_ Europe (Amsterdam, 
NL)
16-17 Mar 2017 1,0
Talk: e Rank Prize Funds mini-symposia on e Role of Wheat in Diet, 
Health and Disease (Grasmere, UK)
24-27 Apr 2017 1,0
Talk: International Conference "Plant Genome Editing & Genome 
Engineering" (Vienna, AT)
03-04 Jul 2017 1,0
Poster: International Celiac Disease Symposium 2017 (New Dehli, IN) 08-10 Sep 2017 1,0
Talk: 4th Conference of Cereal Biotechnology and Breeding, EUCARPIA 
Cereal (Budapest, HU)
06-09 Nov 2017 1,0
Talk: Your Plant science (NIAB, Cambridge, UK) 20-21 Nov 2017 1,0
Talk: 13th International Gluten Workshop, CIMMYT (Mexico city, MX) 14-17 Mar 2018 1,0
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Education statement
▶ IAB interview
▶ Excursions
Cereals 2015 (Lincolnshire, UK)  11 Jun 2015 0,3
Syngenta visit, Crop Protection Technology Process (Jealott's Hill, UK) 25 Nov 2015 0,3
Subtotal Scientic Exposure 27,6
3) In-Depth Studies date cp
▶ EPS courses or other PhD courses
Plant CRISPR-Cas Workshop-training (JIC/TSL, Norwich, UK) 07-08 Sep 2015 0,4
International CEPLAS summer School "Emerging Frontiers in Plants 
Sciences" (Hennef/Cologne, DE)
05-09 Jun 2017 1,5
▶ Journal club
▶ Individual research training
Exome capture & Enrichment for PacBio sequencing (TSL, Norwich, UK) Jun 2016 3,0
Subtotal In-Depth Studies 4,9
4) Personal Development date cp
▶ Skill training courses
EPS PhD introduction course (WUR, Wageningen, NL) 20 Jan 2015 0,2
Intellectual Property: IP for Scientists and Engineers (Cambridge, UK) 12 Apr 2016 0,2
Marie Sklodowska-Curie Action, ESOF Satellite Conference "Researcher 
and Society" (Manchester, UK)
28-29 Jul 2016 0,6
Marie Sklodowska-Curie Action, Conference & General Assembly 2017 
(Salamanca, ES)
24-25 Mar 2017 0,6
International Summer School: Ethical, legal & societal aspects of genome 
editing in agriculture (TTN, Munich/Schoenwag, DE)
02-06 Oct 2017 1,5
Entrepreneurship and how it works: workshop (Judge Business School, 
Cambridge, UK)
14-16 Jun 2017 0,9
Scientic writing (WUR, Wageningen, NL) Apr-Jun 2018 1,8
Negotiating workshop (WUR, Wageningen, NL) 28 Jun 2018 0,1
▶ Organisation of PhD students day, course or conference
Science week, outreach event (Cambridge, UK) 14 Mar 2015 0,3
NIAB open days (NIAB, Cambridge, UK) 23-25 Jun 2015 0,3
▶ Membership of Board, Committee or PhD council
Subtotal Personal Development 6,5
TOTAL NUMBER OF CREDIT POINTS* 52,5
Herewith the Graduate School declares that the PhD candidate has complied with the educational 
requirements set by the Educational Committee of EPS which comprises of a minimum total of 30 ECTS 
credits. 
* A credit represents a normative study load of 28 hours of study.
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is PhD was part of a program called “Maximising the potential of CROP 
researchers” (Max-CROP) which was a Marie Curie Industrial Training Network 
(ITN) nanced by the European Commission through the 7th Framework Program 
(FP7-PEOPLE-2013_ITN-607178). As part of this Program, the work was carried 
out at Plant Breeding, Wageningen University & Research, Wageningen, e 
Netherlands, as well as in the Department of Genetics & Pre-Breeding, National 
Institute of Agricultural Botany, Cambridge, e United Kingdom.
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